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The effect o f  ginger active component (Zerumbone) on human cancer cells
Abstract
Zerumbone, a sesquiterpene extracted from rhizomes of ginger {zingiber zerumbet 
Smith) is reported to have anti-proliferative activities and can induce toxicity in 
human cancer cells. However, its molecular mechanisms are still poorly understood. 
In this study, in vitro antioxidant (DPPH, H2O2 , Fe^  ^chelating and reducing power), 
apoptotic and anti-proliferative activities of zerumbone were investigated in human 
cancer cells. The specific objective was to identify whether zerumbone-induced cell 
death occurs through apoptosis, autophagy, necrosis or another form of cell death by 
undertaking morphological and biochemical characterisation. Human cancer cell line 
(Caco-2, Huh-7 and EA.hy926) viability and activity with time and in the presence of 
different concentrations of zerumbone were investigated using LDH. In addition, 
characterisation of cell death induced by different concentrations of zerumbone 
including changes in cell size, phosphatidylserine extemalization, caspase activation 
and PARP-1 involvement were studied. The results showed that cancer cell death 
occurred in the absence of DNA fi*agmentation and caspase activation at (5 pg/ml). 
Additionally, cancer cell death was characterised by cell shrinkage and an absence of 
necrotic cell death pathway. Anti-proliferative activity of zerumbone (5 and 10 
pg/ml) on human cancer cells was also investigated by changes in the DNA content 
using flow cytometry. Zerumbone showed significant anti-proliferative activity 
against human cancer cells by arresting the cells at different phase of the cell. Similar 
studies were done in normal colon cells (HCEC) and the results showed no or 
minimal effects. Zerumbone acted synergistically with an anti-cancer drug 
(Oxaliplatin and Cisplatin) to effectively kill cancer cells. In conclusion, the studies 
indicate that zerumbone may have potential therapeutic properties.
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1 General Introduction
The effect of ginger active component (Zerumbone) on human cancer cells_______________
1.1 Ginger
There is substantial literature on the use of medicinal plants to treat various ailments. 
Plants were initially used as part of the daily diet to prevent diseases (Braun and 
Cohen, 2010). Scientific investigations have confirmed many of these natural 
products to be safe (Betoret et al., 2011). The driving force behind the success of 
healthy nutrition is mainly due to consumer awareness (Losasso et al., 2012). Food- 
derived bioactive components may help to protect the consumer from chronic 
diseases (Betoret et ah, 2011). Such products, predominantly available in the 
market, include cinnamon, turmeric, cloves and ginger.
Ginger is a well-known herb used in cooking to add flavour and widely used in 
traditional medicines like Chinese medicine (Jiang, 2005). Ginger is known to 
possess various pharmacological activities, namely, antiemetic (Palatty et al., 2013), 
antioxidant (Masuda et al., 2004), anti-inflammatory (Grzanna et al., 2005) and anti­
cancer (Habib et ah, 2008).
The ginger rhizome consists of extractable oleoresins and waxes as well as, vitamins, 
minerals, phytochemicals, moisture, proteins, fats, fibre, ash, and carbohydrates. 
Ginger rhizome, whether fresh or dry, constitutes numerous elements depending on 
its place of origin. Its health-promoting attributes lie in its rich phytochemistry 
(Baliga er a/., 2011).
Langner et al. (1998) demonstrated that the organoleptic features of ginger are 
related to the presence of volatile oil and the non-volatile pungent compounds. Jolad 
et al. (2004) grouped more than 60 compounds found in fresh ginger into two 
broader categories; volatiles and non-volatiles. Onyenekwe and Hashimoto (1999)
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analysed the composition of essential oil in ginger using gas chromatography and gas 
chromatography-mass spectrometry techniques. The presence of volatile oil in ginger 
is responsible for its aroma and flavour and mainly consists of monoterpenes and 
sesquiterpenes. Monoterpene compounds such as curcumene, P-phellandrene, cineole 
and linalool, while sesquiterpene compounds such as Zerumbone, a-zingiberene, p- 
sesquiphellandrene and a-farmesene. On the other hand, the non-volatile pungent 
compounds consist of shogaols, zingerone, gingerols and paradols (Butt and Sultan, 
2011).
Belonging to the family of Zingiberaceae (ginger family). Zingiber zerumbet (L.) 
Smith (Z. zerumbet) is one of the important members of this family due to its high 
medicinal value (Yob et al., 2011). Z. zerumbet is a perennial, tuberous root herb 
plant that grows naturally in damp, shaded parts of the lowland or hill slopes, as 
scattered plants or thickets. It is commonly known as the pinecone or shampoo 
ginger because its inflorescence consists of the mucilaginous substance used as a 
shampoo and a natural conditioner by Hawaiians (Figure 1) (Sabu, 2003; Nalawade,
2003).
It also holds various names depending on the region, for example, in Arabic called 
Zurunbah, in Malaysia and Indonesia Lempoyang, in India Ghatian and Yaiimu, and 
in China called Hong qiu jiang (Yob et al., 2011). Although this plant is believed to 
be native to India and the Malaysian Peninsula, it is not certain where the plant had 
originated from because it has been cultivated for so long in a number of places 
throughout Southeast Asia, the Pacific, and Oceania. It has also been claimed that Z. 
zerumbet was introduced throughout the Pacific by the ancient Polynesian settlers 
(Vimala et al., 1999).
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1.1.1 General composition of Zingiber zerumbet ginger rhizome
In the past 25 years, USA Food and Drug Administration approved about 70% of the 
drugs that based on natural products (Yodkeeree et al., 2009). Rhizomes were 
extracted from Zingiber zerumbet by a silica column to extract non-polar components 
(Ahmad et ah, 1994). Oils extracted from Zingiber zerumbet leaves and flowers were 
found to be different from those obtained from rhizomes of Zingiber zerumbet 
(Chane-Ming et al., 2003). Being the core composition of rhizome oil of Zingiber 
zerumbet, the content of zerumbone was found to vary between 12.6 and 73.1% 
depending on the geographical locations it was obtained from (Kitayama et al., 1999; 
Chane-Ming et al. 2003; Dev, 2006).
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1.1.2 Zerumbone
Modem dmg discovery programmes are adapting the use of phytochemicals and their 
synthetic derivatives, in order to treat several human diseases including cancer (Liu,
2004). Besides the low side effects and cost effectiveness of phytochemicals, these 
natural compounds offer desirable properties for cancer therapy by dysregulation 
multiple of genes that responsible on cell signalling pathways (Wang and Chen, 
2013).
Zemmbone is one of these readily available natural products that found in Zingiber, 
zerumbet. Zemmbone has been investigated for its effective anticancer properties in 
different tumour models (Singh et ah, 2012). In this report, data obtained from in 
vitro and in vivo studies on the effect of zemmbone on molecular targets in cancer is 
discussed. The findings of the chemo-preventive/therapeutic effects in several cancer 
models are also covered.
1.1.2.1 Chemistry of zerumbone
Terpenoids consist of more than 25,000 members making it the largest class of 
secondary metabolites; zemmbone is one of such sesquiterpene. The molecular 
mechanism of zemmbone, in the literature, is explained by its ability to modulate an 
important molecular target array to prevent and treat cancer; although the exact 
molecular mechanism remains to be elucidated (Kitayama et al., 2001).
Zemmbone, is a cyclic eleven-membered sesquiterpene, consists of an isolated 
double bond at C6, and two double bonds at C2 and CIO that form part of a cross­
conjugated dienone system (Figure 2). This system lies in a slightly distorted plane
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perpendicular to the isolated double bond plane. The C6 double bond is located the 
furthest from the gem-dimethyl substituents at C9, and is thus found to be least 
hindered (Kitayama et al., 2001). The biological activity of zerumbone is governed 
by the a-(3 unsaturated carbonyl group at Cl (Kitayama et al., 2001).
CH
CH
Figure 2 Zerumbone chemical structure.
Obtained from Gupta et al. (2010).
1.1.3 Bioactive properties of Zingiber zerumbet
Various epidemiological studies explain the different pharmacological potentials of 
Zingiber zerumbet (Yob et al., 2011). Zingiber zerumbet rhizome exhibited anti- 
inflammatory (Zakaria, gt a/., 2011; Yang, 2012), antimicrobial (Kader gt a/., 2011), 
antioxidant (Nag gt a/., 2013), and anticancer (Zhang gt a/., 2012) at different doses 
and concentrations. The presence of zerumbone as a phytochemical compound in 
Zmgz6gr zgrwm6gt rhizome derived the current research to study the effect of this 
compound on the following activities.
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1.1.3.1 Anti-oxidant effect
The oxidative stress by ROS and nitrosative stress are driven by the excessive 
production of RNS (Valko et ah 2006). Cell structures, such as lipid membranes, 
proteins and DNA, are subject to significant damage caused by the key ROS and 
RNS elements, namely, superoxide anion radical (O2* ), hydroxyl radical (OH*), 
nitric oxide (NO) and hydrogen peroxide (H2O2) (Devasagayam et a l,  2004; 
Halliwell, 2007).
In in vitro tests on various cell free assay systems, ginger extract and its 
phytochemicals scavenged hydroxyl radicals and inhibited the formation of 
conjugated diene in oxidised fatty acid system (Stoilova et al., 2007). Oboh et al. 
(2012) suggested that the antioxidant properties of two different species of ginger are 
related to the ability of phytochemicals to scavenge hydroxyl radicals and to act as 
ferrous chelating. Zingerone (non-volatile pungent components in ginger) can 
significantly scavenge peroxynitrite radicals and hence protect cells from toxicity 
induced by this radical (Shin et al., 2005).
Murakami et al. (2002) found that zerumbone suppressed free radicals (superoxide 
anion) generated from NADPH oxidase, xanthine oxidase, the expression of iNOS 
(inducible nitric oxide synthase) and COX (cyclo-oxygenase)-2, and the release of 
TNF-a. Moreover, Ibrahim et al. (2012) found that zerumbone reduce renal 
dysfunction and organ damage through anti-oxidant glutathione preservation and 
lipid peroxidation preservation. The antioxidant activity of zerumbone is responsible 
for the activation of detoxification system enzymes in normal liver cell line 
(Nakamura et al., 2004).
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Chen et al. (2011) found that zerumbone may protect against UVB-induced 
cataractogensis, where lipid peroxides are reduced and endogenous antioxidant 
glutathione (GSH) level and glutathione reductase (GR) activity are enhanced.
1.1.3.2 Anti-angiogenesis
New blood vessels are formed from pre-existing ones during the process of 
physiological or pathological angiogenesis. The former is the driving engine behind 
organ development in ontogeny, necessary for ovulation, and it is essential for 
wound healing. In tumours, however, pathological angiogenesis take place at 
primary and metastatic sites (Folkman, 2007). During tumour development, the 
angiogenic cascade releases the angiogenic factors, binds them to receptors on 
endothelial cells (EC), activates ECs, degrades the basement membrane using 
proteases, and migrates and proliferate ECs. Sprouting blood vessels are then pulled 
forward through the adhesion molecules leading to the ECs organised into a network 
of new blood vessels (Fan et al., 2006). Various angiogenic mediators are involved 
in the complex signalling pathway of tumour angiogenesis. These signalling 
mediators mainly include epidermal growth factor (EGF), vascular endothelial 
growth factor (VEGF), platelet-derived growth factor (PDGF), fibroblast growth 
factors (FGFs) and angiopoietins (Gordon et al., 2010).
Angiogenesis-modulating properties were found in various nutraceuticals when one 
or more steps in the signalling pathway were targeted. For example, in response to 
VEGF, 6-gingerol (phytochemical compound) blocked capillary-like tube formation 
leading to strong inhibition in the formation of new blood vessels in mouse cornea as 
well as it inhibit the sprouting of endothelial cells in rat aorta were strongly inhibited 
(Kim et al., 2005). According to the role of angiogenesis in tumour development.
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antiangiogenic compounds such as bevacizumab (Avastin), sunitinib (Sutent), 
sorafenib (Nexavar), cediranib maleate (Recentin), and pazopanib have been 
developed (Gordon et ah, 2010).
1.1.3.3 Anti-cancer effect
It is known that a variety of distinct mechanisms are involved in the anti-cancer 
properties of phytochemicals (Lee et al., 2011). Most phytochemical activities do not 
execute a specific biological interaction but rather a multitude of intracellular effects, 
eventually leading to cancer prevention or treatment (Gupta et al., 2010). Tanaka et 
al. (2001) indicated the efficacy of zerumbone in colon and skin cancer prevention. 
The zerumbone study by Tanaka et al. (2001) showed that dose dependant oral 
feeding of zerumbone inhibited azoxymethane-induced colonic aberrant crypt foci in 
male F344 rat. Kirana et al. (2003) revealed that zerumbone inhibited the 
proliferation of HL-60 cell and human colon cancer cell (HT-29). Another research 
study found that dextran sodium sulfate-induced acute colitis in female ICR mice 
was suppressed by oral administration dose of zerumbone (Murakami et al., 2003). 
The range of colonic adenocarcinoma in male ICR mice, initially induced with 
cancer produced from a single injected dose of azoxymethane and colitis-inducing 
agent dextran sodium sulphate, was found to be significantly inhibited by oral 
administration of zerumbone at different concentrations (100, 250 and 500 ppm in 
diet) (Kim et ah, 2009). The proliferation of human colonic adenocarcinoma cell 
lines was inhibited by zerumbone in a dose dependent manner, however, a smaller 
effect was observed on the growth of normal human dermal and colon fibroblast 
(Nakamura et al., 2004).
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Takada et al. (2005) reported that zerumbone suppressed carcinogen induced 
activation of NF-kappa p in human lung carcinoma H I299 cells, and concluded that 
cancer prevention and treatment may be possible through this inhibition. Oral 
administration of zerumbone at concentrations of 250 and 500 ppm showed 
significant inhibition of the range of lung adenomas in female A/J mice with 4-(N- 
methyl-N-nitrosamino)-1 -(3-pyridyl)-1 -butanone-induced lung tumours (Kim et ah, 
2009). Feeding of zerumbone has proved its suppression of cell proliferation, 
apoptosis and suppression of NF-kB and HO-1 proteins.
Studies on animal models with inflammation and cancer showed that zerumbone 
inhibits their tumour growth. It was also seen that the levels of inflammatory 
biomarkers IL-ip, TNF-a and prostaglandin E2 in the mouse colonic mucosa were 
lowered in the presence of zerumbone. Zerumbone has not only been considered for 
modulating many inflammation-related molecular targets, but also for chemo- 
prevention against chronic inflammation such as colorectal and lung cancers (Xie 
and Itzkowitz, 2008).
The suppressive effect of zerumbone on the tumour initiator 7,12- 
dimethylbenz[a]anthracene (DMBA) and TPA-induced initiation and promotion of 
skin tumours in ICR mice were subsequently noted (Murakami et al., 2004). TPA- 
induced COX-2 expression and phosphorylation of ERKl/2 were also suppressed in 
the mouse skin. Moreover, dermal infiltration and leukocyte maturation induced by 
TPA, in addition to the formation of skin tumours, in mice were found to be 
suppressed by zerumbone (Murakami et al., 2004). Murakami et al. (2004) study 
reveals that zerumbone may be able to contribute to the prevention of skin cancer
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after oral administration (1.6 or 16 nM in 100 pi of acetone), addressing the 
associated metabolism and absorption issues.
Zemmbone has been reported as a potential dmg for treating leukaemia and several 
cancer diseases (Kirana et al., 2003; Murakami et al., 2004; Xian et al., 2007). 
Huang et al. (2005) treated human leukaemia cell lines (HL-60) with zemmbone 
observed a time and concentration dependant induction of G2/M cell cycle arrest in 
HL-60 cells. In addition to decreased level of cyelin B1 protein by zemmbone. Xian 
et al. (2007) found that induction of Fas receptors gave zemmbone its efficient 
cytotoxic effect on leukaemia. Histological examination showed that leukocyte 
infiltration suppression and the reduction of proliferating cell nuclear antigen- 
labelling indices were achieved through zemmbone pre-treatment (Xian et al., 2007).
Abdul et al. (2008) observed that cell proliferation of human cervical cancer cells 
(HeLa) were inhibited by zemmbone in a dose dependent manner. Experiments 
performed on female Balb/c mice, prenatally exposed to diethylstilbestrol (DES), 
indicated that its cervical intraepithélial neoplasia was suppressed with zemmbone 
treatment at a similar efficacy to that of the anti-eaneer dmg cisplatin (Abdelwahab 
et al., 2010). Zemmbone was also found to reduce the expression of the proliferating 
cell nuclear antigen (PCNA), the over-expression of pro-apoptotic protein Bax and 
the suppression of the Bel-2 specific mRNA expression, in a dose dependant manner. 
It is therefore concluded that zemmbone has a comparable effect to that of cisplatin, 
and thus providing an intriguing alternative for cervical cancer treatment.
Sung et ah, (2008) reported a dose and time dependant down regulation of the
expression of CXCR4 and HER2-overexpressing breast cancer cells caused by
zemmbone. Chung et al. (2008) found that rhizomes of Zingiber zerumhet have
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histone deacetylase (HDAC) inhibitors capable of proliferation inhabitation and 
inducing differentiation or apoptosis of tumour cells in vivo and in vitro (MDA-MB- 
231 breast tumour cell line). In vivo tests on animal models indicated that various 
types of these histone deacetylase inhibitors provide a potent anti-tumour efficiency 
at very low levels of toxicity. An inhibitory activity was observed on in vivo 
experiments evaluating the effect of such inhibitors against HDAC enzyme assay.
Little cytotoxic and genotoxie effects were found to be exerted by zemmbone at 
doses considered by several studies. For example, Al-Zubairi et al. (2010) found that 
after the intraperitoneal administration of zemmbone, the lethal dose was determined 
at a high level of 2000 mg/kg b.wl. Similarly, no toxic effects were observed in the 
liver and renal tissues of female Sprague Dawley rats at 100-200 mg/kg b.wl doses 
of zemmbone. Tests on diethylnitrosamine (DEN) (single injected dose) and dietary 
2-acetylaminofluorene (AAF)-induced liver tumours in rats demonstrated the anti- 
tumorigenie effects of zemmbone. An in vitro study of the mechanisms of 
zemmbone inducing apoptosis in the hepatoearcinoma cells was performed on a well 
differentiated transformed cell line HepG2 cells (Sakinah et al., 2007). This type of 
cell line has been often considered as a good sample for liver cancer research. 
Zemmbone administration was reported to lower serum levels of alanine 
transaminase (ALT), aspartate transaminase (AST), alkaline phosphatase (AP) and 
alpha-fetoprotein (AFP). It was also found to reduce glutathione level in hepatic 
tissues and PCNA expression in rat liver sections. The protection of rat liver from 
carcinogenic effects of DEN and AAF was also found possible using zemmbone 
(Taha et al., 2010). Zemmbone was reported to exert potential chemo-preventive 
activity against the carcinogenic nitrosamine-initiated and 2-acetylaminofluorene (2-
12
The effect of ginger active component (Zemmbone) on human cancer cells
AAF)-promoted hepatocarcinogenesis (Taha et ah, 2010). To this end, it is clear that 
zemmbone has a therapeutic potential in preventing and treating tumours at its early 
and developed stages.
Hoffman et al. (2002) emphasised that the effect of zemmbone in controlling the 
growth of normal and cancer cells is mediated by the a, p-unsaturated carbonyl group 
and to be the source of the effect. Previous studies focusing on the chemo-preventive 
and chemotherapeutic effects of zemmbone were tested in vitro, while in vivo effects 
have not extensively been investigated.
1.2 Human Cancer
Cancer is a disease which occurs as a result of abnormal growth and changes in 
normal cells. The unregulated growth develops into a lump which becomes tumour. 
Lack of treatment of the tumour could lead to one or more health problems such as 
the spread of the tumour to neighbouring healthy tissues, increased pressure on the 
body stmetures and spread of the tumour to other parts of the body via the lymphatic 
system or bloodstream (Siegel et al., 2012).
There are over 200 types of body cells in the body hence the types of cancer 
available are equivalent to this number. Although different body cells perform 
different roles in the body and have different stmetures (for instance, nerves and 
muscles perform different function and thus are stmeturally different) the basic 
composition of the nucleus and genes is the same (Alberts et al., 2013).
Tumours can either be cancerous (malignant tumour) or non-eancerous (benign 
tumour). Benign tumours consist of cells akin to normal cells; these cells grow at a
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very slow rate, do not spread to other parts of the body and will only become a cause 
of concern if they become very large. On the other hand, malignant tumours consist 
of cancer cells that grow at a faster rate than benign tumour cells, and destroy 
neighbouring tissues and spread to other parts of the body (Alberts et al., 2013).
The place of origin of cancer is termed primary cancer however when spread into 
nearby tissues it is called locally advanced cancer. The mode of transport of cancer 
systems from its primary source to other parts of the body is via the bloodstream or 
through the lymphatic system. A new tumour which breaks away from its primary 
source is termed métastasés or secondary cancer (Rodriguez-Paredes and Esteller, 
2011).
The rate of growth of cancer, the undesirable chemicals it produces, its mode of 
dissemination and its response to any particular treatment is dependent upon the type 
of cell from which the cancer developed. For normal body cells, there are certain 
important features; normal cells can produce an exact replica of themselves, halt 
reproduction at the appropriate time, bind together appropriately, self-destruct when 
damaged and can mature or become specialised (Stratton, 2011) . Cancer cells, on 
the other hand, do not die, do not stop reproducing when transported to another part 
of the body, do not obey other cell signals, do not stick together, do not mature or 
specialise and lose a couple of vital control systems (Stratton, 2011).
Cancer is due to mutation is caused by a gene that is faulty or lost and the cell over
produces or does not produce protein. Proteins act as building blocks of a cell and
are secreted within it. Thus they act as on and off switches that command cell
behaviour. For instance, when a hormonal signal acts on a protein, the latter which is
either within or on the cell instructs the cell to reproduce via cell division by sending
14
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it a series of signals. In sueh cases, the signalling protein can be permanently 
switched on. However, a protein which controls and limits cell division may be 
permanently switched off (Behl and Ziegler, 2014).
Carcinogen is the term used to describe a substance that damages cells and makes it 
more likely to be cancerous. For example, carcinogens can be found in cigarette 
smoke (Xi et al., 2013). Three types of genes are essential to make a cell cancerous. 
These are 1) oncogenes, genes that encourage cell multiplication, 2) Tumour 
suppressor genes, genes that stop cell multiplication and 3) DNA repair genes, genes 
that repair damaged DNA (Vogelstein and Kinzler, 2004; Sharma et al., 2010; Lahtz 
and Pfeifer, 2011).
The continuous growth or cell division of the cancer cells leads to each cell doubling 
as it divides. As a result, the larger the tumour the farther away its centre is from the 
blood vessel within the vicinity of its growth and the lesser the oxygen and nutrients 
it has access to. Subsequently, in order to survive, it grows its own blood supply. 
This process of growing its own blood vessels is termed angiogenesis (Eilken and 
Adams, 2010).
Scientists in the field of tumour growth have suggested that a tumour begins to 
develop its own blood vessel once it is about the size of pin head. It is said that blood 
vessel growth occurs by stimulation of normal cells in order to produce angiogenic 
factor which facilitates angiogenesis. Normal cells can enable the growth of a new 
blood cell when it repairs damaged tissues which have resulted from wounds. That is 
the blood vessel can grow when a wound is healing. More specifically, genes which 
produce angiogenic factors switch on blood vessel growth while genes that produce 
antiangiogenic factor do the opposite (Eilken and Adams, 2010).
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However, a growing cancer should not be confused with carcinoma in situ. 
Researchers interested in angiogenesis have stated that the main difference between 
these two is their ability to grow a new blood vessel. It is suggested that carcinoma in 
situ may be dormant and thus does not spread. However, at some point, it may 
stimulate the growth of capillaries (tiny blood vessels) and thus spreads the cancer to 
surrounding body tissues. The possible explanation for this dormancy could be 
attributed to an imbalance between permanent switch on of angiogenies and 
permanent switch off of antiangiogenic genes. Nonetheless, once the cancer is able to 
stimulate blood vessel growth, it will grow bigger and faster and will trigger the 
growth of hundreds of new capillaries from surrounding blood vessels to survive 
(Lee et al., 2012).
It has also been stated by scientists that angiogenesis play a vital role in the spread of 
cancer. Findings suggest that newly developing capillaries release substances which 
facilitate the detachment of cancer cells from its primary cancer and into the 
bloodstream. Thus making it possible for the cells to travel and start growth 
elsewhere in the body. Angiogenesis may also proffer an explanation for the reason 
secondary cancer outgrows primary cancer (Carmeliet and Jain, 2011).
At the same time, mutation could cause blood vessel growth much later. 
Consequently, a secondary cancer develops rapidly and grows large enough to be 
detected by a scan. Furthermore, it has been observed that angiogenic factors are 
present in the tumour edge and anti-angiogenic drugs may halt the growth of cancer 
into surrounding areas but not necessarily completely get rid of cancer (Carmeliet 
and Jain, 2011). In other words, it may reduce its size or stop its growth in certain 
eases. Examples of anti-angiogenic drugs which have been tested and found to
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dismpt blood vessel growth include Interferon alpha, bevaeizumab (Avastin) and 
Thalidomide. It should also be noted that only newly growing blood cells are 
affected by anti-angiogenie factors and not normal blood cells (Carmeliet and Jain,
2011).
1.2.1 Cancer incidence, survival and mortality
Cancer incidence is a measure of the number of people that get any specific kind of 
cancer annually and is expressed as the number of cancer cases per 100,000 people in 
the general population. It is calculated for every type of cancer. For instance, 
calculations conducted in the UK in 2011 shows that 18,410 (per 100,000) women 
were diagnosed with bowel cancer, while 23,171 (per 100,000) men were identified 
with bowel cancer. In general, more than 331,000 people were diagnosed with cancer 
in the UK in 2011. Other ways of utilising incidence include age group incidence and 
country incidence (Cancer Research UK, 2014).
Another measure different from incidence is prevalence. Prevalence is defined as the 
number of people that have ever had a cancer diagnosis and are still alive, at a 
particular time. The criteria are that some of these people may have had cancer ages 
ago and were cured and others might be more recent. Unlike incidence, prevalence 
(survival) statistics are expressed as a 5 year or 10 year survival .Based on this 
definition; the most common cancers are known to have high survival rate, testicular 
cancer for male (97%) and malignant melanoma for female (92%) (Cancer Research 
UK, 2014). However, the 5 years survival rate for colon cancer is 54.4% for male 
and 55.1% for female.
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The third measure that could be adopted is termed mortality statistics. This basically 
means the number of deceased patients with a particular kind of cancer in annually. 
There were 159,178 deaths from cancer in the UK in 2011. Bowel caneer is the 
second most common cause of cancer death (10%), 8520 in male and 7139 in female. 
Mortality alone, gives very little meaning. However, when used with ineidence or 
other figures it becomes more useful. This is because changes in mortality figures are 
hard to interpret over a period of time. For example, incidence of a cancer may be 
failing and thus fewer people die as a consequence of it or there might be 
advancement in treatment (this could mean cure or that more people live longer after 
cancer diagnosis) hence more people are cured. Consequently, the mortality statistics 
will fall in short terms (Siegel et a l, 2014).
1.2.2 Human Cancer therapy
Conventional caneer treatments include chemotherapy, radiotherapy, surgery, 
hormone therapy and biological therapy as well as stem cell transplants (Guimaraes 
et al, 2011). Although complementary and alternative therapies exist, this thesis will 
only focus on chemotherapy.
Chemotherapy literally means treatment of diseases with drugs. In cancer treatment, 
it refers to treatment with cell killing (cytotoxic) drugs. Chemotherapy damage DNA 
in cells and disrupts cell division. The stage at which the cells are damaged depends 
on the type of drugs used. For example, some drugs eause damage during eell 
splitting; others eause damage prior to eell splitting while the cells make copies of all 
their genes (Kaufinann and Eamshaw, 2000).
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Cytotoxic effect of these drugs eould be done by using just one or a combination of 
different chemotherapy drugs, however with the use of combination more eells are 
killed (Kaufinann and Eamshaw, 2000). There are over 100 different chemotherapy 
dmgs with different side effects. The common side effeets occur such as fatigue, 
nausea and vomiting, hair loss, increased risk of infection, anaemia, bmising, 
bleeding, mueositis, diarrhoea, constipation, depression and loss of appetite. 
Moreover using chemotherapy dmgs cause skin and nails problems, sleep problems 
as well as sexuality and fertility problems, (Carelle et al., 2002). It is also possible to 
eombine chemotherapy dmgs with other cancer treatment such as radiotherapy, 
surgery, hormone therapy and biological therapy (Guimaraes et al, 2013).
1.2.3 Cancer cell death
An irregular balanee between cell proliferation and eell death results in cancer. 
Cancer cells can die by either necrosis or programmed cell death. Programmed eell 
death can be classified into autophagic cell death and apoptosis (Ouyang et a l, 
2012). Any fault in the processes controlling programmed cell death (PCD) will 
extend the life span of cells that participate in tumour initiation and cancer formation 
(Fuchs and Steller, 2011).
1.2.3.1 Apoptosis
Apoptosis is characterised by rounding-up of cells, cell shrinkage, chromatin 
condensation and nucleus fragmentation, slight variation in cytoplasmic organelles, 
blebbing and apoptotie bodies formation that contain nuclear or cytoplasmic material 
(Figure 3), (Kerr et a l, 1994). It is insufficient to only use biochemical analyses like 
DNA ladders to define apoptosis, because DNA ladder can occur without
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oligonucleosomal DNA fragmentation. Further indication is the fact that actively 
suppressing DNA fragmentation or easpase activation does not affect the execution 
of cell death program (Loo, 2011).
A different approaeh is to use 'apoptosis with’ or ‘apoptosis without indications o f  
easpase activation. It may be reasonable to use the former approach, because easpase 
aetivation can help diagnose and better describe cell death type. It is well known that 
apoptotie cell death is habitually aecelerated by or dependent on easpase activation at 
the biochemieal level (Kerr et ai., 1994).
1.2.3.2 Necrosis
Although neerosis is sometimes mistaken for apoptosis, the main differenee is the 
processes of cellular debris disposal whose eonsequences do not damage the 
organism (Kerr et al., 1994). Necrosis is usually given a negative connotation 
because it is defined independent of any signs of apoptosis or autophagy. In other 
words, it is seen as a type of eell death whieh cannot be controlled. Necrosis is 
morphologically exhibited as oneosis, a term described by researchers as an increase 
in cell volume, cytoplasmic swelling, meehanical plasma membrane rupture, dilation 
of eytoplasmie organelles (mitochondria, endoplasmic recticulum and Golgi 
apparatus) and a reasonable condensation of chromatin (Figure 3) (Weerasinghe and 
Buja, 2012).
Reeent research showed that necrosis can be a series of regulated proeess or events 
whieh supports the growth and maintenance of organismal homeostasis. Thus modes 
of non-apoptotic eell death, a term which describes aspects of programmed cell 
suicide), have been described by terms including, oncosis (Weerasinghe et ah, 2013),
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pyroptosis (Miao et ah, 2010), necrapoptosis (Nordberg et al., 2010), and necroptosis 
(Degterev et al. 2005; Vandenabeele et al., 2010).
Apoptosis
(cell shrinks, chromatin condenses)
"Budding"
Viable / T x #
Apoptotie Bodies 
are phagozytosed; 
no inflammation
Necrosis
(cell swells)
Cellular and nuclear 
Cell becomes leaky, lysis causes inflam*
blebbing mation
Figure 3 Apoptotie versus necrotic morphology.
Obtained from Van Cruchten and Van den Broeck, (2002).
1.2.3.3 Autophagy
Autophagic cell death refers to the process of formation of vacuoles that transport 
organelles and cytoplasmic content to lysosomes for degradation (Kolinsky and Emr, 
2000). Autophagy is a word of Greek origin, which means ‘eating of self and was 
first described by Christian de Duve over 40 years ago. In recent years, several 
laboratories have made considerable contributions towards the description and 
understanding of autophagy at the molecular level and towards the appreciation of its 
physiological significance.
The process of autophagy starts with an isolation membrane known as a phagophore. 
Although its exact origin in mammals is contentious, this membrane is possibly
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originates from the lipid bi-layer of the endoplasmic reticulum (ER) and/or trans- 
Golgi and endosomes (Kolinsky and Emr, 2000). It absorbs intracellular substances 
like protein aggregates, organelles and ribosomes by expanding and as a result it 
isolates these loads in a double-membraned autophagosome. The latter fuses with 
lysosome in order to mature and supports the degradation of autophagosomal 
contents by lysosomal acid proteases (Dunn, 1990).
The amino acids and by-products of the degradation are then carried out to the 
cytoplasm by lysosomal permeases and transporters. Thus in the cytoplasm, the 
products of degradation can be reemployed for building macromolecules and 
metabolism. As a result, autophagy can be seen as a cellular ‘recycling factory’ that 
encourages energy efficiency through ATP generation and facilitates damage control 
via the removal of non-functional proteins and organelles (Dawson and Cho, 2000).
Autophagy process (Figure 4) has been identified with six main stages: 1) 
phagophore formation or nucléation; 2) conjugation of Atg5-Atgl2 (Autophagy 
protein 5and 12) followed by multimerisation at the phagophore; 3) insertion of LC3 
(microtubule-associated protein 1 light chain 3) into the extending phagophore 
membrane; 4) autophagosome formation which, capture random or selective targets 
for degradation; 5) fusion of the autophagosome with the lysosome; and 6) 
degradation of engulfed molecules by lysosomal proteases (Behrends et al, 2010).
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Figure 4 The process of autophagy
Obtained from Medical and Biological Laboratories (2013).
In LC3 processing, the subsequent system, similar to the ubiquitin that deals with 
auto-phagosome creation is the handling of microtubule-linked protein light chain 
3 (LC3B) concealed by the Atg8 mammalian homologue (Behrends et al, 2010). 
The LC3B can be found in most kinds of cells and it is a complete-dimension 
cytosolic protein, if autophagy-stimulated, will be proteolytically cut by Atg4, a 
cysteine protease, for the development of LC3B-I. The triggered LC3B-I Is later 
transmitted into the Atg3, a diverse E2-like carrier protein prior to the fusion/union 
of the phosphatidylethanolamine (PE) to the carboxyl glycine for the development of 
administered LC3B-II. In the process of autophagy, LC3 processes and production 
grows, creating cmcial information of the autophagy status in cells (Behrends et a l, 
2010).
1.2.3.4 Necroptosis
The main characteristic of tissue homeostasis, normal development and several types 
of diseases is programmed cell death (PCD). Traditionally, PCD is perceived as 
caspase-instigated apoptosis whereas necrosis is understood as an unintended, 
undesirable, unregulated cell death, a consequence of severe conditions (Bursch et
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al, 2000). However, as previously stated, this is not the case. Thus, necroptosis is a 
term that describes a receptor-induced, caspase-independent and highly regulated 
type of programmed cell death (Christofferson and Yuan, 2010). It is a type of cell 
death process which is morphologically similar to necrosis. Recent research has 
attributed necroptosis aspects of several forms of pathological cell death such as 
ischemic brain injury, neurodegenerative diseases and viral infection. An 
understanding of necroptotic signalling machinery is clinical relevant (Christofferson 
and Yuan, 2010).
In a specific term, necroptosis is a mechanism of necrotic cell death caused by 
external factors; this related to the death domain receptor (DR) and TNF-alpha, Fas 
ligand (FasL) and TNF-related apoptosis-inducing ligand (TRAIL). This happens 
when apoptotie cell death path way is blocked, e.g. by easpase inhibitors. Although 
necroptosis pathway is induced in regulated conditions, shows similar morphology to 
that shown by unregulated necrotic death (Degterev et al, 2005).
It is evident from recent research that a continuum of apoptosis and necrosis are 
responses to a given death stimulus. Apoptosis is induced at low doses while necrosis 
is induced at high doses due to many insults. It has also been confirmed that in 
response to specific doses of death-induced agents, certain features of apoptosis and 
necrosis can exist together in the same cell. Furthermore, where phagocytosis does 
not occur and as a result, the neighbouring cells or cell cultures do not surround the 
dead cells, the latter in the final stages of apoptosis could have necrotic features as a 
result of reduction of energy and plasma membrane integrity; this is referred to as 
apoptotie necrosis or secondary necrosis (Christofferson and Yuan, 2010).
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1.2.3.5 The role of cell cycle in cancer cell death
Mammalian cells contain DNA which is constantly being attacked by damaging 
agents. These agents either causes the one of the three million bases to fail or it 
destroy the phosphodiester backbone on which the bases exist (Kastan and Bartek, 
2004). An example of agents which destroy the base and causes the DNA to fail is 
the oxygen free radical which may be created by exposure of organisms to external 
sources of ionising radiation in the environment or as a result of normal cellular 
metabolism. However, there are sophisticated mechanisms that can repair damaged 
DNA arising from metabolic free radicals or external damaging agents (Kastan and 
Bartek, 2004).
Several repair mechanisms have been developed by cells to combat persistent attacks 
on DNA by damaging agents, for example is the DNA-repair process. These 
mechanisms depend on the type of lesion or injury that occurs. Cells also respond to 
DNA damage by stopping progression of the cell-cycle till DNA replication or 
mitosis can be assured (this is called cell-cycle checkpoint, after which cells 
irreversible proceed to the next stage) or by programmed cell death (PCD) (Hartwell 
and Weinert, 1989; Moniz et al., 2011). Therefore, the study of the response of cells 
to DNA damage is a crucial in the search for anticancer drugs. Therefore, the current 
research focused on the molecular connection between cell viability, cell toxicity and 
cell division cycle.
Eukaryotic cell cycle comprises of four discrete phases named Gap 1 phase (Gl), 
synthesis phase (S), Gap 2 phase (G2) and mitosis phase (M). The Gl phase is 
characterised by cell preparation for DNA synthesis. The S phase, which follows, is
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defined by DNA duplication. Prior to the process of mitosis in which a cell separate 
into two daughter cells, cells continue to grow and hence prepared for cell division in 
the G2 phase. It should be noted that at the GO phase, the cell cycle is inactive 
(Figure 5) (Hartwell and Kastan, 1994).
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Figure 5 The cell cycle phases.
The cell cycle phases (A) and D N A  histogram  (B). O btained from  Tabll and  Ism ail (2011).
Cyclin-dependent kinases (CDKs), a family of serine/threonine protein kinases are a 
key protein which enables transition between cell cycle phases. These proteins are 
activated at specific points during cell cycle. CDK activities are positively regulated 
via association with cyelin (a second subunit) and phosphorylation of the T-loop 
threonine via a CDK-activating kinase. In each phase of cell cycle, specific cyelin 
activates specific CDK via complex formation (van den Heuvel and Harlow, 1993).
The following provides information of the different types of cyclins and the phases 
in which they occur (Figure 6). Cyclins D l, D2 and D3 are induced in GO phase and 
stimulated to enter the cell cycle. In G 1 phase cyelin D form a complex with CDK4 
and CDK6. Furthermore, cyelin E which activates CDK2 is known to occur during 
transition from Gl phase to S phase. In S phase, cyclin A is activated and forms a
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complex with CDKl and CDK2. Cyclin B occurs during exit from G2 phase and 
mitosis phase and it is associated with CDKl (Grana and Reddy, 1995). Although 
cyclin activation levels differ at various phases of the cell division cycle, CDK 
protein levels maintain stable (Vermeulen et al., 2003).
Furthermore, the dual nature of cyclins as pro-apoptotic and anti-apoptotic protein 
should make it possible to use its pro-apoptotic potential to selectively activate 
programmed cell death in cancer cells (Vermeulen et al. 2003). However this is a 
theoretical suggestion which is yet to be confirmed practically. Thus, an extensive 
understanding of the roles of cyclins will lead to major scientifie advances in cancer 
treatment. The ability to strategize and design innovative anti-cancer agents requires 
insight into mechanism responsible for dysregulation in cell division. This is because 
any fault in the regulation of cell cycle process can lead to abnormalities and cancer 
growth.
rclln
CDK2
rclln
CDK2
CDKl
rclln
CDK6
Figure 6 Cyclin-dependent kinase (CDK) regulation.
Obtained from Vermeulen et al. (2003).
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1.2.3.6 The role of ROS in cancer cell death
Reactive oxygen species are oxygen embodied compounds class which contain 
responsive organic properties, free radicals like peroxyl (ROO ), hydroxyl (HO ) and 
superoxide (O2 ~) radicals. Free radicals are characterised by presence of one or more 
unpaired electron in their chemical structures (Apel and Hirt, 2004).
Within the body system, the continuous generation of ROS is via different ways 
comprising reactions that are enzyme-mobilized and non-enzymatic ones. Oxidative 
phosphorylation processes that occur in mitochondria involve the distribution of 
electrons in respiratory systems. In this system, a proton gradient is formed through 
the inner mitochondrial membrane in order to produce energy for ATP synthesis 
(Alberts (3/., 2013).
Superoxide creation/production is a crucial biochemical incident within the 
metabolic process. The electron discharge from this transport chain, mostly from 
complex I and III, and its combination with oxygen forms the superoxide radical. 
Also, approximately 2% of the consumed oxygen forms superoxide is consequently 
converted to hydrogen peroxide (Alberts et al., 2013).
Aside from the observation of dominant ROS stress within an extensive range of 
human cancer, the exact mechanism responsible for ROS stress is still undefined. 
The dynamic stability regarding the procedures for forming and reducing ROS 
determines the cell’s level of oxidative stress (Lin and Beal, 2006). The constant 
formation of superoxide radicals during respiration and its ability to be transformed 
into H2O2 and other ROS occurs mainly in the mitochondria (Turrens, 2003). Thus
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mitochondria playing a crucial role in ROS stress within cancer cells (Wallace,
2012).
Furthermore, the production of ROS can be through a group of membrane-bound 
enzymes like NAD(P)H oxidases, known to have an effect on cell proliferation and 
apoptosis (Griendling et al., 2000; Ushio-Fukai and Alexander, 2004). Different 
possible mechanisms have contributed to the increasing rate of ROS within cancer 
cells. For instance, the oncogenic signals have been known to intensify ROS 
generation and subsequently stimulate DNA damage and reduce p53 function (Vafa 
et al., 2002).
Mitochondrial respiratory chain breakdown is an alternative means through which 
cancer cells are known to increase ROS quantities. Meanwhile, the mitochondrial 
DNA (mtDNA) codes for 13 mechanisms of the respiration complexes are without 
introns and transformations of mtDNA might have an effect on the task of its coded 
proteins, leading to the failure of the mitochondrial respiratory chain. mtDNA was 
found to be more susceptible to destruction than nuclear DNA (Copeland et al., 
2002; Carew et al., 2003; Kumimoto et al., 2004).
It was also argued that changes in mtDNA are often found in cancer cells. There are
indications that cellular cancers are innately under increased ROS stress resulting
from different complex factors. Oncogenic signals, dynamic energy breakdown
connected to uncontrolled development of cells, and failure of the mitochondrial
respiration related to mtDNA modifications are likely to provide increased ROS
development within cancerous cells. However, increase in ROS stress in cancer cells
can offer a biochemical foundation to create new beneficial ways of eradicating
cellular cancer using drugs. The management of ROS might include using
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treatments that openly intensify ROS creation, or prevent antioxidant defences, or 
combinations of the two agents. This may help to expand the selection of drugs 
and/or find a way to avoid resistance to conventional chemotherapy agents (Carew et 
al, 2003).
1.3 Conclusion
Zemmbone, a sesquiterpene extracted from rhizomes of ginger {zingiber zerumhet 
Smith) is reported to have anti-proliferative activities and can induce toxicity in 
human cancer cells. However, its molecular mechanisms are still poorly understood. 
Therefore, the aims of this study are:
1. To attempt to identify zemmbone in {Zingiber officinale Rose) ginger.
2. To evaluate the antioxidant properties of zemmbone.
3. To assess the effect of zemmbone on the human colon adenocarcinoma Caco- 
2 cell line.
4. To study the effect of zemmbone on the human liver hepatoma Huh-7 cell 
line.
5. To investigate the effect of zemmbone on the human endothelial cell line 
EA.hy926.
6. To assess the synergistic effects of zemmbone and chemotherapy agents in a 
human cancer cell line.
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2 Identification of zemmbone in 
ginger from the UK and the USA
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2.1 Introduction
Zemmbone is a cyclic eleven-membered sesquiterpene, found in the wild ginger 
rhizomes of the tropical plant Zingiber zerumbet Smith, which belongs to the ginger 
family Zingiberaceae. This ginger family contains numerous other species such as 
(Zingiber officinale Rose) the most commonly known type of ginger (Butt and 
Sultan, 2011).
It should be noted that HPLC, LC-MS and GC-MS were previously used to identify 
and detect ginger components, in general, and to detect zemmbone in particular. For 
example. Bid et al., (2010) used HPLC to verify zemmbone levels in human plasma. 
However, to the best of our knowledge, no previous research has attempted to detect 
zemmbone in ginger (Zingiber officinale Rose), although this ginger species is 
commonly used worldwide in the human diet.
2.1.1 High-performance liquid chromatography (HPLC)
High performance liquid chromatographic (HPLC) method was used by Chang et al. 
(2012) to confirm the components of the rhizomes of Zingiber zerumbet (L.) Smith, 
Taiwan. HPLC method was also conducted for the analysis of zemmbone in human 
plasma, where zemmbone was easy to detect by this method (Bid et al, 2010).
Bedawey et a l (2010) used HPLC in the separation and identification of phenolic 
compounds from plant sources such as Sesame {Sesamum indicum L.), Rice bran 
{Oryza sativa), guava seeds and leaves (Psidium guajava L.), orange peel 
{Citrusaurantium), wheat germ {Triticum aestium) and ginger roots {Zingiber 
officinale L.). Wang et al. (2011) used HPLC to analyse the gingerol-related
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compounds in fresh ginger, where 25 gingerol-related compounds were identified 
from fresh ginger. Chen and Sang (2012) also used HPLC to identify the phase II 
metabolites of thiol-conjugated [6]-shogaol from ginger {Zingiber officinale Rose) in 
mouse urine.
The four main components of a standard HPLC system are a pump and sample valve, 
a stationary phase, a mobile phase, and a detector(s) (MacNair et al., 1997). The 
pump generates a pressurised liquid causing a constant flow rate through each 
column in order to separate sample components. Sample valves, tolerating pressures 
up to 10,000 p.s.i, are placed between the pump and the column. A combination of 
water and organic solvents such as methanol or acetonitrile form the mobile phase 
and move through the stationary phase. The column consists of micro particles 
packed into a thin tube (column) and represents the stationary phase of the HPLC 
(MacNair et al., 1997). The most commonly used columns are composed of a 
chemically modified silica stationary phase whose polarity is determined by a 
specific chemical (e.g. C l8 BEH, CIS Monolithic, C4 and C8 columns) (Kim et ah, 
2007). Since these types of columns differ in diameter, length, housing materials, 
advantages and shortfalls, it is necessary to use the appropriate type according to the 
analytical properties and requirements.
Depending on the nature of the sample, interactions with the column and the solvents 
of varying strength/affinity take place (MacNair et al., 1997; Nufiez et al., 2005). A 
crucial step for the analysis is the hydrophobic interactions between the mobile phase 
of reversed phase liquid chromatography (RP-LC) and the alkyl chains of the column 
material (C l8, C8 and C4) (Frohlich and Arnold, 2006). In the RP-LC system.
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columns contain a more polar mobile phase than the stationary phase, and analytes 
with greater polarity elute faster than the less polar ones (Yamane, 2002).
2.1.2 Liquid chromatography-mass spectrometry (LC-MS)
Determining atomic composition, and identifying natural products and new 
molecular entities important to food identification from biomolecules is possible 
through mass spectrometry (MS). In fact, several MS techniques have been used to 
characterise products ranging from small-synthetic to large molecules, as described 
below.
Liquid chromatography-mass spectrometry (LC-MS) was used to identify 
zemmbone in the rhizomes of Zingiber zerumbet Smith, Taiwan (Change et al, 
2012). LC-MS method was also used by Bid et al. (2011) in the determination of 
zemmbone in human plasma as a rapid, sensitive, specific and selective method.
He et al. (1998) performed LC-MS analysis to identify the pungent constituents of 
Zingiber officinale Rose ginger extract, where seven major pungent constituents of 
ginger were identified including [6]-gingerol, [6]-shogaol, and [6]-gingediol.
Jiang et al. (2005) also used LC-MS to investigated gingerol-related substances in 
ginger rhizome (Zingiber officinale Rose.). Kim et al. (2012) also used LC-MS as a 
rapid and sensitive method to quantify of [6]-gingerol from the rhizome of Zingiber 
officinale in mouse plasma.
Electro Spray Ionisation (ESI) and Matrix-Assisted Laser Desorption Ionisation 
(MALDI) are the most commonly used techniques for generating ions for analysis 
(Vestling, 2003). The former MS technique (ESI-MS), when coupled with Liquid
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Chromatography (LC), offers a powerful tool for separating and detecting complex 
mixtures (Griffiths et ah, 2001; Coon et al., 2005).
LC-MS systems are commonly composed of the solvent, which makes up the mobile 
phase; voltage cone and sample that all play a vital role. It is fundamentally 
important to consider the appropriate solvent for the mobile phase as their 
compositions affect chromatographic flow, the spectral characteristics, and 
sensitivity of the analysis (Chakraborty and Berger, 2005). The choice of such 
components depends on the properties of the analyte with respect to the ion detection 
mode of the LC-MS system, the reversed-phase column, and the ionisation process 
(Garcia et al., 2002; Chakraborty and Berger, 2005).
Capillary voltage (Cap V) and sample cone selection does not depend on specific 
experimental optimisations but are chosen depending on the instrument 
manufacturer’s handbook or based on personal experience (Marginean et ah, 2009). 
Cap V refers to the voltage applied to the capillary tube from which liquid sample is 
sprayed to form scattered charged droplets. A Cap V within a 3-5kV range (Lim and 
Lord 2002) is tested for each experimental setting and it is usually applied in RP-LC. 
The concentration of the sample is also an important factor that may affect the 
analysis (Quekelberghe et al., 2008).
2.1.3 Gas chromatography-mass spectrometry (GC-MS)
Separating, identifying, and quantifying complex mixtures of chemicals, such as low 
molecular weight compounds found in environmental materials, can be achieved by 
using Gas Chromatography Mass Spectrometry (GC-MS). This method requires that 
the compound to be analysed is sufficiently volatile and thermally stable.
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GC-MS was also used previously to assess the components of essential oils of the 
rhizomes of Zingiber zerumhet, Hedychium coronarium and Etlingera cevuga 
collected from Tahiti Island. They found that the rhizomes of Zingiber zerumbet was 
rich in zemmbone (65.3%) (Lechat-Vahima et al, 1993).
Thubthimthed et a l (2003) used GC-MS to analyse the rhizome of Zingiber ottensii 
ginger collected in Thailand, where twenty-eight constituents were identified 
including zemmbone (40.1%). More recently, Sivasothy et a l  (2012) used GC-MS to 
identify the chemical composition of leaves and rhizomes from Zingiber spectabile 
Griff, Malaysian ginger. Around 80 compounds were identified in its leaf and 
rhizome oils including zemmbone (59.1%).
GC-MS analysis is used for organic solutions only, and therefore, materials like soils, 
sediments, and tissues are initially solvent extracted and treated with various 'wet 
chemical' techniques. The sample solution is then inserted into the GC inlet for 
vaporisation and consequently carried through the chromatographic column by the 
carrier gas (like helium). This sample is separated as a result of their different 
interaction with the column (stationary phase) and the carrier gas (mobile phase). 
The mobile phase travels through a heated transfer line to the entrance and on to the 
ion source where the eluted compounds are converted into ions using the Electron 
Ionisation (El) method or the Chemical Ionisation (Cl) technique (Karasek and 
Clement, 1988).
With El, sample molecules are ionised through a beam of electrons that causes the
loss of one electron; i.e. an ion is produced and it is represented by M^ (a radical
cation). Analysis by MS gives a peak from this ion which gives the molecular weight
of the substance. As the molecular ion is subject to a large amount of energy, it
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fragments and further smaller ions are produced with 'fingerprint' characteristics for 
that molecular structure. This allows the identification of particular compounds and 
facilitates the elucidation of unknown mixture compositions.
Cl, being the alternative to El, begins with ionising a suitable gas like methane to 
produce a radical, that ionises the sample molecule resulting in [M+H]^ molecular 
ions. This method, however, employs less energy to ionise a molecule compared with 
EL This means that there is less fragmentation and therefore less information about 
the detailed structure of the molecule is obtained. Nonetheless, detection of the 
molecular ion is much more reliable using Cl compared with El and thus the two 
methods are found to complement one another. As the ion is detected, it is repelled 
out of the ionisation chamber using a small positive charge (Karasek and Clement, 
1988; Lisec et ah, 2006).
Various mass analysers (filters) are available such as quadruples, ion traps, magnetic 
sector, time-of-flight, radio frequency and cyclotron resonance, where the first two 
are the most commonly used. Depending on their properties, the MS separates the 
positively charged ions according to their mass-related properties. These ions then 
enter a detector, which sends information to a computer that controls the MS 
operation and saves all the data produced, and converts the electrical impulses into 
visual and hard copy displays (Karasek and Clement, 1988; Lisec et ah, 2006).
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2.2 Aims and objectives
The purpose of this chapter is to fill in the missing gaps in the available literature and 
to propose a method of identifying zemmbone in ginger {Zingiber officinale Rose) 
from the UK and the USA ginger in methanol and ethanol extractions by various 
analytical methods. Prior to analysis of the ginger samples, HPLC, LC-MS, and GC- 
MS systems were optimised using a zemmbone standard; a vital step in minimising 
interference fi*om factors other than those in the investigated samples and in 
mitigating false-positive results.
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2.3 Materials and methods
2.3.1 Materials
Materials Suppliers
Zemmbone (Z3902) Sigma-Aldrich Ltd, Poole, UK
All other solvents and chemicals
VWR International Suwanee, GA., 
USA
HPLC column:
Supelcosil LC-18 column, 25 c m  x 4 mm x 5 pm
Supelco, Bellefonte, PA, USA
LC column:
C l8 reverse-phase column (Shim pack XR-ODS 
column, 50 mm x 3.0 mm id x 2.2 p
Shimadzu Scientific Inst., Columbia, 
MD, USA
GC column:
Agilent capillary column HP-5MS, 30 m x 0.23 
mm X 0.25 pm, part number 19091S-433
Agilent Technologies, Santa Clara, 
CA., USA
2.3.2 Methods
Sample preparations and HPLC, LC-MS and GC-MS analysis were conducted in Dr 
Mary Ann Lila’s lab. Plants for Human Health Institute, North Carolina State 
University, Karmapolis, USA, under the supervision of Dr Mary Grace.
2.3.2.1 Sample Preparation
Fresh ginger was purchased from the local stores in the UK and USA; both samples 
were harvested from China in November 2012. Ginger was peeled and stored 
overnight at -80 °C, and then freeze-dried for 2 days. The freeze-dried ginger was 
ground to fine powder and stored at -80 °C until extraction.
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2.3.2.2 Sample preparation for HPLC, LC-MS and GC-MS
Extraction was performed based on procedures developed by Grace et al (2009). 
Briefly, 5 g of ffeeze-dried ginger powder was treated 3 times with 25 ml 100% 
methanol or ethanol, vortexed and then sonicated for 10 min at room temperature. 
Samples were then centrifuged at 4000 rpm for 10 min using a Sorvall Legend 
centrifuge (Thermo Scientific, Asheville, NC, USA). The supernatants were 
separated, and the plant material was re-extracted with another 25 ml of 100% 
methanol or ethanol. After centriftigation, the supernatant was added to the previous 
collected solution. All supernatants were subjected to vacuum evaporation using a 
Buchi rotary evaporator (Flawil, Switzerland). Samples were prepared in methanol at 
a concentration of 5 mg/ml, and then filtered through 0.2 pm PTFE filters into an 
HPLC amber vial for HPLC, LC-MS and GC-MS analysis.
2.3.2.3 HPLC analysis
HPLC analyses were performed using an Agilent 1200 HPLC system (Agilent 
Technologies, USA). A Supelcosil LC-18 column, 25cm x 4mm x 5pm (Supelco, 
Bellefonte, PA, USA) was used for the separation. The mobile phase solvents used 
were solvent (A) 1% acetic acid in Millipore water, or solvent (B) 100% methanol. 
The flow rate was 1 ml/min. Gradient conditions were 65%, 80%, 65% and 65% of 
solvent (B) at 0, 20, 35 and 40 min, respectively. Column temperature was 
maintained at 30 °C. Each sample (5 pi) was injected into the HPLC column after 
being filtered through 0.2 pm PTFE filters. Three concentrations of zemmbone were 
prepared: 0.05, 0.1 and 0.5 mg/ml. Zemmbone was quantified from the peak areas 
recorded at 245, 280, and 360 nm against a calibration curve obtained with reference 
standards of zemmbone.
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2.3.2.4 LC-MS analysis
Electrospray ionization ion-trap time-of-flight mass spectrometry LCMS-IT-TOF 
(Shimadzu, Tokyo, Japan) was used for zemmbone analysis. HPLC was conducted 
on the integrated LC system (SEL-20A HT autosampler, LC-20AD pump system, 
SDP-M20A photo diode array detector). LC separation was performed using a Cis 
reverse-phase column (Shim-pack XR-ODS column, 50 mm x 3.0 mm id x 2.2 p, 
Shimadzu Scientific Inst., Columbia, MD, USA). The mobile phase consisted of 
solvent (A) 0.1% formic acid in H2O and solvent (B) 100% methanol. Gradient 
conditions 40, 85, 85 and 40% B in A over 35 min at 0, 5, 15 and 35 min, 
respectively. Samples were filtered through 0.2 mm PTFE filters before injecting 5 
pi into the LC-MS column (30 °C) at a flow rate of 0.4 ml/min. The column was re­
equilibrated for 5 min at initial conditions (5% B) prior to the next injection. The 
temperature of the heat block and curved desolvation line (CDL) were kept at 200 
°C. Nitrogen gas was used as nebuliser and drying gas with the flow rate set at 1.5 
ml/min. the voltage ESI source was adjust to 4.5 kV and the detector was adjust to
1.5 V. Sodium TEA solution was used as an external standard to calibrated the 
instrument to minimise error in mass accuracy <5 ppm. A conventional ESI source 
was used to perform the ionisation in positive ionisation mode. Data was acquired at 
m/z 150-1500 range. Shimadzu’s LCMS Solution software (Shimadzu Scientifie 
Inst., Columbia, MD, USA) was used analysis the data. Zemmbone was quantified 
from the peak areas recorded at 245 nm against the calibration curve obtained with 
reference standards of zemmbone.
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2.3.2.S GC-MS analysis
GC-MS analyses were performed using an Agilent 7890A GC system (Agilent 
Technologies, USA) interfaced with an Agilent 5975C mass deteetor. An Agilent 
capillary column (HP-5MS, 30 m x 0.23 mm x 0.25 pm, part number 19091S-433, 
USA) was used in the sample separation. Operating conditions: column oven 
temperature programmed at 40 °C for 2 min, then to 270 °C at 10 /min, then and hold 
for 2 min; Injector/transfer line/ion source temperatures 220/250/200 °C, 
respectively; electron voltage, 70 eV. UHP helium was used as the carrier gas at a 
flow rate of 1.2 ml/min. Injection volume was 1 pi and splitless mode. Eluted 
compounds were identified using the NIST Mass Spectral library Version 2.0 (NIST/ 
EPA/Nm, USA).
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2.4 Results
2.4.1 Analysis of ginger extract by HPLC
Pure zemmbone standard purchased from Sigma-Aldrich Ltd was subjected to HPLC 
analysis in order to optimise this experiment. HPLC analysis of zemmbone showed 
that 0.5 mg/ml was the best concentration for the detection of a single peak at a 
retention time of 17.574 min (Figure 7-A). Different wavelengths were used to 
identify the wavelength of optimal absorbance; the highest absorbance of zemmbone 
was observed at 245 nm (Figure 7-B). Thus, the standard concentration of 0.5 mg/ml 
and a wavelength of 245 nm wavelength were used in all following experiments. 
HPLC chromatograms of ethanol and methanol extractions of ginger (5 mg/ml) 
purchased in the UK showed no peak at the retention time of 17.754 min (Figure 8-A 
and Figure 8-B, respectively). No zemmbone peak was detected over a range of 
wavelengths (245, 280 and 360).
Ethanol extractions of ginger (5 mg/ml) purchased from UK and USA markets were 
compared to the zemmbone standard by HPLC analysis at 245 nm. The 
chromatograms revealed that only the zemmbone standard had a peak at 17.574 min 
(Figure 9-A, B and C).
Methanol extractions of ginger (5 mg/ml) from UK and USA markets also yielded 
similar results when compared with the zemmbone standard. Neither UK nor USA 
ginger showed any peak at 17.574 min (Figure 10-A, B and C).
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Figure 7 HPLC analysis of zerumbone standard.
(A) 0.05, 0.1, and 0.5 m g/m l concentrations o f  zerum bone w ere prepared  in 100% m ethanol.
(B) 0.5 m g/m l o f  zem m bone w as analysed at various w avelengths (245.8, 280.4 and  360.8 
nm ). The Supelcosil LC-18 H PLC  colum n (25 cm  x 4 m m  x 5 pm , B ellefonte, PA , U SA ) 
w as used  at a  flow  rate o f  1 m l/m in and at a colum n tem perature o f  30 °C. The m obile  phase 
w as solvent (A) 1 %  acetic acid in M illipore w ater, so lvent (B) 100 %  m ethanol. G radien t 
conditions w ere: 65% , 80% , 65%  and 65%  o f  B in A  at 0, 20, 35 and 40 m in, respectively .
44
The effect of ginger active component (Zemmbone) on human cancer cells
n  0AD1 A. Si9*254,8 R«f=off(2ER.GIN-11-09-12ZER METHOD-B 2 0 ia é é - M  1Mfl-Q£\1ED-(M01.D)
mAU
□  DAD1B,Si9=280,4Rt^off(ZER_GIN-11-09-12 ZER METHOD-B 20 |-11-0910-0402\1ED -0401 ,0 )
mAU
□  DAD1 C. Sij=3C0.8 Rtf=off(ZER_OIN-11-09-12ZER METHOD-B 2012-11-09 10-04-0^1ED-(M01,D)
mAU
\W  = 360.8 nm
□  DAD1 A, Si9*254,8 Ref=oH(ZER.&IN-11-09-12ZER METHOD-B 2 0 1 2 # * 0 »  1 »# 0(\1E E -05 01 .D )
W \ -  245.8 nm
26 mit
M  = 280.4 nm
28 mit
W V = 360.8 nm
□  DAD1 B,Si9s280.4Rtf*o«(2ER.OIN-11-09-12ZERMETHOD-B20l|-11-0910-CI402T1EE-OKI1.D)
1— '— '— '— I— '— '— '— I— '— '— '— I— T —— '— r - f
10_ _ _ _ _ _ _ _ _ _ _ 12_ _ _ _ _ _ _ _ _ _ _ 14_ _ _ _ _ _ _ _ _ _ _ 16 .  18   20
□  DAD1 C. 8 i(=% 0,8  Rtf=oft(ZER_OIN-11-09-12 ZER METHOD-B 2012-11-09 10-04-0^1EE-0501.D)
tnAU
15
10
5
0-
-  ■ Jg . 26 mit
Figure 8 HPLC analysis of ginger from the UK.
(A) 5 m g/m l o f  extract from  the U K  ginger w as prepared in 100% ethanol. (B) 5 m g/m l o f  
the U K  ginger ex tract w as prepared  in 100% m ethanol. V arious w avelengths (245.8, 280.4 
and 360.8 nm ) w ere used  for the analyses. A Supelcosil LC-18 H PLC  colum n (25 cm  x 4 
m m  X 5 pm , B ellefonte, PA, U SA ) w as used at a flow  rate o f  1 m l/m in and at a colum n 
tem perature o f  30 °C. The m obile phase solvent w as (A) 1 %  acetic acid  in M illipore w ater, 
so lvent (B) 100 % m ethanol. G radient conditions w ere: 65% , 80% , 65%  and  65%  B in  A  at 
0, 20, 35 and 40 m in, respectively.
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Figure 9 HPLC analysis of UK and USA ginger in ethanol.
(A) 0.5 m g/m l o f  zerum bone standard prepared in 100% ethanol. (B) 5 m g/m l ex tract from  
the U K  ginger prepared  in 100% ethanol. (C) 5 m g/m l o f  extract from  the U SA  ginger 
d issolved in 100% ethanol. A  w avelength  o f  245.8 nm  w as used. A  Supelcosil L C -18 H PLC  
colum n (25 cm  x 4 m m  x 5 pm , B ellefonte, PA, U SA ) w as used w ith a flow  rate o f  1 m l/m in  
and at a colum n tem perature 30 °C. The m obile phase w as solvent (A) 1 % acetic acid  in 
M illipore w ater, so lvent (B) 100 % m ethanol. G radient conditions w ere: 65% , 80% , 65%  and 
65%  B in  A  at 0, 20, 35 and 40 m in, respectively.
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Figure 10 HPLC analysis of UK and USA ginger in methanol.
(A) 0.5 m g/m l o f  zem m bone standard w as prepared in 100%  m ethanol. (B) 5 m g/m l extract 
from  the U K  ginger w as prepared  in 100% m ethanol. (C) 5 m g/m l o f  extract from  the U SA  
ginger w as d issolved in 100% m ethanol. A  w avelength  o f  245.8 nm  w as used. A  Supelcosil 
LC-18 H PLC  colum n (25 cm  x 4 m m  x 5 pm , B ellefonte, PA, U SA ) w as used  w ith  a flow  
rate o f  1 m l/m in and at a colum n tem perature 30 °C. The m obile phase w as solvent (A) 1 % 
acetic acid in M illipore w ater, so lvent (B) 100 % m ethanol. G radient conditions w ere: 65% , 
80% , 65%  and 65%  B in A  at 0, 20, 35 and 40 m in, respectively.
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2.4.2 Analysis of ginger extract by LC-MS
Further analyses by LC-MS were conducted in order to identify zerumbone in ginger 
purchased in the UK and USA against a zerumbone standard (MW 218.33 g/mol). 
Standard zerumbone was analysed in the positive ionisation mode. The results 
showed that zerumbone standard could be identified by a molecular ion at m/z 219 
[M+l]"*" in the positive scan mode. This peak was the only peak in the mass spectrum 
(Figure 11-A). In contrast, LC-MS analysis of the UK and USA ginger extracts 
showed no peak at m/z 219. (Figure 11-B and C and Figure 11-D and E, 
respectively).
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Figure 11 LC-MS analysis of zerumbone, UK  ginger and USA ginger.
(A) 0.5 mg/ml of zemmbone standard was prepared in 100% methanol. (B) 5 mg/ml extract 
from the UK ginger was prepared in 100% ethanol. (C) 5 mg/ml of extract from the UK 
ginger was prepared in 100% methanol. (D) 5 mg/ml of extract from the USA ginger was 
prepared in 100% ethanol. (E) 5 mg/ml of extract from the USA ginger was prepared in 
100% methanol. Wavelength of 245 nm was used. A Shim-pack XR-ODS C-18 column (50 
mm X 3.0 mm id x 2.2 p, USA) was used at a flow rate of 0.4 ml/min and at a column 
temperature of 30 °C. The mobile phase was solvent (A) 0.1% formic acid in Millipore 
water, solvent (B) 100% methanol. Gradient conditions were: 40%, 85%, 85% and 40% B in 
A at 0, 5,15 and 35 min, respectively.
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2.4.3 Analysis of ginger extract by GC-MS
GC-MS analysis of the zerumbone standard revealed a clear peak at m/z 218, 
corresponding to the molecular weight of zerumbone (Figure 12-A). In contrast, the 
GC-MS chromatogram analysis of methanol extracted ginger from the UK showed 
no peak at m/z 218 (Figure 12-B), which was the same for methanol extracted ginger 
from the USA (Figure 12-C).
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Figure 12 GC-MS analysis of zerumbone, UK ginger and USA ginger.
(A ) 0.5 m g/m l o f  zem m bone standard w as prepared in 100% m ethanol. (B) 5 m g/m l o f  
extract from  the U K  ginger w as prepared in 100% m ethanol. (C) 5 m g/m l o f  ex tract from  the 
U SA  ginger w as prepared  in 100% m ethanol. A n A gilen t capillary colum n (H P-5M S, 30 m  x 
0.23 m m  x 0.25 pm , P art num ber 19091S-433, U SA ) w as used. The carrier gas, he lium  w as 
used  at a constant flow  rate o f  1.2 m l/m in). T he oven tem perature w as m ain tained  at 40 °C to 
270 °C.
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2.5 Discussion
In the present study we investigated if zerumbone could be detected in the ginger 
species Zingiber officinale Rose. To the best of our knowledge, no previous research 
has been conducted to detect zerumbone in this species. More importantly, it is 
commonly believed that the benefits of ginger come firom Zingiber officinale Rose, 
whereas Zingiber zerumbet Smith ginger possesses very beneficial qualities such as 
anti-bacterial, anti-viral, anti-malarial, anti-inflammatory and anti-cancer agents 
(Prasannan et al., 2012).
HPLC, LC-MS, and GC-MS were used to detect zerumbone in two different ginger 
specimens purchased from local markets in the UK and the USA. Methanol and 
ethanol solvents were used for the extraction process and a zerumbone standard was 
used to identify the zerumbone retention time and molecular ion mass (Abdul et al., 
2008). Different optimisation parameters were used such as sample concentrations 
and wavelengths. The purpose of this optimization stage was to determine the best 
conditions given the characteristics of the sample under investigation.
Zerumbone was not detected in ginger specimens from the UK or the USA by any of 
the detection methods when using either extraction procedure. In contrast, a 
zerumbone standard was detected with a clear and sharp peak by HPLC, LC-MS, and 
GC-MS. These results indicate that each ginger species contains unique components 
and that zerumbone, which is present in zingiber zerumbet Smith is not detected in 
zingiber officinale Rose.
Some of peaks which detected by LC-MS and GC-MS, identifed in Appendix 7.
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2.6 Conclusion
In conclusion, we were unable to detect zerumbone in ginger of the Zingiber 
officinale Rose species from the UK and USA, despite using different extraction 
solvents and three different powerful techniques (HPLC, LC-MS, and GC-MS). This 
suggests that zerumbone is not present in Zingiber officinale Rose at least in high 
enough quantities to be detected using these techniques. It is therefore unlikely that 
the potential therapeutic properties of ginger of the Zingiber officinale Rose species 
are mediated via zerumbone.
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3 Antioxidant properties of 
zerumbone
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3.1 Introduction
Safeguarding fats against oxidation is one of the main concerns of food safety, since 
the auto-oxidation affects food quality and reduces nutritional values. Moreover, 
when polyunsaturated fatty acids of biological membrane are subject to oxidation, 
serious damage is caused; such as atherosclerosis (Leitinger, 2003) and cancer 
(Valko et al., 2006).
Protection against these oxidative processes is usually possible by restricting access 
to oxygen or by adding antioxidants. Antioxidants are significant preventive agents 
against food spoilage and various diseases because superoxide and hydroxyl radicals 
initiate lipid peroxidation (Basaga, 1990; Halliwell and Chirico, 1993; Aruoma, 
1994). Previously, antioxidants in the form of synthetic phenols, for example 
butylated hydroxytoluene (BHT) and butylated hydroxyanisole (BHA) were used as 
food additives; however, their safety is questionable (Stoilova et al., 2007). 
Therefore, more attention is drawn towards natural antioxidants, such as polyphenol 
compounds (Aruoma et al., 1994; Kim and Heo, 1997; Yen et al., 2003; Scalbert et 
a l, 2005).
Eukaryotic cells are equipped with antioxidant defence system include molecules and 
enzymes to defend themselves against the damage caused by their constant exposure 
to fi"ee radicals. These help to mitigate the deleterious effect incurred by biological 
macromolecules (Halliwell, 1999; Devasagayam et a l, 2004). This means that any 
imbalance in the antioxidant mechanism encounters puts the cell at risk of free 
radical damage, which can potentially causes disease.
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In in vitro tests on various cell free assay systems, ginger extract and its 
phytochemicals scavenged hydroxyl radicals and inhibited the formation of 
conjugated diene in oxidised fatty acid system (Stoilova et al., 2007). Oboh et al, 
(2012) suggested that the antioxidant properties of two different species of ginger are 
related to the ability of phytochemicals to scavenge hydroxyl radicals and to act as 
ferrous chelating. Zingerone (non-volatile pungent components in ginger) can 
significantly scavenge peroxynitrite radicals and hence protect cells from toxicity 
induced by this radical (Shin et al., 2005).
Valko et al. 2006 concluded that oxidative stress by reactive oxygen species and 
reactive nitrogen species are driven by the excessive production of RNS and ROS. 
Cell structures, such as lipid membranes, proteins and DNA, are subject to 
significant damage caused by the key ROS and RNS elements, namely, superoxide 
anion radical (02"), hydroxyl radical (OH'), nitric oxide (NO) and hydrogen 
peroxide (H2O2) (Devasagayam et a l, 2004; Halliwell, 2007).
Murakami et a/. (2002) found that zerumbone suppressed free radicals (superoxide 
anion) generated from NADPH oxidase, xanthine oxidase, the expression of iNOS 
(inducible nitric oxide synthase) and COX (cyclo-oxygenase)-2, and the release of 
TNF-a. Moreover, Ibrahim et al. (2012) found that zerumbone reduce renal 
dysfunction and organ damage through anti-oxidant glutathione preservation and 
lipid peroxidation preservation. The antioxidant activity of zerumbone is responsible 
for the activation of detoxification system enzymes in normal liver cell line 
(Nakamura et a l, 2004).
Several assays are used to evaluate the antioxidant activity of natural compounds.
These assays are based mainly on the ability of antioxidant compounds to scavenge
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free radicals, to chelate metal ions and their ability as reducing agent. A radical- 
generating system such as the DPPH assay is a rapid, simple and inexpensive method 
to measure the ability of natural compounds which act as free radical scavengers 
(Kedare and Singh, 2011). As many factors affect the antioxidant activity, 
particularly in biological system, different assays are required to validate the result. 
Therefore, this study will cover three common antioxidant assays, including DPPH 
scavenging activity, hydrogen peroxide scavenging activity, metal chelating and 
reducing power assay to test the antioxidant properties of zerumbone; these tests 
have not been reported to date.
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3.2 Aims and objectives
1. To assess the radical-scavenging activity of zemmbone on DPPH and 
hydrogen peroxide scavenging at different concentrations.
2. To assess the ferrous-chelating activity of zemmbone at various 
concentrations.
3. To assess the reducing power of zemmbone at different concentrations.
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3.3 Materials and Methods
3.3.1 Materials
Materials Suppliers
DPPH (1,1 -diphenyl-2-picrylhydrazyl)
Ferrous chloride
EDTA
Ferrozine
Sigma-Aldrich Ltd, Poole,
Hydrogen peroxide
UK
Potassium ferricyanide
Phosphate buffer
Ferric chloride
Sodium nitrite and aluminium chloride
Ethanol
Trichloroacetic acid (TCA) Fisher Scientific,
Sodium carbonate Loughborough, UK
Sodium hydroxide
3.3.2 Methods
3.3.2.1 The radical scavenging activity of l,l-diphenyl-2-picryIhydrazyI 
(DPPH)
DPPH is a purple coloured crystalline powder consisting of stable free-radical 
molecules. DPPH turns from purple to yellow diphenyl-picrylhydrazine (DPPH-H)
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upon reduction (the acceptance of a hydrogen or electron from a donating substrate). 
Therefore, the degree of colour change reflects the ability of a substrate to scavenge 
(reduce) DPPH, at the maximum absorbance of 517 nm. Substances with the ability 
to do this are considered radical scavengers or antioxidants (Ebrahimzadeh et al., 
2008).
According to the method of (Bersuder et al, 1998), 500 |il zerumbone at different 
concentrations (50, 100 and 150 pg/ml = 0.23, 0.46 and 0.69 mM, respectively) was 
mixed with 500 gl of 99.5% ethanol and 125 pi of 0.02% w/v DPPH in 99.5% 
ethanol. The mixture was vortexed and then incubated at room temperature in the 
dark for 60 min. Then the colour of the solution was read at an absorbance 
wavelength of 517 nm using a UV-visible spectrophotometer (Kontron Instrument 
Unikon 860, UK). BHT and trolox (both 100 pg/ml = 0.45 and 0.4 mM, respectively) 
were used as synthetic and natural antioxidants respectively, in comparison with 
zerumbone. The DPPH radical scavenging activity was calculated as follows:
, , Control absorbance — Sample absorbance
DPPH radical scavenging activity (%) = ------------------------ :—:----- :----------------------- x  100
Control absorbance
Control absorbance was measured using 500 pi deionized water instead of sample 
and sample absorbance was the absorbance of the zerumbone or positive control 
BHT and trolox. The lower absorbance of the reaction mixture indicated a higher 
DPPH radical-scavenging activity.
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3.3.2.2 Hydrogen peroxide scavenging activity
The ability of zemmbone to scavenge the hydrogen peroxide radical was assessed 
according to Gulcin et al. (2010). One ml zemmbone at different concentrations (50, 
100 and 150 pg/ml = 0.23, 0.46 and 0.69 mM, respectively) was mixed with 0.6 ml 
of 40 mM H2O2 in a phosphate buffered saline at pH 7.4. The solution was incubated 
for 10 min at room temperature before reading the absorbance at 230 nm. BHT and 
trolox solutions (100 pg/ml = 0.45 and 0.4 mM, respectively) were used as positive 
controls. The percentage of H2O2 scavenging was calculated as follows:
,  ^ Control absorbance — Sample absorbance
Hydrogen peroxide scavenging effect (%) =  ---------------- --------- ;—;----- ;------------------------ x 100
Control absorbance
Control absorbance measured using 500 pi deionized water instead of sample and 
sample absorbance is the absorbance of the zemmbone or positive control (BHT and 
trolox).
3.3.2.3 Ferrous chelating activity assay
The ability of zemmbone to chelate ferrous (Fe^^) ions was assessed according to
Dinis et al. (1994). Ferrozine, a known chelator of ferrous iron becomes magenta-
coloured when it forms a water soluble complex with ferrous ions. The formation of
the magenta form of ferrozine is inhibited in the presence of other chelating agents,
such as zemmbone. Thus, lower absorbance indicates higher chelating activity of
zemmbone. Zemmbone (500 pi) at different concentrations (50, 100 and 150 pg/ml
= 0.23, 0.46 and 0.69 mM, respectively) was mixed with 1.5 ml of deionised water
and 50 pi of 2 mM FeCl2 , and vortexed. After 30 sec, 100 pi of 5 mM of ferrozine
61
The effect of ginger active component (Zemmbone) on human cancer cells_______________
was added to the solution. The mixture was vortexed, and then incubated at room 
temperature for 10 min. Absorbance was read at 562 nm. Ethylenediaminetetraacetic 
Acid (EDTA) solution (100 pg/ml = 0.34 mM) was used as a positive control. The 
activity of the zemmbone to chelate Fe^ "^  was calculated as:
Control absorbance — Sample absorbance
Ferrous chelating activity (%) =  ------------------------- :—;----- ;------------------------ x  100
Control absorbance
Control absorbance was measured using 500 pi deionized water instead of sample 
and sample absorbance is the absorbance of the sample or positive control.
3.3.2.4 Reducing power assay
To assess the ability of zemmbone to reduce Fe^ "^ , a reducing power assay was used 
(Yildinm et al. 2000). In the presence of an antioxidant, the substrate potassium 
ferricyanide produces potassium ferrocyanide, which reacts with ferric chloride to 
form ferric ferrous complex. The higher the absorbance at 700 nm, the higher 
electron donating ability (of the reduced product), which indicates the reducing 
power of the antioxidant.
In this assay, 1 ml zemmbone at different concentrations (50, 100 and 150 pg/ml = 
0.23, 0.46 and 0.69 mM, respectively) was mixed with 2.5 ml (0.2 M, pH 6.6) 
phosphate buffer and 2.5 ml (1%) potassium ferricyanide. After incubating the 
mixture at 50 °C for 30 min, 2.5 ml of (10 %) trichloroacetic acid was added. The 
solution was centrifuged at 1600 rpm for 10 min. Thereafter, the solution supernatant 
(2.5 ml) was mixed with 2.5 ml distilled water and 0.5 ml (0.1%) ferric chloride. The 
mixture was kept then for 10 min at 22 °C and the absorbance read at 700 nm.
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3.3.3 Statistical analysis
Data represent the mean plus or minus standard error of the mean (±SEM (n=3)). All 
data were analysed by one-way analysis of variance (ANOVA) with Bonferroni 
multiple comparisons correction (Graphpad Prism version 5.0 for Mac OS X) 
software. The alpha value for the limit of significance was set at (* = p < 0.05; * * = p
<0.01; * * * = p < 0.001).
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3.4 Results
3.4.1 DPPH radical-scavenging activity
Figure 13 illustrates the scavenging activity exhibited by 50, 100 and 150 pg/ml 
zemmbone on the DPPH radical. The investigation revealed that the scavenging 
power of zemmbone increased in a dose dependent manner. The scavenging activity 
exhibited by zemmbone was significantly lower than that of BHT (26.5%) at 50 
pg/ml concentration (9.7%, p<0.001) and (22.1%) for 100 pg/ml, but reached 
equivalent activity (28.2%) at the highest dose of 150 pg/ml zemmbone (Figure 13 
A). The scavenging activity of 50, 100 and 150 pg/ml zemmbone was significantly 
lower (9.7%, 22.1% and 28.2% respectively) (at least p<0.001 for all) than that of 
trolox (57%) (Figure 13 B). However, scavenging activity increased with increased 
zemmbone dose, suggesting that the same activity as trolox could be reached at 
higher doses of zemmbone.
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Figure 13 Comparative radical scavenging activity of zemmbone and controls 
by the DPPH method.
Concentrations of (50, 100 and 150 pg/ml = 0.23, 0.46 and 0.69 mM, respectively) 
zemmbone (ZM) were used. DPPH scavenging activity was compared against (A) BHT as a 
synthetic antioxidant (100 pg/ml = 0.45 mM) standard and (B) Trolox as a natural 
antioxidant standard at (100 pg/ml = 0.4 mM). Scavenging activity was read at an 
absorbance of 517 nm. The data represent the mean ± SEM of three independent 
experiments. Comparisons of means were made using a one-way ANOVA followed by 
Bonferroni's post hoc test (* = p < 0.05; ** = p < 0.01; *** = p < 0.001).
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3.4.2 Hydrogen peroxide scavenging activity
The H2O2 scavenging activity of 50, 100 and 150 pg/ml zemmbone increased in a 
dose-dependent manner (Figure 14). The hydrogen peroxide scavenging activity of 
zemmbone was compared with that of BHT and trolox (Figure 14 A and B, 
respectively). Figure 14-A shows that the hydrogen peroxide scavenging activity of 
zemmbone was significantly lower than that of BHT at 50 pg/ml (3.96% vs 16.3%, 
P<0.001) and at 100 pg/ml (8.1%). At the higher 150 pg/ml zemmbone 
concentrations activity was not significantly different from BHT (p>0.05). The 
positive control trolox was a more effective scavenger than zemmbone at the 
concentrations used (Figure 14-B). Zemmbone activity at 50, 100 and 150 pg/ml was 
3.96%, 8.17% and 14.4% respectively compared with trolox (24.4%; at least p<0.05 
for all). However, at higher doses of zemmbone, similar activity to trolox may have 
been observed, since over this range activity was dose dependant.
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Figure 14 Comparative H2O2 scavenging activity of zemmbone and controls
Concentrations of (50, 100 and 150 pg/ml = 0.23, 0.46 and 0.69 mM, respectively) 
zemmbone were used. Scavenging activity was compared with (A) BHT as a synthetic 
antioxidant standard (100 pg/ml = 0.45mM) and (B) Trolox as a natural antioxidant standard 
at (100 pg/ml = 0.4 mM). Scavenging activities was read at an absorbance of 230 nm. The 
data represent the mean ± SEM of three independent experiments. Comparisons of means 
were made using a one-way ANOVA followed by Bonferroni's post hoc test (* = p < 0.05;
** = p <0.01; *** = p <0.001).
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3.4.3 chelating activity assay
The ferrous chelating activity of zemmbone at different concentrations (50, 100 and 
150 pg/ml) increased in a dose-related manner and was compared to that of 100 
pg/ml EDTA (Figure 15). Although the activity increased with the dose, zemmbone 
possessed a significantly lower chelating activity (4.8%, 10.0% and 22.4%) at all 
concentrations (p<0.001) compared with EDTA (96.8%).
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Figure 15 Chelating activity o f zerumbone at different concentrations compared 
with EDTA.
The activity of different concentrations of zemmbone (50, 100 and 150 pg/ml = 0.23, 0.46 
and 0.69 mM, respectively) was compared to EDTA as a synthetic antioxidant standard (100 
pg/ml = 0.34 mM). Chelating activity was read at an absorbance of 562 nm. The data 
represent the mean ± SEM of three independent experiments. Comparisons of means were 
made using a one-way ANOVA followed by Bonferroni's post hoc test (* = p < 0.05; ** = p
<0.01; *** = p<  0.001).
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3.4.4 Reducing power assay
The ability of zerumbone to reduce a ferricyanide to its ferrous form is shown in 
(Figure 16). The reducing power of 50, 100 and 150 pg/ml zerumbone increased in 
a dose-dependent manner (0.13, 0.17 and 0.29, respectively).
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Figure 16 Reducing power assay o f zerumbone
Reducing power of zemmbone using (50, 100 and 150 pg/ml = 0.23, 0.46 and 0.69 mM, 
respectively) zemmbone. The activity was measured at an absorbance of 700 nm. Data 
correspond to the means ± SEM of three independent experiments.
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3.5 Discussion
In the past twenty years, some investigations tried assess ginger extract and its 
related phytochemicals as antioxidants (Hinneburg et al., 2006; Ghasemzadeh et al., 
2010). However, limited work has been undertaken on the component zerumbone as 
an antioxidant. Therefore, several antioxidant mechanisms were assayed to 
understand the action of zerumbone as an antioxidant.
The DPPH experiment showed that zerumbone can scavenge DPPH free radicals in a 
dose-dependent maimer, due to its hydrogen donating ability. The activity of 
zerumbone in this regard was similar to the synthetic antioxidant BHT but less 
effective than trolox as a natural antioxidant standard. This result is in agreement 
with the findings of Joshi et al. (2008) who assessed the radical scavenging activity 
of a different terpenoid (terpin-4-ol). Our findings do however suggest that 
zerumbone can be used as natural antioxidants in place of synthetic alternatives. The 
a,P-unsaturated carbonyl group of zerumbone is believed to be responsible for the 
mechanism of action of this interesting sesquiterpenoid (Murakami et al., 2002).
The hydrogen peroxide scavenging activity of zerumbone, measured in this research 
showed that zerumbone has the ability to scavenge H2O2 in a concentration- 
dependent manner by donating an electron to H2O2 , thereby converting it to H2O. 
Zerumbone exhibited similar H2O2 scavenging activity to the synthetic antioxidant 
BHT but again was less active than trolox. When abundant, the hydrogen peroxide 
attacks biological molecules, which may result in cancer and several other diseases 
(Valko et ah, 2004), so protecting against this may be important for disease
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prevention. The hydrogen peroxide scavenging activity of ginger Zingiber officinale 
Rose has also been reported previously (Ajith et al., 2007).
The ferrous ion chelating activity of zerumbone was also measured in this study. 
Zerumbone chelated Fe^^ ions, reducing the formation of the water-soluble ferrozine 
complex in a dose-dependent manner. The chelating activity of zerumbone at the 
concentrations used was less than that of EDTA, which is a well-known synthetic 
metal-chelating agent. Transition metal ions such as Fe^^ react relatively quickly 
with peroxides by acting as electron donors to form alkoxyl radicals (Wong and 
Kitts, 2001). Thus, chelation of transition metal ions by zerumbone at higher doses 
may inhibit this oxidation reaction.
Chelation activity of a different terpenoid (terpin-4-ol) was also reported in a 
previous study, which suggested that the terpenoid could either directly bind the 
metal ions or indirectly suppress their chelating reactivity by inhibiting their 
coordination positions (Joshi et al., 2008). The results of our study suggest that 
zerumbone could be an effective chelating agent and could play a role in the 
protection against oxidative damage, if excess transition metal ions are involved.
Finally, the ability of zerumbone to reduce Fe^Vferricyanide complex to the ferrous 
form was measured. Again, the reducing power of zerumbone increased in a 
concentration dependent manner. The reducing power assay is usually used to assess 
the ability of an antioxidant to donate an electron, which is known to have a direct 
association between antioxidant activity and reducing power (Gulcin et al., 2011). 
Our result is in agreement with previous work on another terpenoid (terpin-4-ol) 
which also showed good reducing power (Joshi et al., 2008).
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3.6 Conclusion
Zerumbone demonstrated the ability to aet as an antioxidant free radical scavenger 
with similar activity to synthetic antioxidant BHT but with lower activity compared 
the natural antioxidant trolox in both DPPH and H2O2 assays. While zerumbone 
exhibited Fe^^chelating activity, this activity was significantly lower than that of the 
known chelator, EDTA at the concentrations used. Zerumbone also acted as a 
reducing agent in a dose dependent manner.
72
The effect of ginger active component (Zemmbone) on human cancer cells
4.The effect of zerumbone on the 
human colon adenocarcinoma 
Caco-2 cell line
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4.1 Introduction
4.1.1 Colon Cancer
Colon cancer is defined as any malignant neoplasm starting at the inner lining of the 
colonie epithelium. It is the third primary cause of cancer-assoeiated deaths for both 
men and women in the United States and fourth in Saudi Arabia (Jemal et aA, 2011; 
Zubaidi, 2008). The 5-year survival rate of eolon eancer after diagnosis at an early 
and deferred stage is 90%, however, this survival rate drops to 10% when distant 
metastasis has occurred (Sack et al., 2011). The incidence of colon cancer is strongly 
linked to age, with 90% of the cases occurring in people over 50 years. Both genders 
have equal risk for colon cancer until age 50, but in later life, the risk increases in 
males (Nagy et al., 2004). In addition to age, diets high in fat and low in fruits and 
vegetables, and smoking are also risk factors for colon cancer (Cappell, 2007; Kim 
and Milner, 2007).
4.1.2 Colon Cancer Therapy
Carcinogenesis is a multistep process resulting in the generation of abnormal cells 
with abnormal molecular signal cascades (Manson et ah, 2005). Given that 
progression is a multistage process, there are many points at which intervention ean 
act to delay or reduce carcinogenesis prior to the development of invasive 
malignaney. A chemo-preventive agent should offer several desirable features such 
as high efficacy at multiple sites, low cost, and little or no toxieity, for human use. 
Currently, scientists can provide natural products for cancer prevention due to their 
various health benefits, lack of side effects and toxicity (Manson et al., 2005).
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The biologieally active phytochemicals (e.g. flavonoids, earotenoids and phenolics) 
are present in natural products and play a crucial role in suppressing early and late 
stages of eareinogenesis (Nishino et al., 2007). An inverse relationship between the 
risk of several types of eancer and diets rich in fresh fruit and vegetables has been 
confirmed by epidemiological studies (Satia-About et ah, 2004; Williams and Hord, 
2005; Vainio and Weiderpass, 2006).
This project investigates the chemo-preventive effieaey of ginger constituent 
(zerumbone) colon cancer models in vitro. Many studies indieate that ginger can 
change a variety of molecular pathways implicated in eancer initiation and 
progression. Therefore, natural produets with anti-careinogenic properties could be 
used as novel chemo-preventive agents for treating colon cancer. Further studies with 
ginger may identify different molecular mechanisms and targets for tumour growth 
inhibition and induction of apoptosis. In vivo and in vitro research is necessary to 
investigate the safety and ehemo-preventive efficacy of ginger and its components in 
isolation or in combination with chemotherapy drugs used to treat colon cancer.
Therefore, this chapter will attempt to fill the gap in the literature by focusing on the 
effects of the zerumbone ginger active eomponent on Caco-2 human colon cancer 
eells by assessing this effeets on Poly [ADP-ribose] polymerase 1 (PARP-1), 
Microtubule-associated protein light chain 3 (LC3), caspase 3 (cas-3), caspase 9 
(cas-9), caspase 8  (cas-8 ) gene expression; the cell cycle. Reactive Oxygen Species 
(ROS) and mitochonrial Reactive Oxygen Species (mtROS).
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4.2 Aims and Objectives
1. To study the morphological changes involved in zerumbone-induced Caco-2 
cell death, including cell volume, DNA fragmentation and phosphatidylserine 
externalisation.
2. To study the involvement of caspase and PARP-1 in zerumbone-induced 
Caco-2 cell death.
3. To evaluate the effect of zerumbone-induced Caco-2 cell death on the 
mitochondrial membrane potential as an important parameter of 
mitochondrial function used as an indieator of cell health.
4. To evaluate mitochondrial membrane potential (AYm) eorrelation with 
production of reactive oxygen species in response to zerumbone injury.
5. To examine the effect of zerumbone on the cell cycle in Caco-2 cells after 
exposure to different durations and concentrations of zerumbone treatment.
6 . To examine the effects of zerumbone on HCEC normal colon cells versus 
Caco-2 human colon cancer eells.
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4.3 Materials and Methods
4.3.1 Materials
Materials Suppliers
Carbonyl cyanide 3-chlorophenylhydrasone (CCCP)
Sigma-Aldrich Ltd, 
Poole, UK
Cyclosporine A, Annexin V-FITC Apoptosis 
Detection Kit, Necrostatin-1
Zemmbone
L-glutamine (lOOx)
penicillin/ streptomycin (antibiotics solution at 50 
U/ml)
Trypsin-EDTA solution (Ix)
Dulbecco’s phosphate buffered saline (DPBS) (Ix) - 
free, (DPBS)
Triton X-100
Dimethylsulfoxide (DMSO)
Propidium iodide, RNase &
T etramethylrhodamineethylester (TMRE)
5-(and -6)-Chloromethyl-2'& 1’- 
dichlorodihydrofluorescein diacetate acetyl ester 
(CM-H2DCFDA)
Invitrogen, Paisley, UK
MitoSOX (C4 3H43N 3IP) & non essential amino acids 
(NEAA)
Dulbecco’s modified Eagle’s medium (DMEM) & 
Foetal bovine semm (FBS)
Western Breese Chemiluminescence (Western Blot 
Kit), NuPAGENovex 4-12% Bis-Tris Gel, PVDF 
membranes
Bio-Rad Protein Assay kit Bio-Rad, Hercules CA
Staurosporine
Alexis Biochemicals, 
Bingham, UK
Polyclonal anti-PARP-1 antibody
Cell Signaling 
Technology, UK
Cell culture flasks, Uni versais and Falcons tubes NUNC
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4.3.2 Methods
4.3.2.1 Cell culture and treatment
Caco-2 cells are a human eoloreetal carcinoma cell line, obtained from the European 
Collection of Cell Cultures (ECACC), Salisbury, UK. Caco-2 cells were grown in 
Dulbecco’s modified Eagle's medium (DMEM) containing 20% foetal bovine serum 
(FBS), 50 U/ml penicillin/streptomycin, 1% non-essential amino acids (NEAA) and 
1% 2 mM L-glutamine (complete culture medium). Cells were seeded in T75 cm^ 
flasks and maintained at 37°C in air with 5% CO2 , and were sub-cultured every four 
days using complete culture medium. Cells were used when they reached 80-90% of 
confluence. Cells were seeded at a density of 1x10^ cells/ml prior to each 
experiment. Cells were washed with PBS and then detached using 2 ml of 
trypsin/EDTA.
Cells were treated with different zerumbone concentrations (5, 10, 20 and 50 gg/ml = 
23, 46, 92 and 229 pM, respectively).
HCEC cells are a non-carcinomatous colon cell line derived from a 69-year-old 
female undergoing surgery for diverticular disease. These cells were a generous gift 
from Dr Karen Brown University of Leicester, UK. HCEC cells were grown in 
D6429 high glucose media containing 10% FBS. Cells were seeded in T75 em^ 
flasks or in 96 wells plates and maintained at 37 °C in air with 5% CO2 , and were 
sub-cultured every four days using complete culturing medium. Cells were plated at 
1:10 dilution, and washed with PBS and then detached using 2 ml of trypsin/EDTA. 
All flasks/wells were pre-coated 10-15 min prior to seeding cells. The pre-coating 
solutions were 50 ml of D6429 high glucose media (without FBS), 65 pi BSA (100
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mg BSA in 2 ml H2O), 0.5 ml collagen (250 pi stock + 9.75 ml H2O) and 125 pi 
fibronectin. Pre-coating media were sterilised filtered prior to use.
For treatment purposes: HCEC cells were seeded at a density of 3  x 10  ^ eells/ml in 
T25 em^ flasks and incubated for 24 h. Prior to each experimental treatment, the 
culture medium was replaced by fresh medium containing 10% FBS when cells were 
at 50% confluence.
Cells were treated with different zerumbone concentrations (5 and 10 pg/ml = 23 and 
46 pM).
4.3.2.2 Cell death and LDH assay
The lactate dehydrogenase (LDH) release assay was performed to assess amount of 
cell death (Griffiths et a l, 1990). Caco-2 cells were seeded at 25 x 1 0  ^ cells per well 
in 24-well plates, incubated for 24 h, and the release of LDH into the culture media 
was tested. Prior to cell treatment, the culture medium was replaced by fresh media 
containing 20% FBS. Cells were then treated with different zerumbone 
concentrations. After 24 and 48 h incubation (37 °C), 110 pi of post-treatment 
medium was tested for LDH following manufacturer’s instructions (Roche, Lewes, 
UK).
Briefly, supernatants were centriftiged at 1000 x g  for 5 min and 100 pi was placed 
in 96-well plates. Plates were incubated for 30 min following addition of 100 pi of 
LDH reaction mixture (prepared as per the manufacturer's instructions). An ELISA 
reader was used to assess the absorbance of the solution at a wavelength of 490 nm. 
Cell death was presented as a percentage of total lysis, which was calculated from 
treatment with 0.1% Triton X-100. Triton X-100 was used as a positive control to
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release total LDH from each well. As a negative control, 100 pi of complete medium 
was used to assess ELISA reader background.
4.3.2.3 Cell cytotoxicity assay (MTT)
Cell cytotoxicity was measured by MTT assay using a tétrazolium dye, according to 
the method described by Mosmann (1983). Caco-2 cells were plated at a density of 
5%10  ^ cells/ml in 96 well plates in a volume of 200 pi. Cells were allowed to grow 
and attach in the humidified incubator for 24 h at 37 °C and 5% CO2 . Cells were 
treated with different concentrations of zerumbone. Concentrations were prepared by 
dissolving zerumbone in complete medium. 50 pi of each stock solution was added 
to the 200 pi of medium already present in the wells. Cells were then incubated for 
48 h. The assay was terminated by incubating the cells with 0.05 mg/ml MTT for 
approximately 3 h at 37 °C. The medium was removed and the formazan crystal 
products were dissolved in 200 pi DMSO. The absorbance of the solutions obtained 
from each well was read at 540 nm using an automated plate reader (Labsystems 
Multickan RC plate reader) with Genesis 3.05 software. A graph of cell viability 
against zerumbone concentration was plotted from the mean absorbance values, by 
calculating the percentage death of zerumbone treated cells against control cells. 
Assays were performed in triplicate or quadruplicate and the percentage of cell death 
relative to control was calculated from the mean. The I C 5 0  for each experiment was 
interpolated from this dose response curve.
4.3.2.4 Confocal microscopy study
Caco-2 eells were seeded at 50 x 10^  cells/ml in 4-well plates and cultured for 24 h 
and 48 h. Prior to cell treatment and when eells were 50% confluent, culture medium
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was replaced by fresh medium containing 20% FBS. Fluorescence images were 
photographed with a Zeiss LSM 510 fluorescence microscope and camera with x6  
objective. Samples were analysed using both red fluorescence (excitation at 543 
nmfrom an argon laser and a 560 nm long-pass filter), and green fluorescence 
(excitation at 488nm from an argon laser and a 500-550 nm band pass barrier filter).
4.3.2.S Annexin V-FITC
A well-known method for confirming apoptosis is Annexin V-FITC, which has high 
affinity for phospholipid phosphatidylserine (PS) in the presence of calcium (Ca^^ 
(Vermes et a l, 1995). In addition, propidium iodide (PI) is normally used to 
differentiate apoptotic from dead cells. Cells stain positively with Annexin V-FITC 
in early stages of apoptosis, at which stage PI staining would be negative. Cells show 
positive response to both stains as they start to die. Healthy cells with intact cell 
membranes do not stain with either PI or Annexin V-FITC, and in certain cases of 
necrosis, PI staining only is observed (Appendix 2) (Koopman et a l, 1994).
Caco-2 cells cultured in T25 cm^ flasks were trypsinised for 1 min and then 
centrifuged for 3 min at 130 x g. Cell pellets were washed with 1 ml PBS for 3 times 
and then re-suspended in annexin-binding buffer with a density of 1 x 1 0  ^ cells/ml. 
Next, 5 jil, Annexin V conjugate was added to 100 gl aliquots of cell suspension 
before incubation at 22 °C in the dark for 15 min. Then, 400 gl of Annexin V 
Binding Buffer and 1 gg/ml of PI were added to the cells. Contents of the plates were 
mixed and incubated on ice until analysis by flow cytometry using a Beckman 
Coulter Epics XL.
81
The effect of ginger active component (Zemmbone) on human cancer cells_______________
Flow cytometer set up: forward and side scatter gatings were set to exclude cell 
debris and analysed in FL-1 for Annexin V (520 nm emission) and FL-3 for PI (620 
nm emission). Importantly, at least of 10,000 events were acquired in list mode.
4.3.2.6 Western blotting
Cells were grown in T75 flasks (until confluent). On the day of protein extraction, 
cells were removed from the flask by scraping, centrifuged at 1000 x g  for 5 min, re­
suspended in ice cold of 1 ml PBS and centrifuged again. The supernatant was 
removed and the cell pellet was incubated with freshly prepared cell lysis buffer on 
ice for 20 min. Cell lysis buffer (50 nM Tris-HCl (C4HiiN0 3 *HCl), 150 mM NaCl, 
adjusted to pH 7.0 with concentrated HCl, in Milli-Q water) was supplemented with 
1% Nonidet® P-40 detergent, 0.2% sodium dodecyl sulfate (SDS), 1 mM 
phenylmethylsulphonyl fluoride (PMSF). Finally, cells were lysed mechanically by 
passing through a 2 Gauge needle.
Cell protein content was estimated using the Bio-Rad DC protein assay. This is a 
dye-binding assay based on the differential colour change of the dye in response to 
different protein concentrations. According to manufacturer’s instructions, samples 
were diluted 1:10 in Milli-Q water (100 gl total volumes) and mixed. The 
concentrated dye reagent was also diluted 1:5 in Milli-Q water and 5 ml of diluted 
dye was added per sample. Samples were mixed thoroughly. After 10 min, the 
absorbance was measured at 690 nm using a Lab systems Multickan RC plate reader. 
The protein concentration of cell lysates was estimated based on interpolation of a 
BSA protein standard curve prepared in the same way as the samples.
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Western blotting analysis was performed on the cell lysates using an Invitrogen^^ 
life technologies system. Following the manufacturer’s instructions, cell lysates (20 
gg to 50 gg) were prepared in NuPAGE® LDS sample buffer (diluted 1:4 in Milli-Q 
water) and NuPAGE® reducing agent (diluted 1:10 in Milli-Q water), heated at 70°C 
for 5 min then subjected to electrophoresis. The proteins were separated on 10% 
NuPAGE®NovexBis-Tris Gels using 4-12% NuPAGE® MOPS SDS running buffer 
and transferred to a PVDF membrane in an assembly provided by the manufacturer. 
Blocking solutions were provided by Chemiluminescent Western Blot 
Immunodetection Kit from Invitrogen™. Blocking solution was prepared with 5% 
milk powder and/or BSA to block the non-specific binding sites on the membrane 
according to the manufacturer’s instructions (Penna and Cahalan, 2007).
Primary antibody was prepared (1:200 dilution) in antibody diluents provided in the 
kit. The membrane was incubated with primary antibody overnight with gentle 
shaking. The membrane was then washed with prepared antibody wash solution 
(provided in the kit) for 5 min to remove unbound primary antibody. The membrane 
was then incubated with secondary antibody solution (provided in the kit) for 1 h 
with gentle shaking. The membrane was washed again with 10 ml antibody wash 
solution and finally rinsed with Milli-Q water. The signal was detected by 
chemiluminescent substrate provided in the kit on Amersham film.
4.3.2.7 Mitochondrial membrane potential (ATm)
Flow cytometry with the fluorescent probe tetra methyl rhodamine ethyl ester 
(TMRE) was used to study the changes in mitochondrial membrane potential 
(Scaduto and Grotyohann, 1999). The cytometer was set up to exclude cell debris
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with forward and side scatter gatings and analysed in FL-3 (620 nm emission). At 
least 1 0 0 0 0  events were acquired in list mode.
TMRE is a lipophilic dye used in the present study to identify and quantify the ATm. 
Briefly, 1 ml PBS with 5 mM glucose was used to re-suspend cells, which were then 
treated with TMRE (100 nM) for 40 min at 37 °C prior to examination with a 
Beckman Coulter Epics XL.
A group of cells were incubated for 3 min (prior to loading with TMRE) at 22 °C 
with 20 pM of the uncoupler carbonyl cyanide 3-chlorophenylhydrasone (CCCP), 
which was used as a positive control. Cells were washed and re-suspended in 1 ml 
PBS and then kept on ice until TMRE fluorescence was assessed.
4.3.2.8 The assessment of cellular reactive oxygen species (ROS)
2’,7’ -dichlorofluorescein diacetate (DCFDA) is a non-fluorescent dye that used to 
identify ROS production (Appendix 3) (Bass et al., 1983). In this study, cells were 
detached by trypsin in T25 cm^ flasks and centrifuged at 130 x g  for 3 min. Cells 
were re-suspended twice in 1 ml PBS, and incubated for 30 min at 37 °C with 5 pM 
of fresh DCFDA stock solution. This mixture was stored in low-light conditions 
because of the high susceptibility of DCFDA to photo-oxidation. Cells were washed 
and re-suspended in 1 ml of PBS, and stored on ice until DCFDA florescence 
analysis on a Beckman Coulter Epics XL flow cytometer. The flow cytometer was 
gated to exclude cell debris, and was set up with forward and side scatter gating and 
analysed in FL-1 (520 nm emission). At least 10000 events were acquired in list 
mode.
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4.3.2.9 The assessment of mitochondrial reactive oxygen species (mtROS)
For this experiment, cells were detached from T25 cm^ flasks with trypsin and 
centrifuged for 3 min at 130 x g. Cells were washed with PBS and re-suspended in 1 
ml of Hank’s Buffered Salt Solution (HBSS). Cells were incubated at 37 °C for 10 
min with 5% CO2 and with 5 pM of fresh stock solution (5 mM MitoSox: [3, 8- 
phenanthridinediamine, 5-(6'-triphenylphosphoniumhexyl)-5,6 dihydro-6-phenyl], in 
DMSO). Cells were washed three times and re-suspended in 1 ml HBSS before 
storing on ice until florescence analysis on a Beckman Coulter Epics XL flow 
cytometer (Robinson et ah, 2008). The flow cytometer was gated to exclude cell 
debris and analysed in FL-3 (620 nm emission). A minimum of 10,000 events were 
acquired in list mode.
4.3.2.10 PI staining for DNA quantification and cell cycle study
PI stain can measure the amount of DNA bound to suspended permeabilised eells as
PI fluorescence intensity is relative to the amount of DNA present (Appendix 4). In
this experiment, flow cytometry was used to quantify the nuclear DNA content of
Caco-2 cells. The flow cytometer was set up as follows: the gating of forward and
side scatters was set to exclude cell debris and further gating was used in the
auxiliary scatter and FL3 to yield good discrimination between singlets and doublets.
Cells were analysed in FL-3 (620 nm emission). At least 10000 events were acquired
in list mode. Cells were trypsinised in T25 em^ flasks and centrifuged at 130 x g  for
3 min. The cells were washed with PBS, and re-suspended with 200 pi of ice-cold
PBS. Then, 2 ml of ice-cold fixing buffer (70% ethanol in PBS) was added drop-wise
to samples while mixing. Samples were then stored overnight at 4 °C. Ethanol
present in the fixing buffer was removed from samples by centrifugation, followed
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by washing with PBS. RNA was removed by using 10 |iM of RNAse. Samples were 
then treated with 10 pi of 1 mg/ml PI stock and incubated in the dark at 37 °C for 30 
min. Cells were stored on ice until analysis on a Beckman Coulter Epics XL flow 
cytometer.
4.3.2.11 Statistical analyses
Data represent a mean plus or minus standard error of the mean (±SEM) of at least 3 
independent experiments. All data were analysed by multiple comparison using one­
way analysis of variance (ANOVA) with Bonferroni multiple comparisons 
correction (Graphpad Prism version 5.0 for Mac OS X) software. The alpha value for 
the limit of significance was set to (*= p<0.05; **= p<0.01; ***= p<0.001).
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4.4 Results
4.4.1 The cytotoxicity of zerumbone on the HCEC cell line
HCEC cells treated with 5 and 10 pg/ml zemmbone for 24, 48 and 72 h showed no 
time- or concentration-dependent cell death induction as measured by MTT assay 
(Figure 17), (No significant differences between control and treated cells).
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Figure 17 The effect o f zerumbone on HCEC cell viability
Cells were treated with zemmbone 5 and 10 pg/ml. MTT assay was monitored over 24 h 
panels A, 48 h panel B, and 72 h panel C. The data represent the mean (n=3 ± SEM) of three 
independent experiments. Comparisons of means were made using a one-way ANOVA 
followed by Bonferroni’s post hoc test.
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4.4.2 The effect of zerumbone on HCEC cells morphology
The effect o f zemmbone on the HCEC cell line was also assessed by microscopy. 
Zemmbone show no effect or very limited cytotoxicity on HCEC cell line when 
treated with 5 and 10 pg/ml zemmbone for 24, 48 and 72 h (Figure 18, Figure 19 and 
Figure 20 respectively).
Figure 18 Microscopy images of the effect of zerumbone on the HCEC cell line 
at 24 h.
Cells w ere treated  w ith zerum bone for 24 h. Panel A  untreated  cells, panel B cells treated  
w ith  5 pg/m l, and panel C cells treated  w ith 10 pg/m l. Im ages w ere captured using  L eica  a 
D M LB  m icroscope (m agnification: lOX).
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Figure 19 Microscopy images o f the effect of zerumbone on the HCEC cell line 
at 48 h.
Cells were treated with zerumbone for 48 h. Panel A untreated cells, panel B cells treated 
with 5 pg/ml, and panel C cells treated with 10 pg/ml. Images were captured using a Leica 
DMLB microscope (magnification: lOX).
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Figure 20 Microscopy images of the effect of zerumbone on the HCEC cell line 
at 72 h.
Cells were treated with zemmbone for 72 h. Panel A untreated cells, panel B eells treated 
with 5 pg/ml, and panel C cells treated with 10 pg/ml. Images were captured using a Leica 
DMLB microscope (magnification: lOX).
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4.4.3 The effect of zerumbone on ROS production in HCEC cells
HCEC treated with 10 pg/ml zerumbone for 24 h showed increased ROS formation 
versus eontrol (untreated cell) (Figure 21 A). However, at 48 h, treatment with 5 
pg/ml zerumbone eaused a deerease in ROS produetion compared with eontrol cells 
(untreated cell), whereas 10 pg/ml zerumbone had little effeet (Figure 21 B), (No 
signifieant differences between eontrol and treated cells).
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Figure 21 The effect o f zerumbone on ROS production in HCEC cells.
HCEC cells were treated with zerumbone 5, and 10 pg/ml. Cells were loaded with CM- 
H2DCFDA and DCF fluorescence was measured by flow cytometry as a marker of ROS 
formation. Panel A cells treated for 24 h and panel B cells treated for 48 h. The data 
represent the mean (n=3 ± SEM) of three independent experiments. Comparisons of means 
were made using a one-way ANOVA followed by Bonferroni's post hoc test.
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4.4.4 The cytotoxicity of zerumbone on Caco-2 cells
Cells treated with 5,10, and 50 pg/ml zerumbone showed time- and concentration- 
dependent induction of cell death as measured by LDH release (Figure 22). By 24 
(A) and 48 h (B) of 10 and 50 pg/ml zerumbone treatment, cell death was 
significantly higher compared with LDH release from untreated control cells (p<0.05 
and p<0.001 for each dose respectively). Cell death increased markedly to 
approximately 26% and 42% after 24 h exposure to 10 pg and 50 pg/ml zerumbone 
respectively (Figure 22-A). Cell death increased to 37% and 52% of treated cells 
after 48 h treatment at 10 pg/ml and 50 pg/ml zerumbone, respectively (Figure 22- 
B).
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Figure 22 The effect o f zerumbone on Caco-2 cell viability.
Cells were treated with zerumbone 5, 10 and 50 pg/ml. LDH release was monitored over a 
24 h panel A and 48 h panel B. The data represent the mean ± SEM (n=3) of three 
independent experiments. Comparisons of means were made using a one-way ANOVA 
followed by Bonferroni's post hoc test (* = p < 0.05; ** = p <0.01;*** = p < 0.001).
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4.4.5 Morphological changes associated with zerumbone- 
induced toxicity
To determine the type o f cell death induced in Caco-2 cells by zemmbone treatment, 
morphological changes o f  cells treated with 5, 10 and 50 pg/ml zemmbone were 
examined at 24 h (Figure 23) and 48 h (Figure 24). The figures shows a clear reduce 
in cells number and volume, shrinking and rounded cells increased in dose and time 
dependent manner.
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Figure 23 Microscopy images of the effect of Zerumbone on Caco-2 cells at 24 h.
C ells w ere treated  w ith zem m bone for 24 h. Panel A  untreated  cells, panel B eells treated  
w ith 5 pg/m l, C cells treated  w ith 10 pg/m l and D cells treated  w ith 50 pg/m l. Im ages w ere 
captured using a L eica D M LB  m icroscope (m agnification: lOX).
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Figure 24 Microscopy images of the effect of zerumbone on Caco-2 cells at 48 h.
Cells were treated with zerumbone for 48 h. Panel A untreated cells, panel B cells treated 
with 5 pg/ml, C cells treated with 10 pg/ml, D cells treated with 50 pg/ml and E cells treated 
with 2 pM staurosporine for 48 h. Images were captured using Leica DMLB microscope 
(magnification: lOX).
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4.4.6 Zerumbone-induced toxicity is associated absence of DNA 
fragmentation
DNA fragmentation are signs of apoptosis; however, in eontrast to classic apoptosis, 
DNA fragmentation was absent in zerumbone-treated Caeo-2 cells (Figure 25). 
When inducing classical apoptosis by staurosporine, peaks in the sub G1 region were 
visible when analysed by flow cytometry using PI stain (Figure 25 D), whereas sub 
Glpeaks were absent in both untreated control and zerumbone-treated eells (Figure 
25).
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Figure 25 Flow cytometery analysis o f DNA fragmentation in zerumbone- 
treated Caco-2 cells.
Caco-2 cells were treated with zerumbone (5 and 10 pg/ml) and fixed in 70% ethanol at 24 
h, followed by staining with 10 pi of 1 mg/ml PI stock. Panel A untreated cells, B cells 
treated with 5 pg/ml zerumbone, C cells treated with 10 pg/ml zerumbone, and in panel D 
cells treated with 2 pM staurosporine.
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4.4.7 Zerumbone induced toxicity is not associated with 
phosphatidylserine (PS) externalisation.
When Caco-2 cells were treated with 5 and 10 pg/ml zerumbone for 48 h, the 
number of PI positive cells (C4 quadrant) increased significantly in a concentration- 
dependent manner (Figure 27). In comparison, the number of PI and arm exin-V 
positive cells in C3 increased relatively less compared to the cells in C4. This means 
that either the Caco-2 cells in C3 underwent necrosis, making their membranes 
permeable to PI and annexin-V, or that the Caco-2 cells were in the late phase of 
apoptosis. However, early apoptotie cells (PI negative, Annexin V-FITC positive) 
were not present in C2 at either 5 or 10 pg/ml zerumbone treatments, suggesting 
necrotic cell death. No major ehanges observe of PS externalisation at 24 h treatment 
as show in (Figure 26).
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Figure 26 Zerumbone toxicity is not associated with phosphatidylserine 
externalization at 24 h.
Caco-2 cells w ere treated  w ith zerum bone and analysed by flow  cytom etry  using  annexin-V  
(A V ) and propid ium  iodide (PI) staining. Panel A: untreated  cells, panel B: cells trea ted  w ith  
5 pg/m l zerum bone, and panel C: 10 pg/m l zerum bone. C 1-C 4 indicates the quadrant on the 
flow  cytom eter im age. C l =  H ealthy  cells; C2 =  C ells conjugated  w ith A V  only; C3 =  C ells 
conjugated  w ith A V  and stained w ith PI; C4 =  C ells stained w ith  PI only.
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Figure 27 Zerumbone toxicity is not associated with phosphatidylserine 
externalization at 48 h.
Caco-2 cells w ere treated  w ith  zerum bone and analysed by  flow  cytom etry  using annexin-V  
(A V ) and propidium  iodide (PI) staining. Panel A: untreated  cells, panel B: cells treated  
w ith  5 pg/m l zerum bone, and panel C: 10 pg/m l zerum bone. C1-C4 indicates the quadrant 
on the flow  cytom etry  im age. C l =  H ealthy  cells; C2 = C ells conjugated w ith  A V  only; C3 = 
C ells conjugated w ith  A V  and stained w ith  PI; C4 =  C ells stained w ith  PI only.
4.4.8 Zerumbone induced toxicity is associated with PARP-1 
cleavage
As shown in (Figure 28 A), 10 and 20 pg/ml zerumbone caused PARP-1 cleavage, 
which is an indicator o f apoptosis pathway activation. However, at 5 pg/m l the 
PARP-I cleavage was not detected indicating that the process o f cell death at 5 
pg/ml is initiated in a caspase independent manner.
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Figure 28 Western blot of PARP-1 expression in Caco-2 cells treated with  
zerumbone.
Protein  w as extracted from  Caco-2 cells after treatm ent w ith d ifferent concentrations o f  
zerum bone. Panel A: cell treated  w ith 5, 10, and 20 pg/m l zem m bone fo r 24 h, panel B: 
treated w ith  5, 10 pg/m l zem m bone for 48 h and panel. C ells w ere treated  w ith  2 pM  
staurosporine (St) Panel A. PARP-1 = 116, 89 kDa. Protein  loading (20 pg/m l) p e r lane w as 
determ ined using  p-actin  expression.
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4.4.9 Mitochondrial dysfunction in zerumbone-induced Caco-2 
cytotoxicity
The effects of zemmbone treatment on mitochondrial function assessed by the 
TMRE experiment, where more TMRE dye accumulation by mitochondria is 
proportional to A'Fm- The flow cytometer results and the live imaging results of this 
experiment showed that Caco-2 cells treated for 24 h with 5 and 10 pg/ml zemmbone 
underwent dose-dependent decreases in AYm (Figure 29 and Figure 30), (No 
significant differences between control and treated cells).
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Figure 29 The response o f TMRE fluorescence to mitochondrial depolarisation  
by zerumbone.
Caco-2 cells were treated with zemmbone for 24 h. Cells were loaded with 10 nM TMRE 
probe for 40 min. Positive control cells were incubated with carbonylcyanide m- 
chlorophenylhydrazone (CCCP), a membrane depolariser, at room temperature for 3 min 
prior loading with TMRE. The data represent the mean of three independent experiments 
(n=3 ± SEM). Comparisons of means were made using a one-way ANOVA followed by 
Bonferroni's post hoc test.
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Figure 30 Confocal live images for the response of TMRE fluorescence to 
mitochondrial depolarisation by zerumbone.
Caco-2 cells treated  w ith  5 pg/m l zerum bone (A) and w ith  10 pg/m l zerum bone (B). Cells 
w ere loaded w ith  10 nM  T M R E probe for 40 m in, then m onitored by  fluorescence im aging 
as described in the m aterials and m ethods section  4.3.2.4.
4.4.10 The effect of zerumbone on ROS production
CM-H2DCFDA stain was used to detect the cytoplasmic ROS changes with 
zerumbone treatment. Findings showed that ROS production decreased significantly, 
in a dose-dependent manner (p<0.05) at 10 pg/ml zerumbone (Figure 31). 
Intracellular level of ROS decreased by 40% compared with control cells (untraded 
cell) after 48 h of 5 pg/ml treatment with zerumbone and by 60% with 10 pg/ml 
treatment.
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Figure 31 Zerumbone induces ROS in a dose-dependent manner.
Caco-2 cells were treated with 5 and 10 pg/ml zerumbone for 48 h. Cells were loaded with 
CM-H2DCFDA and the fluorescence of DCF was measured by flow cytometry to monitor 
ROS formation. The data represent the mean (n=3 ± SEM) of three independent 
experiments. Comparisons of means were made using a one-way ANOVA followed by 
Bonferroni's post hoc test (* = p < 0.05; ** = p < 0.01; *** = p < 0.001). ZM: zerumbone.
4.4.11 Zerumbone-induced mitocondrial ROS (mtROS)
To investigate the role of zerumbone in mitocondrial ROS production, the 
fluorescent MitoSox red dye was used. MitoSox is a very selective dye that detects 
mitochondrial superoxide only. The results confirmed that zerumbone did induce a 
concentration-dependent increase in the fluorescent products of MitoSox oxidation 
(Figure 32). At 5 pg/ml zerumbone, mtROS were increased by approximately 30% 
(p<0.01) compared with control (untraded cell) and at 10 pg/ml zerumbone, mtROS 
was increased by almost 70% compared with untreated control (p<0.001). This 
ultimately indicates that zerumbone increases the amount of mtROS in Caco-2 cells.
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Figure 32 Zerumbone-induced mtROS production in Caco-2 Cells.
Caco-2 cells were treated with 5 and 10 pg/ml zemmbone for 48 h. Cells were loaded with 
MitoSox red mitochondrial superoxide indicator and the fluorescence measured by flow 
cytometry to monitor mtROS formation. The data represent the mean (n=3 ± SEM) of three 
independent experiments. Comparisons of means were made using a one-way ANOVA 
followed by Bonferroni's post hoc test (* = p < 0.05; ** p = <0.01;*** = p < 0.001). ZM: 
zemmbone.
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4.4.12 The effect of zerumbone on overall ROS status in Caco-2 cells
The overall status of ROS production in Caco-2 cells was assessed by eonfocal live 
imaging, using both CM-H2DCFDA and MitoSox stains at the same time. In (Figure 
33) it can be seen that the red MitoSox, which represent the mtROS is increasing by 
increasing the zerumbone concentration. In contrast, the green (Figure 33-B) dye 
which reflects the ROS production decreased in zerumbone treated compare to the 
untreated cells.
Figure 33 Confocal live imaging of Caco-2 cells treated with zerumbone using 
both M itoSox stain for mtROS and DCFDA stain for ROS.
Caco-2 cells w ere treated  w ith zem m bone for 48 h. C ells w ere then loaded w ith  C M - 
H 2 D C FD A  and  M itoSox, fo llow ed by  fluorescence im aging as described  in the m ateria ls and  
m ethods section 4.3.2.4. Panel A: untreated  cells. Panel B: cells treated  w ith  5 pg /m l 
zem m bone, and  Panel C: cells treated  w ith w ith 10 pg/m l zem m bone.
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4.4.13 The effect of zerumbone on the Caco-2 cell cycle
The effect of zemmbone treatment on the Caco-2 cell cycle was investigated using 
flow cytometric analysis. Dose-response using 5 and 10 pg/ml zemmbone and time- 
dependency experiments at 24 and 48 h were carried out with PI staining (Figure 34 
and Figure 35).
Treatment of cells with 5 pg/ml zemmbone caused cell-cycle arrest in the G2/M 
phase (Figure 34 B and Figure 35 B). Fewer cells were arrested in the G2/M phase 
with 10 pg/ml zemmbone (Figure 34 C and Figure 35 C). Staurosporine was used as 
a positive control to initiate apoptosis; staurosporine is known to block the cell cycle 
at the S/G2 phase (Figure 34 D). In addition, nocodozol was used as cell-cycle 
arresting agent that is known to arrest the cell cyele at the G2/M phase (Figure 35 D). 
The results showed that treatment with 5 pg/ml zemmbone gave the same effect of 
nocodozol on the cell cycle profile, while treatment with 1 0  pg/ml zerumbone had 
similar effects to 2 pM Staurosporine. These results indicate that zemmbone dose 
determines the phase at which cell-cycle arrest occurs.
103
The effect of ginger active component (Zerumbone) on human cancer cells
li
F13UN FL3UNF U U N
G2/M
Sob C l
102
DNA content (PI)
Figure 34 Caco-2 cell cycle analysis when treated with zerumbone for 24 h.
Caco-2 cells were treated with zerumbone (5 and 10 pg/ml) and fixed in 70% ethanol at 24 
h, followed by staining with 10 pi of 1 mg/ml PI stock. Panel: A untreated cells, Panel B: 
cells treated with 5 pg/ml zerumbone, Panel C: cells treated with 10 pg/ml zerumbone, and 
Panel D: cells treated with staurosporine.
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Figure 35 Caco-2 cell cycle analysis when treated with zerumbone for 48 h.
Caco-2 cells were treated with zerumbone (5 and 10 pg/ml) and fixed in 70% ethanol at 48 
h, followed by staining with 10 pi of 1 mg/ml PI stock. Panel A: untreated cells, Panel B: 
cells treated with 5 pg/ml zerumbone, Panel C: cells treated with 10 pg/ml zerumbone and 
Panel D: cells were treated with 100 pM nocodozol.
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4.4.14 The effect of zerumbone on autophagy in Caco-2 cells
LC3 (microtubule-associated protein 1 light chain 3) is involved in major regulatory 
pathways that trigger the induction of autophagy. In this experiment, LC3 expression 
level was assessed to detect the extent of autophagosome formation. Results show 
that there is a dose- and time-dependent upregulation of LC3 expression with 10 
pg/ml zerumbone treatment (Figure 36).
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Figure 36 W estern blot of LC3 expression in Caco-2 cells treated with 
zerumbone.
Protein  w as extracted  from  C aco-2 cells after treatm ent w ith  5 and 10 pg/m l zem m bone for 
24 h (A) and 48 h (B). Cells w ere treated  w ith  2 pM  staurosporine (St.). L C 3=  14, 16 kDa. 
Equal protein  loading (20 pg/m l) p er lane w as determ ined using  P-actin  expression.
4.4.15 The effect of zerumbone on caspase-9 expression in Caco-2 
ceils
Caspase-9 has a major role in apoptotie cell death. However, its role in induced 
apoptosis in Caco-2 cells is still unclear. In this experiment caspase-9 expression was 
detected in Caco-2 cells treated with zerumbone and in control untreated cells 
(Figure 37). No caspase-9 cleavage was observed by Western blotting at any 
concentration of duration of treatment with zerumbone.
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Figure 37 Western blot of caspase-9 expression in Caco-2 cells treated with 
zerumbone
P rotein  w as ex tracted  from  C aco-2 cells after treatm ent w ith  5 and 10 pg/m l zerum bone for 
24 h  panel A  and 48 h panel B. caspase-9=  47, 37 kDa. Equal pro tein  loading (20 pg/m l) per 
lane w as determ ined using p-actin  expression.
4.4.16 The effect of zerumbone on caspase-3 expression in Caeo-2 
cells
Caspase-3 activation (by cleavage) is also known to induce apoptosis in various 
colon cell lines. Caspase-3 activation induces the processing of other caspases 
downstream in the apoptotie cell death pathway. Western blotting analysis of 
caspase-3 expression showed that no ehanges were observed with zerumbone 
treatment compared with control eells (untreated cell). This was true at different 
concentrations and durations of zerumbone treatment (Figure 38).
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Figure 38 Western blot of caspase-3 expression in Caco-2 cells treated with 
zerumbone
Protein  w as extracted from  C aco-2 cells after treatm ent w ith 5 and 10 pg/m l zerum bone for 
24 h panel A  and 48 h panel B. caspase-3=  35 kDa. Equal protein  loading (20 pg/m l) per 
lane w as detenn ined  using P-actin expression.
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4.4.17 The effect of zerumbone on caspase-8 expression in Caco-2 
cells
Caspase- 8  activity was measured by Western blotting following treatment of Caeo-2 
eells with zerumbone at different concentrations and for different durations (Figure 
39). The results showed no difference in caspase- 8  expression between treated and 
untreated Caeo-2 cells.
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Figure 39 Western blot of caspase-8 expression in Caco-2 cells treated with 
Zerumbone
Protein  w as ex tracted  from  Caco-2 cells after treatm ent w ith 5 and 10 pg/m l zerum bone for 
24 h panel A  and 48 h panel B. caspase-8=  57 kDa. Equal protein  loading (20 pg/m l) per 
lane w as detenn ined  using p-actin  expression.
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4.4.18 The effects of necrostatin-1 (Nec-1) on zerumbone-induced 
Caco-2 cell death
A caspase-independent cell death pathway with similar morphological characteristics 
to necrosis was identified and termed necroptosis (Degterev et al., 2005). When 
necrostatin-1 (Nee-1), was used as an inhibitor of the necroptosis pathway, LDH 
release was decreased when Nec-1 used in combination with 5 or 50 pg/ml 
zerumbone (Figure 40).
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Figure 40 The effects o f Nec-1 on zerumbone-induced Caco-2 cell death.
Caco-2 cells were treated for 24 h with (5, 10 or 50 pg/ml) zerumbone and 50 pM/ml Nec-1. 
LDH release was measured after 24 h. Cell death is expressed as a percentage of total 
cellular LDH release, with each bar representing the mean (n=3 ± SEM) of three 
independent experiments. Comparisons of means were made using a one-way ANOVA 
followed by Bonferroni's post hoc test (* = p < 0.05; ** = p < 0 .0 1 *** = p < 0 .0 0 1 ).
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4.5 Discussion
Natural products may play role in the prevention of cancer. Additionally, natural 
products can potentially provide many of the lead chemical structures for use as 
templates for the construction of novel compounds with better biological properties. 
Based on this theory, in the present study we focused our interest on ginger and in 
particular on zerumbone, with the aim of investigating the effect of this element on 
colon cancer.
The aim of this study was to investigate the cell death pathway occurring in Caco-2 
cells in response to treatment with zerumbone and to examine its anti-proliferative 
effects. It is still not well known if zerumbone-induced Caco-2 cell death occurs 
through apoptosis, autophagy, necrosis or a newly identified form of cell death such 
as necroptosis.
Programmed cell death is an important element of tissue homeostasis, normal 
development, and various diseases. Apoptosis is considered as programmed cell 
death and is caspase-mediated, whereas necrosis is un-programmed and occurs in an 
un-regulated manner. Recently, the term “necroptosis” was introduced to describe a 
form of cell death by regulated necrosis (Dunai a/., 2011).
This study provides evidence that zerumbone can induce cell death via necroptosis 
but that different concentration and exposure times of zerumbone induce different 
forms of cell death. We believe that zerumbone-induced cell death in the Caco-2 cell 
line occurs via a mixture of necroptosis, apoptosis, and autophagy pathways at 
different times. It appears that zerumbone triggers necroptosis at an early stage and 
has faster kinetics compared with other forms of Caco-2 death (Degterev et al.,
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2008). Furthermore, if Caco-2 cells escape from cell death via necroptosis, 
zerumbone preferentially induces apoptosis but can also induce autophagy.
It therefore appears from these preliminary results that zerumbone has the ability to 
induce a range of cell death forms in Caeo-2 cells. The form of cell death induced 
depends on Caco-2 cell behaviour. In addition, it is believed that necroptosis and 
apoptosis work in conjunction to ensure that cell death occurs via either pathway if 
one is compromised (Hitomi et al., 2008).
The confocal images showed clearly that after zerumbone treatment, necroptosis was 
induced in Caco-2 cells. When cells were treated with the necroptosis inhibitor, Nec- 
1 (Kim et al., 2009), cells switched to apoptosis as their primary cell-death pathway. 
The connection of autophagy with the processes of necroptosis is still unclear, but it 
may work to clear up the debris of cell death via necroptosis or apoptosis (Degterev 
et al., 2008; Dunai et al., 2011).
Zerumbone-induced apoptosis or necroptosis was found to be concentration 
dependent; where 5 pg/ml induced necroptosis and 10 pg/ml induced apoptosis. 
Necroptosis is characterised by cell shrinkage that occurs in the absence of 
phosphatidylserine externalization and DNA fragmentation (Degterev et ah, 2008). 
Additionally, a different cell-death response is achieved when cells are exposed to 
different concentrations of zerumbone.
With 10 pg/ml zerumbone treatment, cell death appears to be triggered via TNF and 
caspase activation, given that PARP-1 cleavage was achieved (Takada et al., 2005). 
This is based on the fact that PARP-1 cleavage usually needs caspase activation 
either through the TNF receptor or cytochrome C release. Moreover, a previous
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study showed that zemmbone caused PARP-1 cleavage via up- regulation of TNF 
(Zhang et ah, 2011). PARP-1 has also been implicated in apoptotic pathways when 
cleavage occurs by the action of caspase 3, which is activated via the extrinsic 
pathway through death receptor signalling (Zhang et al., 2011). In this study, 5pg/ml 
zemmbone treatment did not lead to PARP-1 cleavage, indicating that zemmbone- 
induced cell death occurs via a caspase-independent pathway.
The present study also aimed to investigate the key mitochondrial processes 
contributing to zemmbone-induced cell death in Caco-2 cells. Early studies showed 
that cells undergo either apoptosis or necrosis depending on mitochondrial 
dysfunction (Giordano et al., 2007). Cells may also undergo early necrotic cell death 
due to ATm collapse, whereas viable cells survive with relatively intact mitochondria 
and undergo apoptosis at later time points.
The results of the present study indicate that Caco-2 cell death neither occurs via 
apoptosis nor necrosis in response to zemmbone insults. Instead, treated cells 
displayed some morphological features of both types of cell death. In addition, Caco- 
2  ATm experimental results show that the AYm collapse involved in zemmbone- 
induced Caco-2 cell death is dose-dependent. These observations could reflect the 
correlation between degree of A'Pm reduction and the type of cell death pathway 
induced.
Cell cycle analysis in the present study revealed that 5 pg/ml zemmbone has the
ability to partial block the Caco-2 cell cycle at the G2/M phase. At the higher dose of
10 pg/ml zemmbone, only completely block of the cell cycle was observed. Mitotic
division is the mechanism by which cells proliferate. During mitosis, both chromatin
segregation and cytokinetic fission require assembly of specialised cytoskeletal
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structures composed of microtubules, microfilaments, and centrosomes (Piel et ah, 
2001; Casenghi et al., 2003). Chemicals such as nocodozol known to inhibit the 
formation of the microtubule cytoskeleton and microtubule stabilisation have been 
used to target cell proliferation (Wood et al., 2001). Like nocodozol, zemmbone 
potentially has the ability to inhibit microtubule formation, which ultimately results 
in cell cycle arrest in G2/M phase. By comparing the effect of zemmbone on Caco-2 
cells with positive controls (nocodozol), we can conclude that 5 pg/ml zemmbone 
induced cell death after cell cycle arrest, while the cell cycle arrest induced by 1 0  
pg/ml zemmbone was due to initiation of cell death. Thus, cell cycle arrest may 
occur by a different mechanism when different doses of zemmbone are used.
Another possible mechanism of cell cycle arrest in zemmbone-treated Caco-2 cells is 
that cell proliferation also requires mitogenic signals such as ROS to achieve DNA 
replication during S phase of the cell cycle (Chiamgi et al., 2003). Depending on the 
cellular context, ROS can promote either cell survival or cell death (Mazure and 
pouyssegur, 2010). Caco-2 cells contain high levels of ROS that could be responsible 
for the activation of the cell cycle as a survival mechanism. Targeting sites of ROS 
production can influence a range of intracellular signalling events, including 
mitogenic signalling. Indeed, inhibition of ROS production has been shown to inhibit 
cell proliferation (Brar et al., 2003; Scaife, 2004). However, in the present study, 
zemmbone reduced overall ROS but increased mtROS levels, indicating that the 
effects of zemmbone on the cell cycle are fundamentally different. mtROS 
production is important for a necrotic cell death response (Han et al., 2009). 
Therefore, the increased mtROS level induced by zemmbone treatment may result in 
the induction of cell death by necroptosis.
112
The effect of ginger active component (Zemmbone) on human cancer cells
4.6 Conclusion
When treated with zemmbone, Caco-2 cells die via a form of programmed cell death 
that is similar to classical apoptosis and necrosis. This cell death is characterised by 
cell shrinkage with the absence of membrane asymmetry and DNA fragmentation.
This study provides support for the idea that zemmbone-induced cell death occurs 
via a new form or a mix of cell death pathways. In addition, different concentrations 
of zemmbone induce specific mechanisms that result in death by different means. 
However, it must be considered that different cell lines respond differently and 
induce different forms of cell death subsequently or in parallel in some cases. The 
type of cell death induced depends on the set of proteins available in different types 
of cells. Moreover, cell death phenomenon such as necroptosis, apoptosis, necrosis 
are likely to be a cell-type dependent.
Finally, the results of this study also provide some mechanistic insight. It is possible 
that cell cycle arrest in the G2/M phase after treatment with 5pg/ml zemmbone is 
responsible for the initiation of Caco-2 cell death.
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S.The effect of zerumbone on the 
human hepatoma Huh-7 cell 
line
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5.1 Introduction
5.1.1 Liver cancer
The liver consists of various cell types such as those that form bile ducts, blood and 
blood vessels, and those that store fat. However, hepatocytes comprise over 80% of 
the liver tissue (Soto-gutierrez et al., 2008). Liver cancer, also known as 
hepatocellular carcinoma, primary liver cancer or hepatoma, is the third most 
common type of cancer that causes death within one year of the disease. In the last 
decade, approximately 600,000 people were diagnosed with liver cancer worldwide, 
of which a considerable number died (Ferlay, et al., 2010).
Liver cancer signs are not explicit as no abdominal pain is associated with this 
disease. The earliest symptoms due to simple worsening of cirrhosis and liver 
function are not easily detectable. Weight loss and unexplained fever are, however, 
common liver cancer warning symptoms in patients with cirrhosis.
5.1.2 Liver cancer therapy
Treatment selection of liver cancer depends on the disease stage and the patient’s 
overall condition. For example, in the case of small tumours (<3cm), liver removal is 
the only confirmed therapy (Yokoyama et al., 1990; Yao et al., 2001). To date, 
therapies such as chemotherapy, chemoembolisation, ablation, and proton beam 
therapy have not shown satisfactory results.
Doxorubicin (Adriamycin) and 5-fluorouracil (5 FU) are two of the most common 
systemic chemotherapeutic agents used together or in combination with new
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experimental agents (Taïeb et al., 2003; Llovet, and Bmix, 2003). Both of these 
agents are, however, toxic and exhibit low efficacy. Tamoxifen (Nolvadex) is 
another drug that has shown promising results with some patients only. In one study, 
octreotide (Sandostatin) was found to slow the progression of large liver tumours. 
Recent research has also suggested that combining dmgs such as gemcitabine, 
cisplatin, or oxaliplatin can lead to the minimisation of tumours in some patients 
(Gallo and Kaufman, 1997; Louvet et al., 2005).
It is vital to understand the genetic constitution of liver tumours, and the dependency 
of cancer cells on processes such as angiogenesis, in order to develop suitable 
therapies. Angiogenesis, the development and recruitment of tiny new blood vessels 
to feed the tumour and enable it to spread to other parts of the body (as detailed in 
Chapter 6 ), is becoming an area of interest to researchers in the field of oncology and 
pharmaceutical development (Fernandez et ah, 2009). It has been found that some 
drugs used to block components of the angiogenesis pathway, such as sorafenib 
(Nexavar), are suitable for the management of liver cancer (Keating and Santoro, 
2009).
As discussed in chapter 1, a significant contribution to modem dmgs including those
used in cancer treatment has been achieved through the identification of bioactive
components (phytochemicals), extracted from natural products. The active
components of ginger, 6 -shogaol and 6 -gingerol are considered to play significant
roles in the anti-invasion activity of hepatoma cells (HepG2), by regulating MMP,
TIMP-1 and inhibiting MARK and PI3k/Akt pathways and NF-kB (Weng et al.,
2012). Recent studies have also reported that zemmbone exhibits anti-proliferation
activity and induces apoptosis in the HepG2 liver cancer cell line via DNA
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fragmentation and Bax up-regulation (Prasannan et a l, 2012). In vivo, zerumbone 
has also demonstrated anti-cancer activity, whereby Taha et al. (2010) reported that 
zerumbone (60 mg/kg body wt.) protected rat liver from induced tumours. Moreover, 
zerumbone (pretetment 0 .2 % v/v) has been found to prevent necrosis of liver tissue, 
reduce some liver enzyme levels, and suppress fatty liver formation (Fakurazi et ah,
2009).
To this end, it is clear that many studies have investigated the effect of zerumbone on 
liver cancer but no research has yet defined whether these effects are cell-type 
specific or cell-type independent. In addition, we will be examining for the first time, 
the effect of the active component of ginger, zerumbone on the human hepatoma 
Huh-7 cell line as a model of hepatocellular carcinoma.
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5.2 Aims and objectives
7. To study the morphological changes occurring during zemmbone-induced 
Huh-7 cell death. Changes include cell volume, DNA fragmentation, and 
phosphatidylserine (PS) externalisation.
8 . To study the involvement of caspase gene expression (caspase-3, caspase-9, 
and caspase-8 ) and PARP-1 expression in zemmbone-induced Huh-7 cell 
death.
9. To evaluate the effect of zemmbone on the mitochondrial membrane 
potential, as an important parameter of mitochondrial function used as an 
indicator of cell health.
10. To evaluate mitochondria correlation with production of reactive oxygen 
species (ROS and mtROS) in response to zemmbone injury.
11. To examine the effect of zemmbone on the Huh-7 cell cycle at different time 
points/concentrations of zemmbone treatment.
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5.3 Materials and methods
Materials and methods were carried out as described in section 4.2 chapter 4 
methods.
5.3.1 Cell culture and treatment
Cells of the Huh-7 hepatoma cell line are well-differentiated hepatocytes originally 
taken from a liver tumour in a 57-year-old Japanese male in 1982. This cell line (our 
laboratory stocks) was obtained from the European Collection of Cell Cultures 
(ECACC) Salisbury, UK. Huh-7 cells were grown in complete culture medium; 
Dulbecco’s modified Eagle’s medium (DMEM) containing 10% foetal bovine serum 
(FBS), 1% penicillin/streptomycin, 1% non-essential amino acids (NEAAs) and 
2mM L-glutamine. Cells were seeded in T75 cm^ flasks and maintained at 37°C in 
air (5% CO2), and were sub-cultured every four days using complete culturing 
medium. For sub-culture, cells were plated at 1:10 dilutions, washed with PBS and 
then detached using 2 ml of trypsin/EDTA.
Cells were treated with different zerumbone concentrations (1,5, 10 and 20 pg/ml = 
4.6, 23, 46 and 92 pM, respectively).
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5.4 Results
5.4.1 Zerumbone reduces the proliferation of Huh-7 ceils
Cells treated with 1, 5, 10, and 20 pg/ml zerumbone showed time- and 
concentration-dependent induction of cell death as measured by LDH release (Figure 
41). By 24 and 48 h at 20 pg/ml zerumbone concentrations, cell death was 
significantly higher compared with untreated cells. Cell viability reduced to 
approximately 6 8 .6 % and 53.9%, (p< 0.001 versus control) after 24 h of exposure to 
10 pg/ml and 20 pg/ml zerumbone respectively (Figure 41 A). Cell death increased 
significantly to reach 78.9%, and 85.9%, (both p< 0.001 versus control) of treated 
cells after 48 h treatment at 10 pg/ml and 20 pg/ml zerumbone, respectively (Figure 
41 B).
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Figure 41 The effect o f zerumbone on the Huh-7 cell line.
Cells were treated with zerumbone 1,5, 10 and 20 pg/ml. LDH release was monitored at 24 
h (A) and 48 h (B). The data represent the mean ± SEM (n=3) of three independent 
experiments. Comparisons of means were made using a one-way ANOVA followed by 
Bonferroni's post hoc test (* = p < 0.05; ** = p < 0.01; *** = p < 0.001 versus control).
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5.4.2 Morphological changes associated with zerumbone 
induced toxicity
The effect of zerumbone on of the size of Huh-7 cells was detected by microscopy at 
24 and 48 h. When cells were exposed to 5 and 10 pg/ml zerumbone, degenerated 
and rounded cells were clearly visible in the culture medium (Figure 42-B and C; and 
Figure 43-B and C). The effects were increased in time and dose-dependent manner.
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Figure 42 Microscopy images for the effect of zerumbone on the Huh-7 cell line 
at 24 h.
C ells w ere treated  w ith zerum bone for 24 h. (A ) untreated  cells (B) cells treated  w ith  5 pg/m l 
and  (C) cells treated  w ith 10 pg/m l zerum bone. Im ages w ere captured using a L eica  D M LB  
m icroscope (m agnification: lOX).
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Figure 43 Microscopy images for the effect of zerumbone on the Huh-7 cell line 
at 48 h.
C ells w ere treated  w ith zerum bone for 48 h. (A) U ntreated  cells, (B) cells trea ted  w ith  5 
pg/m l and (C) cells treated w ith  10 pg/m l zerum bone. Im ages w ere captured using  a L eica 
D M LB  m icroscope (m agnification: lOX).
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5.4.3 Zerumbone effects on DNA fragmentation
DNA fragmentation is a sign of apoptosis; however, in contrast to classic apoptosis 
DNA fragmentation was absent (Figure 44). Inducing classical apoptosis by 
staurosporine caused cells to appear in the sub G1 area (Chapter 4, Figure 20 D) 
when stained and analysed by flow cytometry, whereas cells in sub G 1 were absent 
in both untreated control and zemmbone-treated cell populations (Figure 44).
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Figure 44 Flow cytometry analysis o f DNA fragmentation in zem m bone-treated  
Huh-7 cells.
Huh-7 cells were treated with zemmbone (5 and 10 pg/ml) for 24 h and fixed in 70% 
ethanol, followed by staining with 10 pi of Img/ml propidium iodide stock. (A) Untreated 
cells (B) cells treated with 5 pg/ml (C) cells treated with 10 pg/ml zemmbone and (D) cells 
treated with 2 pM staurosporine.
5.4.4 The effects of zerumbone on PS externalisation
When Huh-7 cells were treated with 5 and 10 pg/ml zemmbone for 24 and 48 h, the 
number of propidium iodide (PI) positive cells (C4 quadrant) increased considerably 
in a time and concentration-dependent manner (Figure 45 and Figure 46). In 
comparison, the number of annexin-V positive cells in C2 and C3 increased
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relatively fewer compared to the cells in C4. This means that the Huh-7 cells in C3 
had either undergone necrosis, making their membranes penetrable to PI or annexin- 
V, or that the Huh-7 cells were in the late phase of apoptosis.
;C3C4 C4 C3C3 C4
C2C2a.
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Figure 45 Zerumbone toxicity at 24 h associated with phosphatidylserine 
externalization.
Flow  cytom etry  im ages o f  H uh-7 cells treated  w ith  zem m bone. (A) untreated  cells, (B) cells 
treated  w ith  5 pg/m l zem m bone and (C) 10 pg/m l treatm ent. C ells w ere harvested  and 
sta ined  w ith  propid ium  iodide (PI) and A nnexin  V  (A V ). C 1-C 4 indicates the quadran t on 
the flow  eytom eter im age. C l =  U nstained  healthy  cells; C2 =  C ells conjugated w ith  A V  
only; C3 =  Cells conjugated  w ith  A V  and stained w ith PI; C4 =  C ells stained w ith  PI only.
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Figure 46 Zerumbone toxicity at 48 h associated with phosphatidylserine 
externalization.
Flow  cytom etry  im ages o f  H uh-7 cells treated  w ith zem m bone. (A) untreated  cells, (B) cells 
treated  w ith  5 pg/m l zem m bone and (C) 10 pg/m l treatm ent. C ells w ere harvested  and 
sta ined  w ith propid ium  iodide (PI) and A nnexin  V (AV). C 1-C 4 indicates the quadran t on 
the flow  eytom eter image. C l =  U nstained  healthy  cells; C2 = C ells eonjugated  w ith  A V  
only; C3 =  Cells eonjugated w ith A V  and stained w ith PI; C4 =  C ells stained w ith  PI only.
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5.4.5 The effect of zerumbone on PARP-1 cleavage
As shown in (Figure 47 A and B), 10 pg/ml and 20 pg/ml of zemmbone caused 
PARP-1 cleavage, which is an indicator of apoptosis pathway activation. However, 
there was no additional PARP-1 cleavage at 5 pg/ml zemmbone compared with the 
control (untreated cells), indicating that the process of cell death at 5 pg/ml is 
initiated in a caspase-independent manner.
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Figure 47 W estern blot o f PARP-1 expression in Huh-7 cells treated with  
zerumbone.
Protein was extracted from Huh-7 cells after treatment with 5, 10, and 20 pg/ml zemmbone 
for 24 h (A) and 48 h (B). PARP-1 = 116, 89 kDa. Equal protein loading (20 pg/ml) per lane 
was determined using P-actin expression.
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5.4.6 Mitochondrial dysfunction in zemmbone-induced Huh-7 
cytotoxicity
The TMRE fluorescent probe was used to measure AYm and to determine the effect 
of zerumbone treatment on this parameter. TMRE dye accumulation by mitochondria 
is proportional to AYm, where greater AWm polarisation correlates with more TMRE 
dye accumulated in the matrix of the mitochondria. The results of this experiment 
showed that the AYm increased to 82.6% (p< 0.01) in Huh-7 cells treated with 5 
pg/ml zerumbone for 24 h, while ARm decreased at 10 pg zerumbone treatment to 
57.2%, (p< 0.05) which is lower than with the 5 pg zerumbone treatment (Figure 48).
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Figure 48 The response of TMRE fluorescence to mitochondrial depolarisation  
by zerumbone.
Huh-7 cells were treated with 5 and 10 pg/ml zemmbone (ZM) for 24 h. Cells were loaded 
with 10 nM TMRE probe for 40 min. The data represent the mean ± SEM (n=3) of three 
independent experiments. Comparisons of means were made using a one-way ANOVA 
followed by Bonferroni's post hoc test (* = p < 0.05; ** = p < 0.01; *** = p < 0.001 versus 
control).
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5.4.7 The effect of zerumbone on ROS production
The result revealed that ROS production increased significantly, which triggers the 
cascade of events that result in cell death of Huh-7 cells (Figure 49). Intracellular 
level of ROS increased by 70.5%, p< 0.01 after 24 h of 5 pg/ml treatment with 
zerumbone and by 73.6%, p< 0.01 increase after 10 pg/ml. This shows that 
zerumbone initiates ROS production in a dose-dependent manner.
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Figure 49 Zerumbone induces ROS in a dose-dependent manner.
Huh-7 cells were treated with 5 and 10 pg/ml zerumbone (ZM) for 24 h. Cells were loaded 
with CM-H2DCFDA and measuring DCF fluorescence by flow cytometry to monitor ROS 
formation. The data represent the mean ± SEM (n=3) of three independent experiments. 
Comparisons of means were made using a one-way ANOVA followed by Bonferroni’s post 
hoc test (* = p < 0.05; ** = p < 0.01; *** = p < 0.001 versus control).
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5.4.8 Zerumbone-induce mitochondrial ROS (mtROS)
To assess the role of zemmbone-induced mitochondrial mtROS production in Huh-7 
cells, cells were treated with zemmbone using the fluorescent dye MitoSox as an 
mtROS indicator. The analysis confirmed that zemmbone induced mtROS in a 
concentration-dependent manner, as observed by the increase in the fluorescent 
products of MitoSox oxidation (Figure 50). mtROS increased to 83.8% (p< 0.001 
versus control) after treatment with 5 pg/ml zemmbone for 24 h and to 86.5% (p<
0 . 0 0 1  versus control) after treatment with 1 0  pg/ml zemmbone at the same time 
point; this ultimately indicated that zemmbone increased the mtROS in Huh-7 cells.
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Figure 50 Zerumbone-induced mtROS production in Huh-7 Cells.
Huh-7 cells were treated with 5 and 10 pg/ml zemmbone for 24 h. Cells were loaded with 
MitoSox stain and the fluorescence measured by flow cytometry to monitor mtROS 
formation. The data represent the mean ± SEM (n=3) of three independent experiments. 
Comparisons of means were made using a one-way ANOVA followed by Bonferroni's post 
hoc test (* = p < 0.05; ** = p < 0.01; *** = p < 0.001 versus control).
5.4.9 The effect of zerumbone on cell cycle progression
In this experiment, both 5 and 10 pg/ml zemmbone arrested a small number of cells 
in the S/G2 cell cycle phase (Figure 51 B and C). As a positive control, apoptosis
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was initiated by Staurosporine, which is known to block the cell cycle at the S/G2 
phase (Chapter 4, Figure 20 D).
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Figure 51 Cell cycle analysis o f Huh-7 cells treated with zerumbone for 24 h.
Huh-7 cells were treated with zerumbone 5 and 10 pg/ml for 24 h and fixed in 70% ethanol, 
followed by staining with 10 pi of 1 mg/ml propidium iodide stock. (A) Untreated cells, (B) 
cells treated with 5 pg/ml zerumbone and (C) 10 pg/ml zerumbone (D) cells treated with 2 
pM staurosporine.
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5.4.10 The effect of zerumbone on autophagy in Huh-7 cells
In this experiment, LC3 expression was assessed to detect the formation of an 
autophagosome. The results revealed that there was an up-regulation of LC3 
expression that occurred in a dose- and time-dependent manner (Figure 52).
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Figure 52 Western blot of LC3 expression in Huh-7 cells treated with 
zerumbone.
Protein  w as ex tracted  from  H uh-7 cells after treatm ent w ith  5 and 10 pg/m l zerum bone for 
24 h (A) and 48 h  (B). LC 3= 14, 16 kDa. Equal p ro tein  loading (20 pg/m l) p er lane was 
determ ined  using p-actin  expression.
5.4.11 The effect of zerumbone on caspase-9 activity
Caspase-9 plays a major role in apoptotic cell death. However, the role of caspase-9 
in apoptosis induced in Huh-7 cells is still unclear. In this experiment, caspase-9 
expression was detected in Huh-7 cells treated with zerumbone and compared with 
the eontrol (untreated cell) (Figure 53). No caspase-9 cleavage was observed by 
Western blotting using different treatment times and zerumbone concentrations.
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Figure 53 Western blot of caspase-9 (Cas-9) expression in Huh-7 cells treated 
with zerumbone.
Protein  w as ex tracted  from  H uh-7 cells after treatm ent w ith  5 and 10 pg/m l zem m bone for 
24 h (A) and 48 h (B). C aspase-9=  47, 37 kDa. Equal p ro tein  loading (20 pg/m l) per lane 
w as determ ined using  p-actin  expression.
5.4.12 The effect of zerumbone on caspase-3 activity
Caspase-3 (Cas-3) expression is also known to induce apoptotic cell death, and 
induces the proeessing of caspase downstream of apoptotie eell death initiation. 
Western blotting analysis of caspase-3 showed that no change in caspase-3 
expression occurred in Huh-7 cells treated with zemmbone at different times and 
concentrations compared with the control (untreated cell) (Figure 54).
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Figure 54 Western blot of caspase-3 expression in Huh-7 cells treated with 
zerumbone.
Protein  w as extracted from  H uh-7 cells after treatm ent w ith 5 and 10 pg/m l zem m bone for 
24 h  (A) and 48 h (B). C aspase-3=  35 kDa. Equal protein  loading (20 pg /m l) p er lane w as 
determ ined using  P-actin expression.
5.4.13 The effect of zerumbone on caspase-8 activity
Caspase- 8  expression was measured by Western blotting following treatment of
Huh-7 cells with zemmbone different concentrations and at 24 and 48 h (Figure 55).
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The results showed no considerable difference in caspase- 8  expression between 
treated and untreated Huh-7 cells.
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Figure 55 Western blot of caspase-8 expression in Huh-7 cells treated with 
zerumbone.
Protein  w as ex tracted  from  H uh-7 cells after treatm ent w ith  5 and 10 pg/m l zerum bone for 
24 h  (A) and 48 h (B). C aspase-8=  57 kDa. E qual p ro tein  loading (20 pg/m l) p er lane w as 
determ ined using P-actin expression.
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5.4.14 The effects of Necrostatin-1 on zerumbone-induced cell death 
in Huh-7 cells
Necrostatin-1 (Nec-1), which was used as an inhibitor of the necroptosis pathway 
caused a considerable decrease in LDH release from cells after treatment with a 
combination of 10 pg/ml zerumbone and Nec-1 (80.9% vs 30.5%). LDH-release was 
only slightly decreased by Nec-1 when used in combination with 5 pg/ml zerumbone 
(50.3% vs 38.6%) (Figure 56).
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Figure 56 The effects o f Nec-1 on zerumbone-induced cell death in Huh-7 cells.
Huh-7 cells were treated for 48 h with zemmbone and 50 pM/ml Nec-1. The amount of LDH 
released was measured after 48 h. Cell death is expressed as a percentage of total cellular 
LDH release, with each bar representing the mean ± SEM (n=3) of three independent 
experiments. Comparisons of means were made using a one-way ANOVA followed by 
Bonferroni's post hoc test (* = p < 0.05; ** = p < 0.01; *** = p < 0.001 versus control).
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5.5 Discussion
Bioactive components of plant extracts have been used to cure illness and disease for 
many years. Large bodies of research have investigated the anti-cancer properties of 
specific plant extracts such as zerumbone. The aim of this chapter was to examine 
the death pathway induced in zemmbone-treated Huh-7 cells and to assess the anti­
proliferative effects of zemmbone.
In this study, zemmbone exhibited anticancer activity in Huh-7 liver cancer cells. 
Previous research has shown that zemmbone (50 pM) has anti-cancer properties in 
colon cancer adenocarcinoma cell lines (LS174T, LSI80, COLO205, and 
COLO320DM) in a dose-dependent manner (Murakami et al., 2002); and MCF-7 
breast cancer cell line treated by zemmbone (10-25 pM) (Kirana et al., 2003). 
Takada et al. (2005) reported that zemmbone treatment (50 pM) inhibits the 
activation of NF-kB in H I299 (lung adenocarcinoma) cell line, KBM-5 (human 
myeloid) cell line, A293 (human embryonic kidney) cell line and FaDu (human 
squamous cell carcinoma) cell line (Takada et ah, 2005). Murakami et al. (2004) 
demonstrated in vivo that zemmone (810 nM in 100 pi of acetone) may prevent the 
developing of mouse skin cancer. These and our findings support the idea that the 
effects of zemmbone are not cell-type specific.
The results of the LDH assay confirm the ability of zemmbone to inhibit the 
proliferation of Huh-7 cells by more than 50% at 5 pg/ml concentrations or higher in 
a concentration-dependent manner. Similarly, Sakinah et al. (2007) reported that 
zemmbone significantly showed anti-proliferation activity in HepG2 human liver 
cancer cell lines. Our results are also in accordance with studies of several other
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sesquiterpenes in HepG2, MCF-7 and A-549 cells, which revealed anti-proliferative 
effects occurring in a concentration-dependent manner (Turkez et ah, 2013).
The visualisation of dose-related cell shrinkage during morphological examination of 
Huh-7 cells in response to zemmbone treatment supports the assumption of cell 
death via the apoptotic pathway. This result is in agreement with the findings of 
Sakinah et al. (2007), who examined the effects of zemmbone on the HepG2 liver 
cancer cell line.
DNA fragmentation is an early event of apoptosis and represents a point of no-retum 
from the pathway to cell death, due to the absence of new protein synthesis for cell 
survival. In this study, no DNA fragmentation was detected in Huh-7 cells after 
zemmbone treatment, which indicates that cell death may be occurring via an 
alternative pathway, such as necroptosis or programmed necrosis. However, Sakinah 
et al. 2007 demonstrated that zemmbone induced DNA fragmentation in the HepG2 
cell line at a concentration of 3.45 pg/ml, and found that the cleavage of double­
stranded DNA in apoptotic DNA degradation was due to activation of endogenous 
Ca^^/Mg^^-dependent endonucleases. A recent study by Kamalidehghan et al. (2012) 
revealed that no DNA fragmentation was detected in HepG2 cells treated with 
zemmbone at the same concentration, despite the presence of caspase-3 during 
apoptosis. Kamalidehghan et al. (2012) hypothesised that fragmentation of 
condensed chromatin may not be necessary to indicate apoptosis in vitro.
In this study, extemalization of PS was detected using Annexin V-FITC and PI 
staining to differentiate between viable and dead (apoptotic and necrotic) cells. Both 
forms of cell death were identified in Huh-7 cells treated with zemmbone after 24
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and 48 h of treatment. Similar results have been reported by Murakami et ah (2002) 
in COLO205 cells treated with zemmbone. The biochemical basis behind apoptotic 
PS extemalization still not fully understood. The most widely accepted model of PS 
extemalization proposes that an enzyme capable of randomizing PS across the 
plasma membrane is activated during apoptosis (Lee et al., 2013). In addition, other 
models of PS extemalization have been suggested such as, the role for the ATP- 
binding cassette (ABC) transporter ABCl; a polypeptide capable of scrambling PS in 
liposomes in vitro. TMEM16F is also involved in Ca^^-dependent phospholipid 
scrambling in blood cells and a recent model suggested a two-step process starting 
with the intemalization of plasma membrane as cells shrink in apoptosis forming 
intracellular vesicles, which is then trafficked back to the cell surface in a Ca^^- 
dependent manner (Lee et al., 2013).
The PARP enzyme is involved in DNA repair in response to environmental stress 
and programmed cell death (Satoh and Lindahl, 1992). Active PARP helps to sustain 
cell viability, thus cleavage of PARP-1 (deactivation) enables cellular disassembly 
and serves as a marker of cells undergoing apoptosis (Rouleau et al., 2010). In this 
study, zemmbone-induced PARP-1 cleavage was observed at 10 pg/ml and 20 pg/ml 
of zemmbone treatment but not at 5 pg/ml zemmbone. Confirmation of PARP-1 
involvement at the higher concentrations supports the previous observation in 
chapter 4 that the cell death pathway in Huh-7 cells is caspase-dependent, while at 
the 5 pg/ml concentration; the cell death pathway is caspase-independent. A similar 
result was reported when zemmbone induced glioblastoma multiforme (GBM) 
apoptotic cell death, which needs caspase-3 activation (Weng et al. 2012).
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Mitochondrial dysfunction was assessed in this study as a key process of cancer cell 
death. Disruption of the mitochondrial membrane potential (AT^m) is associated with 
regulation of apoptosis and is recognised as a major step in the mitochondrion- 
dependent apoptotic pathway (Zhang et al., 2013; Sobhan et al., 2013). The result of 
this assay showed that Huh-7 cells began to lose mitochondrial membrane potential 
at 10 pg/ml zemmbone treatment, which led to apoptotic cell death. Mitochondrial 
dismption in Huh-7 cells was also observed by Wang et al. (2007).
Determination of the effect of zemmbone on ROS and mtROS production in Huh-7 
cells was one of the aims of this project. The results of our analyses show that 
zemmbone increased the production of the intracellular ROS and mtROS 
significantly in a time- and dose-dependent manner. Generation of ROS can inhibit 
tumour cells by reducing mitochondrial membrane potential, triggering a cascade of 
mitochondria-associated events, contributing to mitochondrial damage, causing the 
release of cytochrome C, which subsequently activating the apoptosis cascade 
(Zhang et al., 2013). Similar increases in ROS production have been detected by 
other researchers in various cancer cell lines (Thoppil and Bishayee, 2011).
In the present study, cell cycle analysis was carried out by PI staining followed by
flow cytometry to examine zemmbone-treated Huh-7 cells. Our results indicated that
zemmbone treatment caused a slight increase in the number of cells in the S phase,
which means that cells were arrested in the S/G2 phase of the cell cycle. Cell cycle
control has been proven to play a major role in ensuring precise cellular division
(Mohan et ah, 2010). The S/G2 phase is regulated by cyclin E and associated cyclin-
dependent kinases (CDKs), such as CDK2, forming a E-CDK2 complex (Lu and
Pfeffer, 2013; Jaganathan et al., 2013). Cyclin E-CDK2 complexes phosphorylate
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and various substrates that promote DNA replication and cell cycle progression 
(Errico and Costanzo, 2010).
LC3 is a soluble protein with a molecular mass of approximately 17 kDa, which is 
used as a marker of autophagy (Tanida et al., 2008). Western blotting revealed that 
LC3 expression was up-regulated in Huh-7 cells in a time- and dose-dependent 
manner after treatment with zemmbone. Human LC3 undergoes post-translational 
modification during autophagy (Wu et al., 2006). Cleavage of LC3 at the carboxyl 
terminus immediately after synthesis yields the cytosolic LC3-I form. LC3-I is 
converted to LC3-II during autophagy, via lipidation by a ubiquitin-like system 
involving Atg7 and Atg3. This modification permits LC3-II to become associated 
with autophagic vesicles (Shimizu et al., 2012). The existence of LC3 in 
autophagosomes and the conversion of LC3 to the lower migrating form LC3-II have 
been used as indicators of autophagy (Kabeya et al., 2004; Hsieh et al., 2012).
To investigate the underlying mechanisms involved in zemmbone-induced cell 
death, apoptosis-related molecules were examined by Western blotting. Results 
indicated that after a 24 and 48 h of zemmbone treatment, levels of activated 
caspase-3, caspase-9 and caspase- 8  remained similar to untreated control levels, 
which confirms that involvement of these caspases in zemmbone-mediated cell death 
is not cmcial in Huh-7 cell death pathways.
To investigate the necroptosis cell death pathway as a form of cell death induced by 
zemmbone, Nec-1 was used as inhibitor of this pathway (Takahashi et al., 2012). 
The results showed that co-treatment with Nec-1 resulted in less cell death in Huh-7 
cells compared with cells treated with zemmbone alone. This Nec-1 afforded
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protection which suggests that cell death may occur by a necroptosis pathway. Nec-1 
prevented osmotic nephrosis and formation of contrast-induced AKI (CIAKI) 
(Linkermann et al., 2013) via the inactivation of receptor-interacting protein 1 
(RIPl). Inactivation of RIP 1 will prevent its interaction with RIP3, and prevent the 
formation of a necrosome, which is essential for necroptosis (Wu et al., 2012).
5.6 Conclusion
Zemmbone inhibited the proliferation of Huh-7 cells in a time- and concentration- 
dependent manner. Cell death mechanism via the apoptosis pathway was illustrated 
by the morphology of Huh-7 cell shrinkage which occurred in a dose-dependent 
manner. PS extemalization was detected by Annexin V-FITC and PI staining in Huh- 
7 cells after 24 and 48 h of zemmbone treatment, confirming the apoptosis cell death 
pathway. Huh-7 cells started to lose mitochondrial membrane potential at 10 pg/ml 
zemmbone treatments, which may lead to apoptotic cell death. Zemmbone-induced 
PARP-1 cleavage supported the involvement of caspase in the cell death pathway at 
higher levels of 1 0  and 2 0  pg/ml zemmbone, while cell death occurred in a caspase 
independent manner at a lower concentration of 5 pg/ml zemmbone.
Zemmbone increased the production of intracellular ROS and mtROS significantly 
in a time- and dose-dependent manner that may have contributed to cell death. 
Zemmbone arrested the Huh-7 cell cycle in S/G2 phase which led to cell death.
Zemmbone 5 and 10 pg/ml up-regulated LC3 expression in a time- and dose- 
dependent in Huh-7 cells; this showed the mechanism of cell death via autophagy.
Caspase-3, caspase-9 and caspase- 8  expression remained unchanged after 24 and 48
h of treatment with zemmbone (5 and 10 pg/ml) compared with untreated control
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Huh? cells. Therefore, cell death was independent of caspase activity. No DNA 
fragmentation was detected in the Huh-7 cell line after zemmbone treatment, which 
indicates that cell death occurred via another cell death pathway in additions to 
apoptosis, such as necroptosis (programmed necrosis). Cell death in Huh-7 cells 
decreased when zemmbone treated cells were co-treated with an anti-necroptosis 
agent Nec-1, which suggests that cell death occurred via the necroptosis pathway.
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6.The effect of zerumbone on the 
human endothelial cell line 
EA.hy926
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6.1 Introduction
Angiogenesis is referred to as the process of sprouting new blood vessels from 
existing ones, to feed a tumour and consequently spread it to other parts of the body. 
This process occurs naturally, essentially to grow and repair organs of the human 
body. It is known that blood vessels provide the necessary oxygen, nutrients, and 
instructive trophic signals to promote organ morphogenesis in the embryonic stage 
(Coultas et al., 2005). Angiogenesis contributes to organ growth after birth, and 
occurs in the placenta during pregnancy and in the cycling ovary during adulthood. 
This angiogenic activity becomes reactivated in response to physiological stimuli 
such as wound healing and repair (Alitalo et al., 2005), and is also critical in the 
development of solid tumours and metastasis (Ferrara, 2004).
Solid tumours develop to a maximum size of 1-2 mm^, at which point vascularisation 
is needed to supply nutrients, oxygen, growth factors, and proteolytic enzymes to the 
tumour (Folkman, 1990). The angiogenic activity of endothelial cells, that involves a 
number of proangiogenic proteins, is activated when a tumour is turned into an 
angiogenic phenotype. This means that it recruits blood vessels from the surrounding 
tissue, and develops a dense vasculature providing nutrients to the cancerous tissue.
There has been a growing interest in angiogenesis in the fields of oncology and 
pharmaceutical development (Fernandez et al., 2009). Brown et al. (2009) have 
reported that the angiogenic potential of endothelial cell tubule formation in MILE 
SVEN 1 (MSI) endothelial cells was inhibited by ginger extract 6 -gingerol, as 
measured by Matrigel assays. This selected ginger bioactive was suggested to have 
an indirect effect on MSI endothelial cell-ftmction either by causing the anti­
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proliferation of endothelial cells by attacking cell formation of blood supply or by 
inhibition of MSI endothelial cell tube formation.
Ginger (50, 75 and 100 pg/ml) has also been recommended as a suitable treatment 
and prevention for ovarian cancer, as it was found to reduce the secretion of Vascular 
Endothelial Growth Factor (VEGF) in such cells (Rhode et al., 2007). Other research 
also reported the phytochemical 6 -gingerol to be highly effective in inhibiting 
endothelial cell tube formation (Brown et al., 2009). 6 -Gingerol was shown to inhibit 
both VEGF- and basic Fibroblast Growth Factor (bFGF)-induced proliferation and to 
cause cell cycle arrest in the G1 phase (Kim et al. 2005). The arrest in G1 phase is 
possibly achieved through the down regulation of cyclin D1 in human endothelial 
cells. It was also found to block capillary-like tube formation by endothelial cells in 
response to VEGF. Moreover, growth of endothelial cells in the rat aorta was 
strongly inhibited; consequently the formation of new blood vessels in the rat cornea 
was affected in response to VEGF (Kim et al., 2005).
Laboratory experiments on malignant B16 melanoma bearing mice confirmed that 6 - 
gingerol inhibited pulmonary metastasis (Suzuki et ah, 1997). Anti-angiogenic 
activities in addition to stimulation of the host's immune functions appeared to be 
partially responsible for the decrease in métastasés (Suzuki et al., 1997; Kim et al., 
2005). Another study investigated the effect of increasing 6 -gingerol concentrations 
on the treatment of human breast cancer MDA-MB-231 cells. This resulted in a 
concentration-dependent inhibition of the adhesion, invasion, motility, and activity of 
cells and a simultaneous decrease in the activities of Matrix Metallopeptidase 
(MMP-2) or MMP-9.
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Zemmbone has also shown the ability to down-regulate the expression of C-X-C 
Chemokine Receptor type 4 (CXCR4) in the human epidermal growth factor 
receptor 2 (HER2)-overexpressing breast cancer cells. This was found to occur in a 
dose- and time-dependent manner through transcriptional regulation and inhibition of 
NF-kB activity, and by suppressing protein and DNA interactions. Zemmbone was 
also confirmed to have the ability to inhibit the CXCL12-induced invasion of breast 
and pancreatic cancer cells by suppressing the CXCR4 expression, thereby acting as 
an antimetastatic agent (Sung et ah, 2008). Recent studies showed that zemmbone 
reduces both VEGF expression and NF-kB activity in gastric adenocarcinoma (AGS) 
cells, thus inhibiting angiogenesis (Tsuboi et ah, 2014). This suggests that 
zemmbone may be considered as a new anti-angiogenic and antitumor treatment 
against gastric cancer.
The aim of this chapter is to investigation the effect of zemmbone on angiogenic 
processes in vitro. The human endothelial hybrid cell line, EA.hy926 was used as a 
model (Bauer et ah, 1992). This type of cell line, being continuous and cloneable, is 
characterised by numerous features of vascular endothelial cells (Edgell et ah, 1983).
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6.2 Aims and objectives
1. To study the morphological changes in zemmbone-induced EA.hy926 cell 
death including changes in cell volume, DNA fragmentation and 
phosphatidylserine externalisation (PS).
2. To study the involvement of caspase gene expression (caspase-3, caspase-9, 
and caspase-8 ) and PARP-1 cleavage in zemmbone-induced EA.hy926 cell 
death.
3. To evaluate the effect of zemmbone on the mitochondrial membrane 
potential as an important parameter of mitochondrial function and used as an 
indicator of cell health.
4. To evaluate the correlation of mitochondrial reactive oxygen species mtROS 
production with the cellular ROS production (ROS and mtROS) in response 
to zemmbone injury in EA.hy926 cells.
5. To examine the effect of zemmbone on the EA.hy926 cell cycle at different 
time points/concentrations of zemmbone treatment.
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6.3 Materials and methods
Materials and methods were carried out as described in section 4.2 chapter 4.
6.3.1 Cell culture and treatment
The human endothelial hybrid cell line EA.hy926 was derived by fusion of primary 
human umbilical vein endothelial cells with cells of the human lung carcinoma cell 
line A549 (Emeis and Edgell, 1988). This cell line (our laboratory stock) was 
obtained from the European Collection of Cell Cultures (ECACC) Salisbury, UK. 
EA.hy926 cells were grown in Dulbecco’s modified Eagle's medium (DMEM) 
containing 10% foetal bovine serum (FBS), 1% penicillin/streptomycin and 2mM L- 
glutamine (complete medium). Cells were seeded in T75 cm^ flasks and maintained 
at 37°C in air with 5% CO2 , and were sub-cultured every three days using complete 
culturing medium. For sub-culturing, cells were plated at 1:10 dilution, and washed 
with 1 ml PBS and then detached using 2 ml of trypsin/EDTA.
Cells were treated with different zerumbone concentrations (1,5, 10 and 20 pg/ml = 
4.6, 23,46 and 92 pM, respectively).
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6.4 Results
6.4.1 Zerumbone induced cell death in EA.hy926 cells
Cells treated with 1, 5, 10, and 20 pg/ml zerumbone showed time- and 
concentration-dependent induction of cell death as measured by LDH release at 24 
and 48 h (Figure 57). At both time points, 10 pg/ml zerumbone treatment caused 
significantly more cell death compared with untreated cells (40.6%, p<0.05 and 73.1 
% p<0.001 for 24 h and 48 h, respectively). Cell death increased even further to 
approximately 44.6% after 24 h exposure to 20 pg/ml zerumbone (Figure 57 A; 
p<0.01) and to 81.2% of treated cells after 48 h treatment with 20 pg/ml zerumbone 
(Figure 57 B; p<0.001).
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Figure 57 The effect o f zerumbone on lactate dehydrogenase (LDH) release 
from the EA.hy926 cell line.
Cells were treated with 1, 5, 10 and 20 pg/ml zerumbone (ZM). LDH release was measured 
at 24 h (A) and 48 h (B). Data represent the mean ± SEM of three independent experiments. 
Comparisons of means were made using a one-way ANOVA followed by Bonferroni’s post 
hoc test (* = p < 0.05; ** = p < 0.01; *** = p < 0.001).
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6.4.2 Morphological changes associated with zemmbone- 
induced toxicity
The effect of zerumbone on EA.hy926 cell size and shape was detected by 
microscopy at 24 and 48 h (Figure 58 and Figure 59, respectively). When cells were 
exposed to 5 and 10 pg/ml zerumbone, degenerated and rounded cells were clearly 
visible in the culture medium compared with healthy untreated control cells at both 
time points.
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Figure 58 Microscopy images for the effect of zerumbone on EA.hy926 cell 
morphology at 24 h.
Cells w ere treated  w ith  zerum bone for 24 h. (A) U ntreated  cells, (B) cells trea ted  w ith  5 
pg/m l and (C) cells treated  w ith  10 pg/m l zerum bone. Im ages w ere captured using  a L eica 
D M LB m icroscope (m agnification: lOX).
150
The effect of ginger active component (Zerumbone) on human eancer cells
Figure 59 Microscopy images for the effect of zerumbone on EA.hy926 cell 
morphology at 48 h.
Cells w ere treated w ith  zerum bone for 48 h. (A) U ntreated  cells, (B) cells treated  w ith  5 
pg/m l and (C) cells treated  w ith 10 pg/m l zerum bone. Im ages w ere captured using  a L eica 
D M LB  m icroscope (m agnification: lOX).
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6.4.3 The effect of zerumbone on DNA fragmentation
DNA fragmentation is a sign of apoptosis; however, in contrast to classic apoptosis, 
DNA fragmentation was absent (Figure 60). Inducing classical apoptosis by 
staurosporine showed a population of cells in sub G1 (Chapter 4, figure 20 D) when 
cells were stained with PI and analysed by flow cytometry. No untreated control or 
zemmbone-treated cells were present in the sub G 1 quadrant, indicating the cell 
death occurred without DNA fragmentation (Figure 60).
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Figure 60 Flow cytometry analysis o f DNA fragmentation in zem m bone- 
treated EA.hy926 cells.
EA .hy926 cells w ere treated  w ith  zem m bone (5 and 10 pg/m l) and fixed in 70%  ethanol at 
24 h, fo llow ed by  stain ing w ith  10 pi o f  1 m g/m l propidium  iodide stock. (A) U ntrea ted  cells 
(B) cells treated  w ith 5 pg/m l and (C) cells treated w ith 10 pg/m l zerum bone (D ) cells 
treated  w ith  2 pM  staurosporine.
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6.4.4 The effects of zerumbone on phosphatidylserine (PS) 
externalisation
When EA.hy926 cells were treated with 5 and 10 pg/ml zerumbone for 48 h, the 
number of PI positive cells (C4 quadrant) increased significantly in a concentration- 
dependent manner (24 h: Figure 61 and 48 h: Figure 62). In comparison, the number 
of annexin-V positive cells in C2 and C3 increased slightly compared to the cells in 
C4. EA.hy926 cells in the C3 quadrant have either undergone necrosis, making their 
membranes penetrable to PI or annexin-V or are in the late phase of apoptosis.
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Figure 61 Zerumbone toxicity is associated with phosphatidylserine 
externalisation at 24 h.
Flow  cytom etry  im age show s EA .hy926 cells treated  w ith  zem m bone. (A) U ntreated  cells, 
(B) cells treated  w ith  5 pg/m l zem m bone and (C) 10 pg/m l zem m bone. C ells w ere harvested  
and stained w ith propidium  iodide (PI) and A nnexin  V  (AY). C 1-C 4 indicates the quadrant 
on the flow  cytom eter image. C l =  U nstained healthy cells; C2 =  Cells conjugated  w ith  A Y  
only; C3 =  Cells conjugated w ith A Y  and stained w ith PI; C4 =  C ells stained w ith  PI only.
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Figure 62 Zerumbone toxicity is associated with phosphatidylserine 
externalisation at 48 h.
Flow  cytom etry  im age show s E A .hy926 cells treated  w ith  zem m bone. (A) U ntreated  cells, 
(B) cells treated  w ith  5 pg/m l zem m bone and (C) 10 pg/m l zem m bone. C ells w ere harvested  
and stained w ith  propidium  iodide (PI) and A nnexin  V  (AY). C 1-C 4 indicates the quadrant 
on the flow  cytom eter im age. C l =  U nstained  healthy  cells; C2 = C ells con jugated  w ith  A Y  
only; C3 = Cells conjugated w ith  A Y  and stained w ith PI; C4 =  C ells stained w ith  PI only.
6.4.5 The effect of zerumbone on PARP-1 cleavage
As shown in (Figure 63-A), 10 pg/ml o f zemmbone eaused PARP-1 cleavage, which 
is an indicator o f apoptosis pathway activation. However, at (5 pg/ml), PARP-1 did 
not get cleaved; indicating that cell death at 5 pg/ml is initiated in a caspase- 
independent manner. In contrast, after 48 h o f zemmbone treatment, both 5 and 10 
pg/ml eaused PARP-1 cleavage (Figure 63-B).
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Figure 63 Western blot of PARP-1 expression in EA.hy926 cells treated with  
zerumbone.
Protein  w as ex tracted  from  E A .hy926 cells after treatm ent w ith 5, 10 and 20 pg/m l 
zem m bone for 24 h (A) and 48 h (B). PA R P-1=  116, 89 kDa. Equal p ro te in  load ing  (20 
pg/m l) p er lane w as determ ined using P-actin expression.
154
The effect of ginger active component (Zerumbone) on human cancer cells
6.4.6 Mitochondrial dysfunction in zemmbone-induced EA.hy926 
cytotoxicity
The TMRE fluorescent probe was used to measure mitochondrial membrane 
polarisation (ATm) and to determine the effect of zerumbone treatment on this 
parameter. TMRE dye accumulation by mitochondria is proportional to A'Pm, where 
the greater AYm polarisation, the more TMRE dye is accumulated in the matrix of 
mitochondria. The results of this experiment showed that EA.hy926 cells treated for 
24 h with 5 and 10 pg/ml zerumbone underwent dose-dependent decreases in AYm 
(Figure 64). The TMRE dropped to 22.8% at 10 pg/ml zerumbone treatment 
compared with 39.7% for untreated cells (p<0.05).
1 0 0
Figure 64 The response o f TMRE fluorescence to mitochondrial depolarisation  
caused by zerumbone.
EA.hy926 cells were treated with zerumbone for 24 h. Cells were loaded with 10 nM TMRE 
probe for 40 min. The data represent the mean ± SEM of three independent experiments. 
Comparisons of means were made using a one-way ANOVA followed by Bonferroni's post 
hoc test (* = p < 0.05; ** = p < 0.01; *** = p < 0.001).
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6.4.7 The effect of zerumbone on ROS production
ROS production increased significantly in response to zerumbone treatment, which 
triggered the cascade of events that resulted in cell death of EA.hy926 cells (Figure 
65). Intracellular levels of ROS increased to 64.2% after 24 h of 5 pg/ml treatment 
with zerumbone and to 82% 1 0  pg/ml zerumbone at the same time point.
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Figure 65 Zerumbone induces reactive oxygen species (ROS) in a dose- 
dependent manner.
EA.hy926 cells were treated with 5 and 10 pg/ml zerumbone (ZM) for 24 h. Cells were 
loaded with CM-H]DCFDA and DCF fluorescence was measured by flow cytometry to 
monitor ROS formation. The data represent the mean ± SEM of three independent 
experiments. Comparisons of means were made using a one-way ANOVA followed by 
Bonferroni's post hoc test (* = p < 0.05; ** = p < 0.01; *** = p < 0.001).
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6.4.8 Zerumbone-induced mitochondrial ROS (mtROS)
To assess the role of zemmbone in mitochondrial mtROS production in EA.hy926 
cells, the fluorescent dyes MitoSox was used. The analysis confirmed that 
zemmbone induces mtROS production in a concentration-dependent manner, which 
increases the fluorescent products of MitoSox oxidation to 54.7% and 70.4% when 
EA.hy926 cells are treated by 5 and 10 pg/ml zemmbone respectively (Figure 6 6 ), 
(No significant differences between control and treated cells).
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Figure 66 Zerumbone-induced mtROS production in EA.hy926 cells.
EA.hy926 cells were treated with 5 and 10 pg/ml zemmbone (ZM) for 24 h. Cells were 
loaded with MitoSox stains and the fluorescence was measured by flow cytometry to 
monitor mtROS formation. The data represent the mean ± SEM of three independent 
experiments. Comparisons of means were made using a one-way ANOVA followed by 
Bonferroni's post hoc test.
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6.4.9 The effect of zerumbone on cell cycle progression
In this experiment, zemmbone arrested a small number of cells in the S/G2 phase of 
the cell cycle (Figure 67-B and C) after treatment with 5 and 10 pg/ml zemmbone 
compared with control. As a positive control, apoptosis was initiated by 
staurosporine, which is known to block the cell cycle at the S/G2 phase (Chapter 4, 
Figure 20-D).
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Figure 67 Cell cycle analysis of the EA.hy926 cell line treated with zerumbone 
for 24 h.
E A .hy926 cells w ere treated  w ith  zem m bone 5 and 10 pg/m l, fixed in 70%  ethanol at 24 h, 
and  then  stained w ith 10 pi o f  1 m g/m l propid ium  iodide stock. (A) U ntreated  cells, (B) cells 
treated  w ith 5 pg/m l (C) 10 pg/m l zem m bone and (D) cells treated  w ith 2 pM  staurosporine.
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6.4.10 The effect of zerumbone on EA.hy926 cell autophagy
In this experiment, LC3 expression was assessed by Western blotting to detect the 
formation of autophagosomes. The results revealed that LC3 was up-regulated in a 
dose-dependent manner after 24 h (Figure 6 8 -A). However, after 48 h there was no 
major difference in the expression of LC3 between untreated and treated cells 
(Figure 6 8 -B).
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Figure 68 Western blot of LC3 expression in EA.hy926 cells treated with 
zerumbone.
Protein  w as ex tracted  from  EA .hy926 cells a fter treatm ent w ith  5 and  10 pg/m l zem m bone 
for 24 h (A) and 48 h (B). LC 3= 14, 16 kD a. E qual pro tein  loading (20 pg /m l) p er lane w as 
determ ined using  P-actin expression.
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6.4.11 The effect of zerumbone on caspase-9 activity
Caspase-9 plays a major role in apoptotie cell death. However, the role of caspase-9 
in zerumbone-induced apoptosis in EA.hy926 cells is still unclear. In this 
experiment, caspase-9 expression was equally detected in EA.hy926 cells treated 
with 5 pg/ml zemmbone for 24 h and in untreated control cells. However, there was 
a decrease in caspase-9 expression at 10 pg/ml treatment compared with the 
untreated cells (Figure 69-A). After 48 h zemmbone treatment, there was little or no 
detection of easpase-9 expression after either 5 or 10 pg/ml zemmbone treatment, but 
expression of caspase-9 in untreated control cells was still detected (Figure 69-B). 
No easpase-9 cleavage was observed by Western blotting at either time or 
zemmbone concentration.
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Figure 69 Western blot of caspase-9 expression in EA.hy926 cells treated with  
zerumbone.
Protein  was extracted  from  EA .hy926 cells after treatm ent w ith  5 and  10 pg/m l zem m bone 
for 24 h (A) and 48 h (B). C aspase-9=  47, 37 kDa. Equal protein  loading (20 pg /m l) p e r lane 
w as detenn ined  using  p-actin expression.
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6.4.12 The effect of zerumbone on caspase-3 activity
Caspase-3 activation is also known to induce apoptotic cell death, whieh induees the 
proeessing of easpases downstream of apoptotie eell death. Western blotting analysis 
of easpase-3 showed that no ehange in easpase-3 expression was observed in 
EA.hy926 cells treated with 5 pg/ml zerumbone, but that expression was 
eonsiderably decreased at 10 pg/ml treatment for 24 h versus untreated control 
(Figure 70-A). Opposite to this, at 48 h of zerumbone treatment, caspase-3 
expression was not deteeted at 5 pg/ml zerumbone, but was highly expressed at 10 
pg/ml zerumbone (Figure 70-B). No caspase-3 eleavage was observed by Western 
blotting at either time or coneentration, indicating that caspase-3 may not have been 
activated.
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Figure 70 Western blot of caspase-3 expression in EA.hy926 cells treated with 
zerumbone.
Protein  was extracted from  E A .hy926 cells after treatm ent w ith  5 and 10 pg/m l zerum bone 
for 24 h (A) and 48 h (B). C aspase-3=  35, 19 and 17 kDa. Equal p ro tein  loading (20 pg/m l) 
p er lane w as determ ined using p-actin  expression.
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6.4.13 The effect of zerumbone on caspase-8 activity
caspase- 8  (Cas-8 ) activity was measured by Western blotting following treatment of 
EA.hy926 cells with 5 and 10 pg/ml zerumbone for 24 and 48 h (Figure 71-A and B 
for each time point). There was no major difference in caspase- 8  expression between 
EA.hy926 treated and untreated cells after 24 h (Figure 71-A). At 48 h, caspase- 8  
expression was very low at 5 pg/ml treatment, but was high at 10 pg/ml compared 
with the untreated control (Figure 71-B). No caspase- 8  cleavage was observed by 
Western blotting at either time or coneentration.
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Figure 71 Western blot of caspase-8 expression in EA.hy926 cells treated with 
zerumbone.
Protein  w as extracted from  E A .hy926 cells after treatm ent w ith  5 and 10 pg/m l zerum bone 
for 24 h (A) and 48 h (B). C aspase-8=  57 and 10 kD a. Equal pro tein  loading (20 pg/m l) per 
lane w as determ ined using P-actin expression.
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6.4.14 The effects of Nec-1 on zerumbone-induced EA.hy926 cell 
death
Necrostatin-l (Nec-1), which is used as a necroptosis pathway inhibitor caused a 
significant decrease in LDH release (to 39.9%) after cells were treated with a 
combination of 10 pg/ml zerumbone and Nec-1 compared with when EA.hy926 were 
treated with 10 pg/ml zerumbone alone (66.4%; p<0.01 Figure 72).
1 0 0 n
Figure 72 The effects o f Nec-1 on zerumbone-induced EA.hy926 cell death.
EA.hy926 cells were treated for 48 h with zerumbone (ZM) alone or in combination with 50 
pM Nec-1. LDH released was measured after 48 h. Cell death is expressed as a percentage of 
total cellular LDH release, with each bar representing the mean ± SEM of three independent 
experiments. Comparisons of means were made using a one-way ANOVA followed by 
Bonferroni's post hoc test (* = p < 0.05; ** = p < 0.01; *** = p < 0.001).
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6.5 Discussion
Angiogenesis is a process where new blood vessels form and develop. This process 
is a key element in the formation of a new vascular network to supply oxygen, 
nutrients, and immune cells, in addition to removal of waste products for cancer cells 
(Nishida et al., 2006).
The human endothelial EA.hy926 cell line was used as a model for angiogenic 
processes in vitro, to assess the effects of zerumbone as an anticancer agent that 
works via blocking the development of blood vasculature in cancer. This study 
assessed the cell death effects of zerumbone on EA.hy926 cells by the LDH assay, 
which is based on the leakage of LDH through compromised plasma membranes. 
LDH is a soluble cytoplasmic enzyme that exists in cells, which is only released into 
the extracellular space when the plasma membrane is damaged (Chan et ah, 2013). 
The results revealed that 10 pg/ml and 20 pg/ml zerumbone incubated for 24 and 48 
h caused a significant LDH release. Anti-proliferation effects were clearly observed 
by morphology changes in EA.hy926 cells using light microscopy, where clear 
rounded cells undergoing shrinkage were detected. Cells detached from the culture 
surface and the reduced numbers of cells present were also indicators of cell death. 
Similar results were reported by Arezki et al. (2011), who demonstrated that 
curcuminoid derivatives caused EA.hy926 cell death.
In order to characterise the type of zerumbone-induced cell death occurring in 
EA.hy926 cells, the annexin-V assay were used to detect the translocation of 
membrane PS from the inner side of the plasma membrane to the surface. The result
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indicated that EA.hy926 cells underwent classical early and late apoptosis in 
response to zerumbone, in time- and dose-dependent manner.
In contrast, when the DNA fragmentation assay was used to assess the cell death 
pathway, no DNA fragmentation was detected in cells treated with zerumbone. This 
result either supports the idea that DNA fragmentation is not necessary for the 
apoptosis pathway, or that EA.hy926 cell death induced by zerumbone occurred via 
different cell death pathway such as necroptosis (Buonanno et ah, 2008; 
Christofferson and Yuan, 2010; Dunai et al., 2011). The existence of PARP-1 
cleavage was also assessed as another cell death marker. Our results support previous 
observations that PARP-1 cleavage can be detected at 10 pg/ml zerumbone treatment 
but not at 5 pg/ml, which indicates that a combination of cell death pathways are 
responsible for the induction of cell death by zerumbone in the EA.hy926 cell line 
(Kam et ah, 2012).
To investigate the role of mitochondria in zerumbone-induced cell death in 
EA.hy926 cells, the mitochondrial membrane potential was analysed. Zerumbone- 
induced mitochondrial-dependent cell death following loss of mitochondrial 
membrane potential occurred in dose-dependent manner. This early apoptotic death 
process (Maney et al., 2011) was detected at 10 pg/ml zerumbone treatment but not 
at 5 pg/ml, which means the death pathway induced by zerumbone at 10 pg/ml is 
different from that induced by 5 pg/ml.
Zerumbone increased both ROS and mtROS production as a mechanism to induce 
cell death in EA.hy926 cells. Cell death induced by zerumbone has been shown to be 
mediated by ROS and mtROS that may trigger the mitochondrial pathway in other 
research (Buonannoa et ah, 2008; Sciullo et ah, 2010).
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A small number of EA.hy926 cells were arrested in S/G2 phase after zerumbone 
treatment. S/G2 phase-arrest illustrates the involvements of cyclin-dependent kinases 
E-CDK2 and cyclin A-CDK2. These factors regulate S phase and keep replication to 
only once per cell cycle. Such checks and balances help to prevent inappropriate 
DNA replication. The S/G2 checkpoint is controlled by ataxia telangiectasia mutated 
serine-protein kinase (ATM) signals through a comprehensive network of proteins, 
which lead to CDK2 inhibition and ultimately the prevention of DNA synthesis 
(Woo and Poon, 2003).
LC3 was used as a marker of autophagic cell death, to complete the investigation of 
cell death pathways. Changes in cellular LC3 level are connected to the dynamic 
turnover of LC3 through the lysosome; i.e. autophagic activity (Mizushima and 
Yoshimori, 2007). The results in the present study show no major change in LC3 
expression, which suggests that autophagy is not involved in zerumbone-induced cell 
death in this cell line.
The expression of caspase-3, caspase-9, and caspase- 8  was investigated to determine 
their involvement in zerumbone-induced EA.hy926 cell death. Caspase-9 expression 
in EA.hy926 cells decreased on treatment with 10 pg/ml zerumbone for 24 h and no 
expression was detected in cells after 48 h for both 5 and 10 pg/ml zerumbone 
treatments. Caspase-3 and caspase- 8  were also not expressed at detectable levels 
when exposed to 5 pg/ml zerumbone for 48 h. These easpases are a cluster of 
intracellular cysteine proteases that cause the characteristic morphological changes 
associated with apoptosis (Jiang and Wang, 2000).
Necrostatin-l (Nec-1), which is used as a necroptosis pathway inhibitor was
implemented in this study to assess the role of necroptosis zerumbone-induced
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EA.hy926 cell death. The investigation showed that cell death (10 pg/ml) 
significantly decreased after treatment with zerumbone and Nec-1 combined, 
compared with zerumbone alone. This result indicates that zerumbone causes death 
by necroptosis, which is a previously reported finding (Han et ah, 2009), and that 
Nec-1 protects cells from this fate. Nec-1 specifically inhibits necroptosis, but does 
not affect apoptosis or autophagy (Degterev et ah, 2008).
6.6 Conclusion
Zerumbone significantly increased the LDH level of EA.hy926 cells in a time and 
dose dependent manner indicating cell death of cancer cells.
Anti-proliferation effects of zerumbone were clearly observed by morphology 
change in EA.hy926 cells; rounded, shrunk cells were detected, and decreased 
numbers of cells were visible. Zerumbone induced PS externalisation in EA.hy926 
cells, which underwent a classical apoptosis pathway; in particular, early and late 
apoptosis phases increased in a time and dose dependent manner. Zerumbone 
induced PARP-1 cleavage in 10 pg/ml of zerumbone treatment but not in (5 pg/ml), 
which indicates that the combination of cell death pathways were induced by 
zerumbone in EA.hy926 cell line.
Zerumbone induced mitochondrial-dependent cell death following loss of 
mitochondrial membrane potential in a dose-dependent manner. Zerumbone was able 
to increase the ROS and mtROS production as a mechanism to induce cell death in 
EA.hy926.
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Zerumbone arrested the cell cycle in S/G2 phase in EA.hy926 cells. No DNA 
fragmentation was detected in EA.hy926 cells after zerumbone treatment.
No major change in LC3 expression after zerumbone treatment in EA.hy926 cell 
lines was observed indicating that cell death by the autophagy pathway did not occur. 
EA.hy926 showed a significant decrease in cell death after zerumbone and Nec-1 
combined treatment compared to zerumbone alone, which indicates that zerumbone 
killed the EA.hy926 cells via the necroptosis cell death pathway.
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7. The synergistic effects of 
zerumbone and chemotherapy 
agents in a human cancer cell line
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7.1 Introduction
7.1.1 Chemotherapy
The literal definition of chemotherapy is drug treatment, where cancer ehemotherapy 
refers to the treatment with cell killing (cytotoxic) dmgs. This may involve a single 
drug or a combination of chemotherapy drugs. Chemotherapy provides one type of 
cancer treatment but other cancer treatments like surgery are available. 
Chemotherapy works by the dmgs entering the bloodstream and damaging dividing 
cells (Shuck and Turchi, 2010). This is achieved by damaging the centre controlling 
cell division in each cell in order to avoid any intermption to other chemical 
processes involved in cells (Wang et al., 2005).
7.1.2 Colon cancer therapy
The second leading cause of death in Western countries is colorectal cancer; about 
50% of patients who have undergone surgery relapse and die fi*om metastatic disease 
(Jemal et al, 2010; Agrawal, 2012). It is, however, possible to predict survival from 
a colon tumour in its early stages by determining its spread in the bowel wall and 
lymph nodes involved. 5-Fluorouracil, also known as 5FU, is the chemotherapy 
dmg commonly used to treat colon cancer (Glimelius et al, 2011). Treatment with 
this dmg is often supported by folinic acid, capecitabine (Xeloda), irinotecan 
(Campto), and oxaliplatin (Eloxatin) (Agrawal, 2012).
170
The effect of ginger active component (Zerumbone) on human cancer cells
7.1.2.1 O xalip latin  (E loxatin)
Oxaliplatin, a chemotherapy drug based on platinum and similar to cisplatin and 
carboplatin, is used for the treatment of colon cancer, oesophageal cancer, and 
stomach cancer (Alcindor and Beauger, 2011). Clinical trials are still on going to 
determine efficacy against various other cancer types. This drug however, causes a 
number of side effects such as a temporary drop in the number of blood cells made 
by the bone marrow, fatigue, numbness or tingling, feeling or being sick, diarrhoea, 
sore mouth, taste changes, back pain, kidney damage, hair loss, allergic reactions, 
and loss of fertility (Alcindor and Beauger, 2011).
7.1.3 Liver cancer therapy
Although liver cancer has historically been relatively rare in the UK, the number of 
people suffering from this disease is inereasing. Currently, about 4,200 people are 
diagnosed with liver cancer in the UK each year, with most cases identified in men 
and in older people; approximately 9% of these cases are diagnosed in people over 
the age of 55 years (Ladep et al, 2014). While liver cancer starts from the cells of 
the liver, it is often found to spread to other organs in the body. Transarterial infusion 
chemotherapy includes introducing the chemotherapy drug directly into the main 
artery of the liver (hepatic artery), giving the liver cancer a high dose of 
chemotherapy that causes the tumour to shrink. With this method, fewer side effects 
are encountered compared with chemotherapy into the bloodstream (systemic 
chemotherapy) (House et al., 2011). Advanced primary liver cancer can be treated 
with oral tablets or through a drip into a vein to provide systemic chemotherapy. The
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drugs commonly used to treat liver cancer are doxorubicin (Adriamycin) and 
cisplatin (Platinol) (Albert et al, 2011).
7.1.3.1 C isp latin  (P latinol)
In the late 1970s, cisplatin was confirmed to be suitable for the treatment of testicular 
and ovarian cancer; it is also widely used to treat other types of cancer, such as head 
and neck cancer, bladder cancer, cervical cancer, and non-small cell lung cancer. 
Cisplatin causes severe nephrotoxic, neurotoxic and ototoxic side effects and 
consequently its dosing is limited (Aggarwal and Fadool, 1993).
Patients undergoing a chemotherapeutic procedure may suffer from uncomfortable 
adverse effects caused by the toxicity of cytotoxic drugs such as cisplatin. These 
side effects include kidney malfunction, nausea and vomiting, nerve damage, 
impairment of sight, suppression of the bone marrow and, rarely, seizures. For this 
reason, alternatives to these toxic chemotherapeutics are required. Synergy is 
referred to in preclinical systems as the use of two classes of agents for treatment. 
Abdul et a l  (2009) reported that the combination of zerumbone and cisplatin 
modulates the serum level of interleukin 6  when compared with the treatment with 
isotonic sodium chloride solution (control) in cervical tissues from female BALB/c 
mice.
The hypothesis of this chapter is that the combination of zerumbone with oxaliplatin 
or cisplatin will work synergistically to treat colon and liver cancer in vitro, 
respectively. As far as we are aware, this is the first study conducted on the effect of 
the combination of zerumbone and chemotherapy drugs on human colon and liver 
cells.
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7.2 Aims and objectives
1. To investigate the morphological changes (cell volume and 
phosphatidylserine externalisation) during cell death induced by zerumbone- 
in combination with oxaliplatin in the Caco-2 cell line.
2 . To study the involvement of caspase (caspase-9, caspase-8 ) gene expression 
and PARP-1 expression in - cell death induced by zerumbone in combination 
with oxaliplatin in the Caco-2 cell line.
3. To investigate the morphological changes (cell volume and 
phosphatidylserine externalisation) during - cell death induced by zerumbone 
in combination with cisplatin in the Huh-7 cell line
4. To study the involvement of caspase-9 gene expression and PARP-1 
expression in - cell death induced by zerumbone in combination with 
cisplatin in the Huh-7 cell line.
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7.3 Materials and methods
Materials and methods were carried out as described in section 4.2 chapter 4 
methods.
7.3.1 Cell culture and treatment for Caco-2 cell line
Materials and methods were carried out as described in section 4.2.2.1 chapter 4 
methods.
Cells were treated with different zerumbone concentrations (5 and 10 pg/ml = 23 and 
46 pM).
7.3.2 Cell culture and treatment for Huh-7 cell line
Materials and methods were carried out as described in section 5.3.1 chapter 5 
methods.
Cells were treated with different zerumbone concentrations (5 and 10 pg/ml = 23 and 
46 pM).
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7.4 Results
7.4.1 The synergistic effects of zerumbone and oxaliplatin in the 
Caco-2 cell line
7.4.1.1 Zerumbone and oxaliplatin inhibit the proliferation of Caco-2 
cells
Caco-2 cells treated with 5, 10, 20, 25 and 50 pM oxaliplatin showed time- and 
concentration-dependent cytotoxicity as measured by LDH release at 24 and 48 h 
(Figure 73-A and Figure 74-A, respectively). At 24 h, oxaliplatin treatment caused a 
significant decrease in cell viability at 25 and 50 pM (77.2%, p<0.05 and 40.5%, 
P<0.001, respectively), compared with 98.1% viability for untreated cells (Figure 73- 
A).
Caco-2 cells were incubated with 5 pg/ml zerumbone in addition to 5, 10, 20 and 50 
pM oxaliplatin in order to assess the effect of the combined treatment on the Caco-2 
cell line. The combined treatment caused significant increase in cytotoxicity as 
measured by LDH release compared with oxaliplatin alone (Figure 73-B). 
Cytotoxicity increased to 73.6% and 75.7%, (both p<0.05) and 79.5% (p<0.01) at 5 
pg/ml zerumbone plus 10, 20, and 50 pM oxaliplatin, respectively. The combination 
of 10 pg/ml zerumbone plus 5, 10, 20 and 50 pM oxaliplatin caused a significant 
increase in cell death to 74.3% and 76.4%, (both p<0.01) and 84.1% and 85.9% (both 
p<0.001), respectively (Figure 73-C).
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Figure 73 Zerumbone and oxaliplatin inhibit the proliferation o f Caco-2 cells at 
24h.
LDH release was measured following treatment of cells with zerumbone (ZM) and 
oxaliplatin (Oxi) for 24 h. (A) Cells treated with various Oxi concentrations only, (B) cells 
treated with 5 pg/ml ZM and various Oxi concentrations, (C) cells treated with 10 pg/ml ZM 
and various Oxi concentrations. The data represent the mean ± SEM (n=3) of three 
independent experiments. Comparisons of means were made using a one-way ANOVA 
followed by Bonferroni's post hoc test (* = p < 0.05; ** = p < 0.01; *** = p < 0.001 versus 
control).
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Oxaliplatin 20, 25, and 50 pM caused increased LDH release after 48 h treatment 
(27.8%, p<0.05; 36.2%, p<0.01; and 52.9%, p<0.001, respectively) (Figure 74-A). 
The combination treatment of 5 pg/ml zerumbone and various concentrations of 
oxaliplatin revealed a significant increase in the cytotoxicity on Caco-2 to 88.2%, 
88.3%, 91.3% and 94.5% (p<0.001) for 5, 10, 20 and 50 pM oxaliplatin with 5 pg/ml 
zerumbone, respectively (Figure 74-B).
Similar cytotoxicity was observed when using the combination of 10 pg/ml 
zerumbone and oxaliplatin 5, 10, 20 and 50 pM, where 91% (p<0.01), 94.6%, 97.5% 
and 97.6% (p<0.001), of maximum LDH release was measured respectively (Figure 
74-C).
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Figure 74 Zerumbone and oxaliplatin inhibit the proliferation of Caco-2 cells at 
48 h.
LD H  release w as m easured  fo llow ing treatm ent o f  cells w ith zerum bone (ZM ) and 
oxalip latin  (O xi) for 48 h. (A) C ells treated  w ith  various O xi concentrations only, (B ) cells 
treated  w ith  5 pg/m l ZM  and various Oxi concentrations, (C) cells treated  w ith 10/m l pg  ZM  
and various Oxi concentrations. The data represen t the m ean ±  SEM  (n=3) o f  three 
independent experim ents. C om parisons o f  m eans w ere m ade using a one-w ay A N O V A  
follow ed by  B onferroni's p o st hoc test (* =  p < 0.05; ** =  p <  0.01; *** =  p <  0.001 versus 
control).
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7.4.1.2 M orpholog ica l changes associated  w ith  oxalip latin  and  
zerum bone toxicity
The effects of the zemmbone/oxaliplatin combination on Caco-2 cell degeneration 
were clearly greater than the effects of oxiloplatin alone. For example, the number of 
visible viable cells was decreased substantially at 5 pg/ml zemmbone with 20 pM 
oxaliplatin, compared with 20 pM oxaliplatin alone at 24 h (Figure 75). Similar 
results were obtained for 48 h of treatment with the same chemotherapeutic treatment 
at 5 pg/ml zemmbone with 20 pM oxaliplatin (Figure 76).
Control 5 ^gZ M 10 ug ZM
ï-iægSs mmm
5 uM 0x1 5 fiM 0x1 + 5 ^g ZM 5 uM 0x1 + 10 iig ZM
20 fiM Oxi 20 ^M Oxi + 5 iig ZM 20 uM 0x1 + 10 ug ZM
Figure 75 Microscopy images for the effects of zerumbone and oxaliplatin on 
Caco-2 cell morphology at 24 h.
C ells w ere treated  w ith various concentrations o f  zerum bone (ZM ) only, o r oxalip latin  (O xi) 
only, or treated w ith  m ixture o f  ZM  w ith Oxi for 24h and com pared w ith  an un trea ted  
control. Im ages w ere captured using a Leica D M LB  m icroscope (m agnification: lOX).
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Figure 76 Microscopy images for the effects of zerumbone and oxaliplatin on 
Caco-2 cell morphology at 48 h.
C ells w ere treated  w ith  various concentrations o f  zem m bone (ZM ) only, o r oxalip latin  (O xi) 
only  or w ith  a m ixture o f  ZM  w ith  Oxi for 48h and eom pared w ith  an  un treated  control. 
Im ages w ere captured using  a L eica D M LB  m icroscope (m agnification: lOX).
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7.4.1.3 T he effects o f  zerum b on e and oxalip latin  on C aco-2  
p h osp h atid y lserin e (PS) externalisation
At 24 h, the number of cells in early and late apoptotic stages (C2 and C3 quadrants, 
respectively) was increased by the combination treatment with zerumbone and 
oxaliplatin in comparison with oxaliplatin only. For example, after 24 h treatment 
with 5 pM oxaliplatin with 10 pg/ml zerumbone, the late apoptotic cell-population 
was larger than with 5 pM oxaliplatin only (Figure 77).
PS externalisation was associated with dose and time in the eombined treatment 
group. Figure 78 shows the substantial increase in the late apoptotie cell population 
after 48 h treatment with 5 pM oxaliplatin with 10 pg/ml zerumbone, compared with 
5 pM oxaliplatin only.
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Figure 77 Zerumbone and oxaliplatin treatment is associated with  
phosphatidylserine externalization at 24 h.
Flow  cytom etry im ages show  C aco-2 cells treated  w ith  various concentrations o f  oxalip latin  
(O xi) only  or w ith  a m ixture o f  zem m bone (ZM ) + Oxi for 24 h. Cells w ere harvested  and 
stained w ith  p ropid ium  iodide (PI) and A nncxin  V  (A V ). C 1-C 4 indicates the quadrant on 
the flow  cytom eter im age. C l =  H ealthy  cells; C2 =  C ells conjugated  w ith  A V  only; C3 = 
Cells conjugated w ith  A V  and stained w ith PI; C4 =  C ells sta ined  w ith  PI only.
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Figure 78 Zerumbone and oxaliplatin treatment is associated with 
phosphatidylserine externalization at 48 h.
Flow  cytom etry  im ages show  C aco-2 cells treated  w ith  various concentrations o f  oxalip latin  
(O xi) only or w ith  a m ixture o f  zerum bone (ZM ) w ith  O xi for 48 h. Cells w ere harvested  and 
stained w ith  propid ium  iodide (PI) and A nnex in  V  (AV). C 1-C 4 indicates the quadran t on 
the flow  cytom eter im age. C l =  H ealthy cells; C2 =  C ells conjugated w ith  A V  only; C3 =  
C ells conjugated  w ith A V  and stained w ith PI; C4 =  C ells stained w ith PI only.
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7.4.1.4 The effect of zerumbone and oxaliplatin on Caco-2 PARP-1 
cleavage
A s sh o w n  in  (F ig u re  7 9 -A ) 2 0  p M  o x a lip la tin  a n d  th e  c o m b in a tio n  o f  2 0  p M  
o x a lip la tin  w ith  10 p g /m l z e m m b o n e  c a u se d  P A R P -1  c le a v a g e  a t 2 4  h. In  c o n tra s t, 
a f te r  48  h  o f  o x a lip la tin  a lo n e  a n d  z e m m b o n e  w ith  o x a lip la tin  e o m b in e d  tre a tm e n ts , 
e v id e n c e  o f  P A R P -1  e le a v a g e  w a s  c le a r  in  a ll s a m p le s  e x c e p t fo r  b o th  u n tre a te d  c e lls  
a n d  5 p M  o x a lip la tin  (F ig u re  7 9 -B ).
6 7
-PARP-1
-PARP-1 Cleavaee
4 -  P-actin
PARP-1
-P.A.RP-1 Cleavage 
P-actin
Figure 79 W estern blot of PARP-1 expression and cleavage in Caco-2 cells 
treated with zerumbone and oxaliplatin.
Protein  w as ex tracted  from  Caco-2 cells after treatm ent w ith  zem m bone (ZM ) and  
oxalip latin  (Oxi) for 24 h  panel (A) and  48 h  panel (B). V arious concentrations o f  Z M  and 
O xi treatm ents w ere applied (1= untreated  cells, 2= 5p M  O xi, 3= 20pM  O xi, 4= 5p M  O xi + 
5pg  ZM , 5= 5p M  Oxi +  lO pg ZM , 6= 2 0pM  Oxi +  5 p g  ZM , 7= 2 0 p M  Oxi +  lO pg ZM ). 
PARP-1 =  116, 89 kDa. Equal protein  loading (20 pg) per lane w as determ ined using  P-actin  
expression.
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7.4.1.5 The effect of zerumbone and oxaliplatin on Caco-2 autophagy
In  th is  e x p e rim e n t, L C 3  e x p re s s io n  w a s  a s se s se d  to  d e te c t th e  fo rm a tio n  o f  
a u to p h a g o so m e s . T h e  re su lts  o f  W e s te rn  b lo tt in g  a n a ly s is  re v e a le d  th a t th e re  w a s  an  
u p - re g u la tio n  in  L C 3  e x p re s s io n  in  C a e o -2  c e lls  t re a te d  w ith  th e  c o m b in a tio n  o f  
o x a lip a tin  a n d  z e ru m b o n e  a f te r  2 4  h  (F ig u re  8 0 -A ). S im ila r  re su lts  w e re  o b se rv e d  
a f te r  4 8  h  o f  c o m b in e d  tre a tm e n t, w h e re  L C 3  w a s  u p - re g u la te d  c o m p a re d  w ith  
u n tre a te d  c e lls  (F ig u re  8 0 -B ).
B
LC3 ■«saBss
< — P-actin
LC3
P-actin
Figure 80 Western blot of LC3 expression in Caco-2 cells treated with 
zerumbone and oxaliplatin.
Protein  w as ex tracted  from  C aco-2 cells after treatm ent w ith  zerum bone (ZM ) and 
oxalip latin  (O xi) for 24 h panel (A) and 48 h panel (B). V arious concentrations o f  ZM  and 
O xi treatm ent w ere applied (1= untreated  cells, 2= 5pM  O xi, 3= 20pM  Oxi, 4= 5p M  Oxi + 
5pg  ZM , 5= 5pM  O xi +  lO pg ZM , 6= 2 0 p M  O xi +  5p g  ZM , 7= 2 0pM  O xi +  lO pg ZM ). 
L C 3= 14, 16 kDa. Equal p ro tein  loading (20 pg) per lane w as de tenn ined  using  P-actin  
expression.
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7.4 .1 .6  T he effect o f  zerum b on e and oxalip latin  on caco-2  caspase-9  
activity
Caspase-9 plays a major role in apoptotic cell death. In this experiment, caspase-9 
expression was detected in Caeo-2 cells treated with combinations of oxaliplatin and 
zerumbone. The results show that no major changes in caspase-9 expression occurred 
in response to treatment at 24 h compared with untreated cells (Figure 81-A). Only a 
slight reduction in caspase-9 expression was observed at the highest zerumbone and 
oxilaplatin at 24 h (lane 7). In contrast, caspase-9 expression decreased compared 
with untreated control at 48 h at lower concentrations of both compounds (Figure 81- 
B). Caspase-9 expression was reduced to such an extent that it could not be detected 
at 48 h of 5 pM oxaliplatin with 10 pg/ml zerumbone, 20 pM oxaliplatin with 5 
pg/ml zerumbone, and 20 pM oxaliplatin with 10 pg/ml zerumbone treatments 
(Figure 81-B). No caspase-9 cleavage was observed by Western blotting for any 
treatment combination at either time point.
A B
1 J .) 4 ? O /
< -  p-actin ^ltÊÊÊÊÊÊÊÊÊttÊIIÊÊlÊÊÊÊlKÊÊÊÊÊÊÊÊÊ^
Cas9
p-actin
Figure 81 Western blot of caspase-9 expression in Caco-2 cells treated with  
zerumbone and oxaliplatin.
Protein  w as ex tracted  from  Caco-2 cells after treatm ent w ith  zerum bone (ZM ) and 
oxalip latin  (O xi) for 24 h panel (A) and 48 h panel (B). V arious concentrations o f  
zerum bone and oxalip latin  treatm ent w ere applied ( 1=  untreated  cells, 2=  5p M  O xi, 3=  
20 p M  O xi, 4=  5pM  Oxi +  5p g  ZM , 5=  5pM  Oxi + lO pg ZM , 6=  20pM  Oxi + 5 p g  ZM , 1=  
2 0 p M  Oxi +  lO pg ZM ). C aspase-9 = 47, 37 kDa. Equal protein  loading (20 pg) p er lane w as 
determ ined using P-actin expression.
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7.4 .1 .7  T he effect o f  zerum b on e and oxalip latin  on caco-2 caspase-8  
activity
Caspase- 8  activity was measured by Western blotting following treatment of Caco-2 
cells with combinations of oxaliplatin and zerumbone at various concentrations. The 
results showed no major difference in caspase- 8  expression between treated and 
untreated Caeo-2 cells after 24 h (Figure 82-A). The results also showed no 
difference in caspase- 8  expression between combined oxaliplatin and zerumbone- 
treated cells and untreated control cells after 48 h (Figure 82-B). No caspase-8 
cleavage was observed by Western blotting at any treatment concentration or 
exposure time.
A
1 2 3 4 5 6 7
B
1 2 3 4 5 6 7
B-actinp-actin
Figure 82 Western blot of caspase-8 expression in Caco-2 cells treated with 
zerumbone and oxaliplatin.
Protein  w as ex tracted  from  Caco-2 cells after treatm ent w ith  zerum bone (ZM ) and 
oxalip latin  (Oxi) for 24 h panel (A) and 48 h  panel (B). V arious concentrations o f  Z M  and 
O xi treatm ent w ere applied (1= untreated  cells, 2= 5pM  O xi, 3= 20pM  Oxi, 4= 5p M  O xi + 
5pg  ZM , 5= 5pM  O xi +  lO pg ZM , 6= 2 0 p M  O xi + 5pg  ZM , 7= 20pM  O xi +  lO pg ZM ). 
C aspase-8 =  57 kDa. Equal p ro tein  loading (20 pg) p er lane w as d e tenn ined  using  p -actin  
expression.
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7.4.2 The synergistic effects of zerumbone and cisplatin in the Huh- 
7 cell line
7.4.2.1 Z eru m b on e and cisp latin  in h ib it the p ro liferation  o f  H u h -7  cells
Huh-7 cells treated with 10, 50 and 100 pM cisplatin showed dose-dependent 
cytotoxicity as measured by LDH release at 24 h (Figure 83-A). At 24 h, cisplatin 
treatment caused significant decrease in cell viability at 50 and 100 pM (65.1%, 
p<0.05 and 52%, P<0.01, respectively) compared with 85.6% viability for untreated 
cells (Figure 73-A).
Huh-7 cells were incubated with 5 and 10 pg/ml zerumbone in addition to 50 and 
100 pM cisplatin in order to assess the combination effects of a chemotherapy agent 
and zerumbone on the cell line. The combined treatment caused no significant 
increase in cytotoxicity by LDH release eompared with eisplatin only at 24 h (Figure 
83-B).
After 48 h of the combination treatment there was a signifieant increase in cell death, 
compared with the cisplatin treatments only (Figure 84-B). The cytotoxicity 
increased to 68.1% (p<0.05), 81.3% and 84.4%, (both p<0.01) at 5 pg/ml zerumbone 
with 100 pM cisplatin, 10 pg/ml zerumbone with 50 pM cisplatin, and 10 pg/ml 
zerumbone with 100 pM cisplatin, respectively (Figure 84-B). In comparison, cell 
death was only 32.2% (p< 0.05) and 52.7% (p< 0.001) at 50 and 100 pM cisplatin 
only, respectively (Figure 84-A).
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Figure 83 Zerumbone and cisplatin inhibit the proliferation o f Huh-7 ceils at 
24h.
LD H  release w as m onitored  at 24 h after cells w ere treated  w ith  zerum bone (ZM ) and 
C isplatin  (Cis). (A) C ells treated  w ith various Cis concentrations only, (B) cells treated  w ith  
5 andlO  pg/m l ZM  and various Cis concentrations. The data represen t the m ean ± SEM  
(n=3) o f  three independent experim ents. C om parisons o f  m eans w ere m ade using  a one-w ay 
A N O V A  follow ed by  B onferroni's post hoc test (* =  p < 0.05; ** =  p < 0.01; *** =  p < 
0.001 versus control).
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Figure 84 Zerumbone and cisplatin inhibit the proliferation o f H uh-7 cells at 
48h.
LDH release was monitored at 48 h after cells were treated with zerumbone (ZM) and Cis. 
(A) Cells treated with various Cis concentrations only, (B) cells treated with 5 and 10 pg/ml 
ZM and various Cis concentrations. The data represent the mean ± SEM (n=3) of three 
independent experiments. Comparisons of means were made using a one-way ANOVA 
followed by Bonferroni's post hoc test (* = p < 0.05; ** = p < 0.01; *** = p < 0.001 versus 
control).
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T.4.2.2 M orp h olog ica l changes associated  w ith  C isp latin  and Z eru m b on e  
toxicity
The effects o f the zerumbone with cisplatin combination on Huh-7 cell degeneration 
were associated with increased concentrations o f  the two components. For example, 
the number o f viable cells was decreased at 10 pg/ml zerumbone with 100 pM 
cisplatin, compared with 100 pM cisplatin alone at 24 h as presented in (Figure 85). 
Similar results were also obtained at 48 h using the same treatment concentrations 
(Figure 86).
Control
S' ^' -- g
5 ng ZM 10 Jig ZM
50 pM Cis 50 Cis + 5 fig ZM 50 fiM Cis + 10 fig ZM
100 fiM C is + 5 fig ZM 100 fiM Cis + 10 fig ZM100 fiM C is
Figure 85 Microscopy images for the effects of zerumbone and cisplatin on the 
Huh-7 cell line at 24h.
C ells w ere treated  w ith  various concentrations o f  zerum bone (ZM ) only, or c isp latin  (C is) 
only, o r treated w ith m ixture o f  ZM  w ith  Cis for 24h. Im ages w ere captured using  a L eica 
D M LB  m icroscope (m agnification: lOX) and com pared against untreated  (control) cells.
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Figure 8 6  Microscopy images for the effects of zerumhone and cisplatin on the 
Huh-7 cell line at 48h.
C ells w ere treated  w ith  various concentrations o f  zerum bone (ZM ) only or C is only, or 
treated  w ith m ixture o f  ZM  w ith  Cis for 48h. Im ages w ere captured using  a L eica  D M LB  
m icroscope (m agnification: I OX) and com pared against untreated  (control) cells.
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T.4.2.3 The effects of zerumbone and cisplatin on Huh-7 PS 
externalisation.
The number of early and late apoptotic cells (C2 and C3 quadrants, respectively) was 
increased by the combination of zerumbone and cisplatin treatment compared with 
cisplatin treatment only. For example, after 24 h treatment with 100 pM cisplatin 
with 1 0  pg/ml zerumbone, the number of cells in the late apoptotic cell population 
was higher compared with 100 pM cisplatin only (Figure 87).
PS externalisation was associated with dose and time in the combined treatment 
group. Figure 8 8  shows a significant increase in the late apoptotic cell population 
after 48 h of 50 pM cisplatin with 10 pg/ml zerumbone treatment compared to 50 
pM cisplatin only.
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Figure 87 Zerumbone and cisplatin treatment is associated with 
phosphatidylserine externalization at 24 h.
Flow  cytom etry  im ages show  H uh-7 cells treated  w ith  various concentrations o f  C isplatin  
(C is) only, or w ith  a m ixture o f  zerum bone (ZM ) w ith  C is for 24 h. C ells w ere harvested  and 
stained w ith p ropid ium  iodide (PI) and A nnexin  V  (A V ). C 1-C 4 indicates the quadran t on 
the flow  cytom eter im age. C l =  H ealthy cells; C2 =  C ells conjugated  w ith  A V  only; C3 = 
Cells conjugated w ith A V  and stained w ith PI; C4 =  C ells stained w ith PI only.
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Figure 8 8  Zerumbone and cisplatin treatment is associated with 
phosphatidylserine externalization at 48 h.
Flow  cytom etry  im ages show  H uh-7 cells treated  w ith various concentrations o f  C isplatin  
(C is) only, o r w ith  a m ixture o f  zerum bone (ZM ) w ith  Cis for 48 h. C ells w ere harvested  and 
stained w ith propid ium  iodide (PI) and A nnex in  V  (A V ). C 1-C 4 indicates the quadrant on 
the flow  cytom eter im age. C l =  H ealthy  cells; C2 =  C ells conjugated w ith  A V  only; C3 = 
C ells conjugated  w ith  A V  and stained w ith  PI; C4 =  C ells stained w ith  PI only.
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7.4.2.4 T he effect o f  zerum b on e and cisp latin  on H uh-7  P A R P-1 cleavage
As shown in (Figure 89) all treatments of eisplatin only and combined treatments of 
eisplatin and zerumbone caused PARP-1 cleavage at 24 h (A) and 48 h (B). At both 
time points, PARP-1 cleavage was detected in all lanes other than (lane 1), 
corresponding to untreated cells (Figure 89-A and B).
- p . w - i
-P.ARP-l Cleavage 
-  P-actin
P.-yiP-l
-P.ARP-1 Cleavage 
- P-actin
Figure 89 Western blot of PARP-1 expression in Huh-7 cells treated with 
zerumbone and cisplatin.
Protein  w as extracted  from  H uh-7 cells after treatm ent w ith  zerum none (ZM ) and cisplatin  
(C is) for 24 h  panel (A) and 48 h  panel (B). V arious concentrations o f  ZM  and C is treatm ent 
w ere applied  (1= untreated  cells, 2= 50pM  Cis, 3= lOOpM Cis, 4= 50pM  Cis +  5pg  ZM , 5= 
50pM  Cis + lO pg ZM , 6= lOOpM Cis + 5p g  ZM , 7= lOOpM Cis +  lO pg ZM ). P A R P -1=  
116, 89 kDa. Equal pro tein  loading (20 gg) p er lane w as determ ined  using  P-actin 
expression.
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7.4.2.S T he effect o f  zerum b on e and cisp latin  on H uh-7  au tophagy
In this experiment, LC3 expression was assessed to detect the formation of 
autophagosomes. The results revealed that there was no change in LC3 expression in 
Huh-7 cells treated with the combination of cisplatin and zerumbone after 24 h, 
compared with untreated cells (Figure 90-A). Similar results were observed after 48 
h of combined treatments (Figure 90-B). LC3 expression appeared stable at both 
time points and did not respond to treatment.
p-actin p-actin
Figure 90 Western blot of LC3 expression in Huh-7 cells treated with 
zerumbone and cisplatin.
Protein  w as extracted from  H uh-7 cells after treatm ent w ith  zerum bone (ZM ) and cisplatin  
(C is) for 24 h panel (A) and 48 h panel (B). V arious concentrations o f  ZM  and Cis treatm ent 
w ere applied (1= untreated  cells, 2= 50gM  Cis, 3= lOOgM Cis, 4= 50gM  Cis + 5g g  ZM , 5= 
50gM  Cis + lO gg ZM , 6 = lOOgM Cis +  5g g  ZM , 7= lOOgM Cis + lO gg ZM ). L C 3=  14, 16 
kD a Equal protein  loading (20 gg) p er lane w as determ ined using  P-actin expression.
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T.4.2.6 T he effect o f  zerum b on e and cisp latin  on H uh-7  caspase-9  activ ity
In this experiment, caspase-9 expression was detected in Huh-7 cells treated with 
combinations of cisplatin and zerumbone. The results show that there was a decrease 
in caspase-9 expression when cells were treated with combined zerumbone and 
cisplatin for 24 h (Figure 91-A). In addition, decreased caspase-9 expression was 
also observed at the higher concentrations of zerumbone and cisplatin after 48 h 
(Figure 91-B). No caspase-9 cleavages were observed by Western blotting at either 
time or with any cisplatin, or zerumbone plus cisplatin concentration.
B
2 3 4 5 6 1 2 3 4 5 6
• Cas9 
p-actin
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Figure 91 W estern blot of caspase-9 expression in Huh-7 cells treated with 
zerumbone and cisplatin.
Protein  w as extracted  from  H uh-7 cells after treatm ent w ith  zem m bone (ZM ) and cisplatin  
(C is) for 24 h  panel (A) and 48 h panel (B). V arious concentrations o f  ZM  and C is treatm en t 
w ere applied  (1= untreated  cells, 2= 50gM  Cis, 3= lOOgM Cis, 4= 50gM  Cis + 5 g g  Z M , 5= 
50gM  Cis +  lO gg ZM , 6= lOOgM Cis + 5 g g  ZM , 7= lOOgM Cis +  lO gg ZM ). C aspase-9  = 
47, 37 kD a. Equal protein  loading (20 gg) per lane w as determ ined  using P-actin expression.
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7.5 Discussion
Natural products such as the zerumbone ginger extract may have a low number of 
side effects and low toxicity, which is likely to modulate the factors that are 
important for cell proliferation, differentiation, and cell death. In contrast, 
conventional chemotherapy for cancer treatment has serious side effeets such as hair 
loss, injury to the gastrointestinal traet, infection, nausea and vomiting, etc. The 
increase in cancer multidrug resistanee, decreased efficacy, increasing treatment 
failure of modem dmgs, and the complex multiple interconnected nodes of the cell 
signalling network have raised the possibility of exploring alternative modes of 
treatment and using multiple modulating strategies to achieve clinical success 
(Alexander and Friedl, 2012).
The present study investigated the synergic effects of conventional chemotherapy 
(oxaliplatin and cisplatin) in combination with zemmbone, extracted from a 
generally recognised as ‘safe plant’ (ginger), which is potentially benefieial in the 
prevention and treatment of cancer. The results suggested that the combined effects 
of the dmg and zemmbone were much greater than their individual effects (Figure 76 
and Figure 8 6 ), suggesting the role of multiple components and their synergistie 
mode of action to cause stronger benefieial effects. Increased beneficial effects could 
have oecurred through additive or synergistie aetions of various chemical compounds 
acting at single or multiple target sites associated with a physiological process 
(Hemaiswarya and Doble, 2006; Marx et ah, 2013).
The anti-proliferation effects of zemmbone plus oxaliplatin or Cisplatin were much 
greater than chemotherapy alone. Effects occurred in a time- and dose-dependent
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manner, which indicates that the combination was more efficient at targeting 
multiple pathways in both cancer cell lines (Caco-2 and Huh-7) to induce cell death. 
This conclusion was supported by light microscopy images illustrating decreased cell 
viability and the shrinkage of both Caco-2 and Huh-7 cells after treatment with 
zerumbone and chemotherapeutic agent, whieh are indicators of cell death by 
apoptosis. A previous synergic study shows that some phytochemicals such as 
curcumin possess inhibitory activities against topoisomerase enzymes, which are 
essential for the normal survival of the cell (Hemaiswarya and Doble, 2006). 
Curcumin may also block the functioning and maintenance of some crucial 
macromolecules, whieh results in the inhibition other essential pathways and 
increases the efficacy of drugs used for cancer treatment (Hemaiswarya and Doble, 
2006).
The classieal annexin V apoptosis assay was used to assess the PS externalisation as 
a marker of cell death by apoptosis. The results of treating cells with both zerumbone 
and chemotherapeutic agent revealed that both cell underwent the classical apoptosis 
pathway. Populations of cells undergoing early and late apoptosis increased in a 
time- and dose-dependent manner (Muhammad Nadzri et aL, 2013).
To further investigate the cell death induced by the synergie effects of both 
compounds, PARP-1 expression was assessed by Western blotting. Caco-2 cells 
treated with the combination of zerumbone (10 pg/ml) and oxaliplatin (20 pM) 
showed that PARP-1 was detected in all Caeo-2 treated for 48 h but not in those 
treated for 24 h. This indieates that the synergic effects for these eoncentrations need 
longer than 24 h for their effects on PARP-1 cleavage to be mediated. In contrast.
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Huh-7 cells treated with the zerumbone and cisplatin combination showed PARP-1 
cleavage in all treated cells after 24 and 48 h, as a result of cell death.
Expression of the autophagic marker, microtubule-associated protein 1 light chain 3 
(LC3) was used in the present study to assess the synergic effects of zerumbone and 
chemotherapy on autophagy activation. Caco-2 cells showed increased LC3 
expression in response to the synergic treatment eompared with oxaliplatin alone. In 
contrast, LC3 expression in Huh-7 liver cancer cells did not change 24 and 48 h of 
synergic treatment.
Caspase-9 expression in Caco-2 cells was significantly decreased to the extent that it 
could not be detected at high doses of zerumbone and oxaliplatin after 48 h of 
treatment. Similar results were observed in Huh-7 cells after combined treatment 
with zerumbone and cisplatin. Caspase-9 is a member of the caspase family of 
eysteine proteases, which are implicated in apoptosis and cytokine processing 
(Kuida, 2000). Activation of caspase-9 requires recruitment to a complex that 
includes Apaf-1, dATP and cytochrome C, which is released from mitochondria after 
apoptotic stimulation (Cain et ah, 2002).
Caspase- 8  was assessed as a marker of the activation of the extrinsie apoptosis cell 
death pathway. The result showed that there are was no major change in easpase- 8  
expression in Caco-2 cells after 24 and 48 h of combined treatment. Caspase- 8  is 
known as an initiator caspase, which is involved in the activation of other caspases 
such as caspase-3, -6 , and -7 (Shi, 2002).
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7.6 Conclusion
The anti-proliferation effects of the synergistic combinations of zerumbone plus 
either oxaliplatin or cisplatin were much greater than the drug alone and was in time 
and dose dependent manner in Caco-2 and Huh-7 cells.
Decreased cell volume numbers and the shrinkage of both Caco-2 and Huh-7 were 
deteeted after treated with zerumbone combined with oxaliplatin or cisplatin.
Caco-2 and Huh-7 cell lines treated with the combined synergistic compounds 
(zerumbone combined with oxaliplatin or cisplatin) underwent classical apoptosis 
pathway. Early and late apoptosis cell death population detected by 
phosphatidylserine (PS) externalisation were visible and increased in a time and dose 
dependent manner.
Caco-2 cells treated with the combination of zerumbone and oxaliplatin shows 
PARP-1 cleavages detected in all treated cells after 48 h. Huh-7 treated with 
zerumbone and cisplatin combination also showed PARP-1 cleavage in all treated 
cells after 24 and 48 h as a result of cell death.
Caeo-2 colon cancer cell line showed increased LC3 expression in the combined 
zerumbone-dmg treatment compared to oxaliplatin alone. In contrast, Huh-7 liver 
eaneer eell line showed no significant difference in the LC3 expression after 24 and 
48 h of the combined treatment and eisplatin on its own.
For the combined treatment, caspase-9 expression in Caco-2 cells decreased 
significantly compared to the control. There was no caspase-9 expression for very 
high concentrations of zerumbone (lOpg/ml) and oxaliplatin (20 pM) combinations 
after 48 h of treatment. Similar results were observed in Huh-7 cells after combined
202
The effect of ginger active component (Zerumbone) on human cancer cells
treatment with zerumbone and eisplatin, where no caspase-9 expression was detected 
after the increased combined dose (50 pM cisplatin with 10 pg/ml zerumbone) 
treatment 24 and 48h.
No major change in Caco-2 cells caspase- 8  expression after 24 and 48 h of combined 
treatment (zerumbone and oxaliplatin) was observed.
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8 General Discussion and 
Conclusions
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8.1 General discussion
Natural products may play a role in the prevention of eaneer. Additionally, natural 
products can potentially provide many of the lead chemical structures for use as 
templates for the construction of novel compounds with better biological properties. 
Based on this theory, and previous anti-cancer research, we focused our interest in 
the present study on ginger and in particular on zerumbone, with the aim of 
investigating its effeet on human cancer in vitro.
8.1.1 Identification of zerumbone in ginger from the UK and the 
USA
It is commonly believed that health benefits of ginger come from Zingiber officinale 
Rose. It has also been reported that zerumbone, a sesquiterpene isolated from 
Zingiber zerumbet Smith ginger (Prasannan et ah, 2012) possesses anti-cancer and 
other health properties. To the best of our knowledge, no previous research has been 
conducted to detect zerumbone in Zingiber officinale Rose. Therefore, in the present 
study we investigated if zerumbone could be detected in the ginger species.
Surprisingly, zerumbone was not detected in ginger specimens from the UK or the 
USA by any of the detection methods (HPLC, LC-MS, and GC-MS) when using 
either extraction procedure (Methanol and ethanol solvents). In contrast, a 
zerumbone standard was detected with a clear and sharp peak by HPLC, LC-MS, and 
GC-MS. These results indicate that each ginger species contains unique components 
and that zerumbone, which is present in zingiber zerumbet Smith is absent in 
zingiber officinale Rose.
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8.1.2 Antioxidant Properties of Zerumbone
Limited work has been undertaken on the component zerumbone as an antioxidant. 
Therefore, several antioxidant mechanisms, such as H2O2 , ferrous chelating and 
reducing power were assayed to understand the action of zerumbone as an 
antioxidant. Our findings suggest that zerumbone can be used as natural antioxidants 
in plaee of synthetic alternatives. The a,p-unsaturated carbonyl group of zerumbone 
is believed to be responsible for the mechanism of action of this interesting 
sesquiterpenoid (Murakami et ah, 2002).
Zerumbone scavenging activity measured in this research showed that zerumbone 
has the ability to scavenge DPPH free radicals and H2O2 in a concentration- 
dependent manner. The ferrous chelating activity of zerumbone was also measured, 
where zerumbone chelating increased in a concentration dependent manner. 
Terpenoid is known to either directly bind the metal ions or indirectly suppress their 
chelating reactivity by inhibiting their coordination positions (Joshi et ah, 2008). The 
reducing power assay is usually used to assess the ability of an antioxidant to donate 
an electron, which is known to have a direct association between antioxidant activity 
and reducing power (Gulcin et al, 2011). The reducing power of zerumbone 
increased in a concentration dependent manner.
8.1.3 The effect of zerumbone on the human colon adenocarcinoma 
Caco-2 cell line
The aim of this study was to investigate the cell death pathway oecurring in Caco-2 
cells in response to treatment with zerumbone and to examine its anti-proliferative 
effects. It is still not well known if zerumbone-induced Caco-2 cell death oceurs
206
The effect of ginger active component (Zerumbone) on human cancer cells
through apoptosis, necrosis or a newly identified form of cell death such as 
necroptosis.
The main finding was that 5 and 10 pg/ml killed the Caco-2 colon cancer cells but 
had little or no effect on normal colon cells (HCEC). Thus we can show the 
selectivity of zerumbone in targeting cancer cells. Because of the exciting potential 
of zerumbone as an anti-cancer agent, the mechanism of cell death via neeroptosis, 
apoptosis, and autophagy pathways was further explored and is diseussed below. It 
should be highlighted that this is the first time that the mechanism of necroptosis, 
which has only become the focus of studies recently, has been reported for 
zerumbone.
This study provides evidence that different concentrations of zerumbone (5 and 10 
pg/ml) and exposure times induce different forms of cell death. We believe that 
zerumbone-indueed cell death in the Caco-2 cell line occurred via a mixture of 
neeroptosis, apoptosis, and autophagy pathways at different times. It appears that 
zerumbone triggered necroptosis at an early stage and had faster kinetics compared 
with other forms of Caco-2 cell death (Degterev et aL, 2008). Furthermore, if  Caco-2 
cells escaped from cell death via necroptosis, zerumbone preferentially indueed 
apoptosis but also induced autophagy.
It is therefore appears from these preliminary results that zerumbone has the ability 
to induce a range of cell death forms in Caco-2 cells. The form of cell death induced 
depends on Caco-2 cell behaviour. In addition, it is believed that necroptosis and 
apoptosis work in conjunction to ensure that cell death occurs via either pathway if 
one is compromised (Hitomi et al., 2008). This knowledge of cell death mechanism 
is important for the development of new drugs.
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Zerumbone-induced cell death was found to be concentration dependent. Therefore, 
cell death at low zerumbone treatments (5 pg/ml) showed an increase in LDH level, 
a decrease in cells number, absence of phosphatidylserine externalization, absence of 
DNA fragmentation, no PARP-1 eleavage, high mitochondrial membrane potential, 
arrest of the cell cycle at G2/M phase, decreased intracellular ROS production but 
increased mitochondrial ROS production. There were no changes in the expression 
level of the LC3 (autophagy marker) and no caspase-9, 3, 8  cleavage was detected. 
LDH release was decreased when used in combination with Nec-1 (necroptosis 
pathway inhibitor) with 5 pg/ml zerumbone. Thus, low zerumbone treatment (5 
pg/ml) induce cell death oecurred via a caspase-independent pathway indicating the 
possibility of necroptosis cell death pathway.
Nocodozol, which known to inhibit the formation of the microtubule cytoskeleton 
and microtubule stabilisation have been used to target cell proliferation (Wood et aL, 
2001). Similar to nocodozol, zerumbone potentially has the ability to inhibit 
microtubule formation, which ultimately results in cell cyele arrest in G2/M phase. 
During mitosis, both chromatin segregation and cytokinetie fission require assembly 
of specialised cytoskeletal struetures composed of microtubules, mierofilaments, and 
centrosomes (Piel et ah, 2001; Casenghi et ah, 2003).
Another possible mechanism of cell eycle arrest in zerumbone-treated Caco-2 cells is 
that cell proliferation also requires mitogenic signals such as ROS to achieve DNA 
replieation during S phase of the cell cycle (Chiarugi et al., 2003). Depending on the 
cellular context, ROS can promote either cell survival or cell death (Mazure and 
pouyssegur, 2010). Caco-2 cells contain high levels of ROS that could be responsible 
for the activation of the cell cycle as a survival mechanism. Inhibition of ROS
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production has been shown to inhibit cell proliferation (Brar et aL, 2003; Scaife et 
aL, 2004). However, in the present study, zerumbone redueed overall ROS but 
increased mitochondrial ROS (mtROS). mtROS production is important for a 
necrotic cell death response (Han et aL, 2009). Therefore, the increased mtROS level 
induced by zerumbone treatment may result in the induction of cell death by 
necroptosis.
The following table summaries the effeets of zerumbone on the human cancer cell 
lines Caco-2 compare to non-carcinomatous colon cell line (HCEC):
Caco-2 HCEC
The cytotoxicity o f zerumbone on the cells Dose-dependent
increased
No/ limited 
effects
The effects o f zerumbone on cells 
morphology
Dose-dependent
effects
No/ limited 
effeets
The effects o f zerumbone on ROS 
production
Dose-dependent
decreased
limited effects
The higher dose of zemmbone treatment (10 pg/ml) exhibited PARP-1 cleavage, low 
mitochondrial membrane potential, arrest of the cell cycle at S/G2 phase, an increase 
in the expression level of LC3, an inerease in LDH release level, decreased cells 
number, absence of phosphatidylserine externalization, absence of DNA 
fragmentation, decreased intracellular ROS production and increased mitochondrial 
ROS production, and no caspase-9, 3, 8  cleavage was deteeted. There was no 
decrease in LDH level when is used 10 pg/ml zemmbone in combination with Nec-1. 
Thus, the high dose of zemmbone treatment (10 pg/ml) indueed cell death via a 
caspase-dependent pathway, which was triggered via TNF and easpase activation, 
indicated by PARP-1 cleavage (Takada et aL, 2005). All these faetors indicate the 
possibility of apoptosis or autophagy cell death pathway. PARP-1 eleavage usually
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needs caspase activation either through the TNF reeeptor or cytochrome C release. 
Moreover, a previous study showed that zerumbone eaused PARP-1 cleavage via up- 
regulation of TNF. PARP-1 has also been implicated in apoptotie pathways when 
cleavage occurs by the action of caspase 3, which is activated via the extrinsic 
pathway through death receptor signalling (Zhang et aL, 2011). Previous studies 
showed that eells undergo either apoptosis or necrosis depending on mitochondrial 
dysfunction (Giordano et aL, 2007), where cells may undergo early necrotic cell 
death due to mitochondrial membrane potential (AYm) collapse, while viable cells 
survive with relatively intact mitochondria and undergo apoptosis at later time 
points.
The connection of autophagy with the processes of necroptosis is still unclear, but it 
may work to clear up the debris of cell death via necroptosis or apoptosis (Degterev 
et aL, 2008; Dunai et aL, 2011).
The following diagram summaries the effects of zerumbone on the human cancer cell 
lines Caeo-2:
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Effect o f zerumbone on Caco-2
5jig/ml
Increase LDH 
Decrease cell number 
G2/M arrest 
Decrease ROS 
Increase mtROS
-ve PS
-ve DNA fragmentation 
-ve PARP-I cleavage 
-ve Caspase- 3,8,9 
High MMP
-ve LC3
Decreased LDH~1 
when combined 
with Nec-I
Apoptosis
Autophagy
Necroptosis
lOpg/ml
Increase LDH 
Decrease cell number 
S/G2 arrest 
Decrease ROS 
Jncrease mtROS
4-ve PARP-I cleavage 
Low MMP
No decrease in LDH when 
combined with Nec-I
+ve LC3
-ve PS
-ve DNA fragmentation
8.1.4 The effect of zerumbone on the human hepatoma Huh-7 cell 
line
This study was aim to examine the cell death pathway induced in different 
zerumbone-treated human cancer cells and to assess the anti-proliferative effects of 
zerumbone on liver cancer Huh-7 cells. Zerumbone exhibited anticancer activity in 
Huh-7 liver cancer cells. Our findings and previous researches support the idea that 
the effects of zerumbone are not cell-type specific and may have the potential to treat 
different types of cancers such as colon cancer, breast cancer, lung adenocarcinoma, 
human myeloid and human embryonic kidney (Kirana et al., 2003; Murakami et al., 
20 04; Takada et al., 2005).
The low dose of zerumbone (5 pg/ml) showed that the cell death pathway occurred 
in the absence of PARP-1 cleavage and intact mitochondrial membrane.
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In contrast, a high dose of zerumbone treatment (10 pg/ml) exhibited PARP-1 
cleavage and loose mitochondrial membrane. Confirmation of PARP-1 involvement 
at the higher concentrations supports the previous observation in chapter 4 that the 
cell death pathway in Huh-7 cells is caspase-dependent at 10 pg/ml treatments 
(indicating apoptosis), while at the 5 pg/ml concentration the cell death pathway is 
caspase-independent. A similar result was reported when zerumbone induced 
glioblastoma multiform (GBM) apoptotic cell death, which needs caspase-3 
activation (Weng et ah, 2 0 1 2 ).
Both low and high zerumbone treatments (5 and 10 pg/ml) shared some similar 
effects including increase LDH release, increased cytoplasmic and mitochondrial 
ROS production, increased LC3 expression and an increase of the early and late 
apoptotic cells population which was detected by the phosphatidylserine 
extemalization assay.
Synthesis LC3 is cleaved at the carboxyl terminus to produce the cytosolic LC3-I 
form. LC3-I is converted to LC3-II during autophagy, via lipidation through a 
ubiquitin-like system that includes Atg7 and Atg3. This modification permits LC3-II 
to existent in autophagosomes; the changes from LC3 to the lower migrating form 
LC3-II are marks of autophagy (Kabeya et al., 2004; Hsieh et al., 2012; Shimizu et 
a l, 2 0 1 2 ).
In some cases, generation of ROS can inhibit tumour cells by reducing mitochondrial
membrane potential, triggering a cascade of mitochondria-associated events,
contributing to mitochondrial damage, causing the release of cytochrome C, which
subsequently activating the apoptosis cascade (Zhang et al., 2013). Similar increases
in ROS production have been detected by other researchers in various cancer cell
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lines (Thoppil and Bishayee, 2011). Hoffmann et ah (2002) elucidated that an 
appropriate dose of zerumbone induced a high intracellular redox potential, which 
halted the proliferation of cancer cells. In addition, Sakinah et a l (2007) also 
reported that zerumbone significantly showed anti-proliferation activity in HepG2 
human liver cancer cell lines.
Both treatments also shared the decrease of cells volume, decreased in LDH level in 
the combined zerumbone and Nec-1, absence of DNA fragmentation, arrested a 
small number of cells in the S/G2 cell cycle phase and levels of activated caspase-3, 
caspase-9 and caspase- 8  remained similar to untreated control levels.
Linkermann et a l study showed that Nec-1 prevented osmotic nephrosis and 
formation of contrast-induced AKI (CIAKI) (Linkermann et a l, 2013) via the 
inactivation of receptor-interacting protein 1 (RIPl). Inactivation of RLPl will 
prevent its interaction with RIP3, and prevent the formation of a necrosome, which is 
essential for necroptosis (Wu et a l, 2012).
Sakinah et a l  (2007) demonstrated that zerumbone induced DNA fragmentation in a 
different HepG2 cell line at a concentration of 3.45 pg/ml, and found that the 
cleavage of double-stranded DNA in apoptotic DNA degradation was due to 
activation of endogenous Ca^^/Mg^^ dependent endonucleases. However, similar to 
our finding Kamalidehghan et a l  (2012) revealed that no DNA fragmentation was 
detected in HepG2 cells treated with zerumbone at the same concentration, despite 
the presence of caspase-3 during apoptosis. Kamalidehghan et a l  (2012) 
hypothesised that fragmentation of condensed chromatin may not be necessary to 
indicate apoptosis in vitro.
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These finding support our previous hypotheses that zerumbone-induced cell death in 
the Huh-7 cell line occurred through a combination of necroptosis, apoptosis, and 
autophagy pathways at different times.
The following diagram summaries the effects of zerumbone on the human cancer cell 
lines Huh-7:
Increase LDH 
Increase ROS 
Increase mtROS
+ve PS
-ve PARP cleavage 
High MMP
+ve LC3 }
Decreased LDH ~1 
w hen com bined p  
with Nec-1 -J
A poptosis
5pg/ml
Effect o f  zerum bone on Huh-7
Autophagy
Necroptosis
Increase LDH 
Increase ROS 
Increase mtROS
-t-ve PS
+ve PARP-1 cleavage 
Low^LM P
J j - v e  LC3
{D ecreased LDH w hen com bined w ith N ec-I
8.1.5 The effect of zerumbone on the human endothelial cell line 
EA.hy926
The human endothelial EA.hy926 cell line was used as a model for angiogenic 
processes in vitro, to assess the effects of zerumbone as an anticancer agent that 
works via blocking the development of blood vasculature in cancer cell. 
Angiogenesis process is a key element in the formation of a new vascular network to
214
The effect of ginger active component (Zerumbone) on human cancer cells_______________
supply oxygen, nutrients, and immune cells, in addition to removal of waste products 
for cancer cells (Nishida et ah, 2006).
EA.hy926 cell line treated with zerumbone revealed similar effects by low and high 
concentrations (5 and 10 pg/ml). Both treatments increased LDH level, number of PS 
positive cells, intracellular and mtROS production and cell cycle arrest in S/G2 
phase. In contrast, both treatments decreased number of viable cells, mitochondrial 
membrane polarisation and there were slight or no detection of caspase-9 expression 
and no DNA fragmentation. The treatments also decreased LDH level when 
zerumbone combined with Nec-1. In addition, the effect of zerumbone on EA.hy926 
cells showed PARP-1 cleavage after 48 h of treatments and LC3 up-regulation after 
24 h of treatments.
The zerumbone S/G2 phase-arrest illustrates the involvements of cyclin-dependent 
kinases E-CDK2 and cyclin A-CDK2. These factors regulate S phase and keep 
replication to only once per cell cycle. Such checks and balances help to prevent 
inappropriate DNA replication. The S/G2 checkpoint is controlled by ataxia 
telangiectasia mutated serine-protein kinase (ATM) signals through a comprehensive 
network of proteins, which lead to CDK2 inhibition and ultimately the prevention of 
DNA synthesis (Woo and Poon, 2003).
The absence of the DNA fragmentation result supports either the idea that DNA 
fragmentation is not necessary for the apoptosis pathway, or that EA.hy926 cell 
death induced by zerumbone occurred via different cell death pathway such as 
necroptosis (Buonanno et al., 2008; Christofferson and Yuan, 2010; Dunai et al., 
2011). The decreased cell death induced by zerumbone and Nec-1 combined 
treatment compared with zerumbone alone indicates that zerumbone may causes cell
215
The effect of ginger active component (Zerumbone) on human cancer cells
death by necroptosis pathway, and that Nee-1 protects cells from this fate. Nee-1 
speeifieally inhibits necroptosis, but does not affect apoptosis or autophagy 
(Degterev et al., 2008). PARP-1 cleavage observation which showed that the 
cleavage of PARP-1 can be detected at 10 pg/ml zerumbone treatment but not at 5 
pg/ml. This finding indicates that combinations of cell death pathways are 
responsible for the induction of cell death by zerumbone in the EA.hy926 cell line.
The following diagram summaries the effects of zerumbone on the human cancer cell 
lines EA.hy926:
Effect of zerumbone on EA.hy926
5 pg/ml
+ve PS
-ve DNA fragmentation 
+ve PARP-1 cleavage/48 h 
Low MMP
+ve LC3/24 h
Decreased LDH 
when combined 
with Nec-1
1 1
lOpg/ml
Increase LDH 
Increase ROS 
Increase mtROS 
S/G2 arrest
Decreased cell number
Apoptosis
Autophagy
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8.1.6 The synergistic effects of zerumbone and chemotherapy agents 
in a human cancer cell line
Natural products such as the zerumbone ginger extract may have a low number of 
side effects and low toxicity. In contrast, conventional chemotherapy for cancer 
treatment has serious side effects such as hair loss, injury to the gastrointestinal tract, 
infection, nausea and vomiting, etc. The increase in cancer multidrug resistance, 
decreased efficacy and the increasing treatment failure of modem dmgs have raised 
the possibility of discovering alternative approaches of treatment strategies in order 
to achieve clinical success (Alexander and Friedl, 2012). The present study 
investigated the synergic effects of conventional chemotherapy (oxaliplatin and 
cisplatin) in combination with zemmbone, which is potentially beneficial in the 
prevention of cancer on human colon and liver cancer cell lines (Caco-2 and Huh-7).
Our main finding, suggested that the combined effects of zemmbone and dmg were 
much greater than their individual effects (Figure 76 and Figure 8 6 ), suggesting the 
role of multiple components and their synergistic mode of action to cause stronger 
beneficial effects. Increased beneficial effects could have occurred through additive 
or synergistic actions of several chemical compounds acting at single or multiple 
target sites associated with a physiological process (Hemaiswarya and Doble, 2006; 
Maix et al., 2013).
The light microscopy images revealed the decreased cell viability of both Caco-2 and 
Huh-7 cells after treatment with zemmbone and chemotherapeutic agent, which 
supported that the anti-proliferation effects of zemmbone plus oxaliplatin or cisplatin 
were much greater than chemotherapy alone. The PS extemalisation, as a marker of 
cell death also showed that cells treated with both zemmbone and chemotherapeutic
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agent that underwent the classical apoptosis pathway by increased in cells 
populations in early and late apoptosis. The synergic effects of Caco-2 cells treated 
with the combination of zerumbone (10 pg/ml) and oxaliplatin (20 pM) showed that 
PARP-1 cleavage needs 48 h for their effects to be mediated. The synergic effects of 
zerumbone and chemotherapy on autophagy activation in Caco-2 cells showed 
increased LC3 expression in response to the synergic treatment compared with 
oxaliplatin alone.
A previous synergic study shows that some phytochemicals such as curcumin 
possess inhibitory activities against topoisomerase enzymes, which are essential for 
the normal survival of the cell (Hemaiswarya and Doble, 2006). Curcumin may also 
block the functioning and maintenance of some crucial macromolecules, which 
results in the inhibition other essential pathways and increases the efficacy of drugs 
used for cancer treatment (Hemaiswarya and Doble, 2006).
Caspase-9 expression in Caco-2 cells was significantly decreased to the extent that it 
could not be detected at high doses of zerumbone and oxaliplatin after 48 h of 
treatment. Similar results were observed in Huh-7 cells after combined treatment 
with zerumbone and cisplatin. Caspase-9 is a member of the caspase family of 
cysteine proteases, which are implicated in apoptosis and cytokine processing 
(Kuida, 2000). Activation of caspase-9 requires recruitment to a complex that 
includes Apaf-1, dATP and cytochrome C, which is released from mitochondria after 
apoptotic stimulation (Cain et al., 2002).
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8.2 General conclusions
Identification of zerumbone In ginger from the UK and the USA
• Zerumbone was not detected in ginger of the Zingiber officinale Rose species 
from the UK and the USA, despite using different extraction solvents and 
three different powerful techniques (HPLC, LC-MS, and GC-MS). It is 
therefore unlikely that the potential therapeutic properties of ginger of the 
Zingiber offlcinale Rose species are mediated via zerumbone.
Antioxidant Properties of Zerumbone
• Zerumbone demonstrated the ability to act as an antioxidant free radical 
scavenger with similar activity to synthetic antioxidant BHT but with lower 
activity compared to the natural antioxidant trolox in both DPPH and H2O2 
assays.
• Zerumbone exhibited Fe^^ chelating activity, this activity was significantly 
lower than that of the known chelator, EDTA at the concentrations used.
• Zerumbone also acted as a reducing agent in a dose dependent manner.
The effect of zerumbone on the human colon adenocarcinoma Caco- 
2 cell line
• Caco-2 cells treated with zerumbone die via a form of programmed cell death 
that is similar to classical apoptosis and necrosis. This cell death is 
characterised by cell shrinkage, absence of membrane asymmetry and DNA 
fragmentation.
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• Zerumbone-induced cell death occurred via a new form or a mix of cell death 
pathways. In addition, different concentrations of zerumbone induced specific 
mechanisms that resulted in death by different means. However, different cell 
lines responded differently and induced different forms of cell death.
• Cell cycle arrest in the G2/M phase after treatment with 5 pg/ml zerumbone 
was responsible for the initiation of Caco-2 cell death.
The effect of zerumbone on the human hepatoma Huh-7 cell line
• Zerumbone inhibited the proliferation of Huh-7 cells in a time- and
concentration-dependent manner.
• Cell death mechanism via the apoptosis pathway was illustrated by the 
morphology of Huh-7 cell shrinkage, PS extemalisation; lose mitochondrial
membrane potential for 10 pg/ml zemmbone treatments and PARP-1
cleavage.
• Zemmbone increased the production of intracellular ROS and mtROS 
significantly in a time- and dose-dependent manner, which may have 
contributed to cell death. Zemmbone arrested the Huh-7 cell cycle in S/G2 
phase which led to cell death.
• Zemmbone 5 and 10 pg/ml up-regulated LC3 expression in a time- and dose- 
dependent in Huh-7 cells; this showed the mechanism of cell death via 
autophagy.
• Caspase-3, caspase-9 and caspase- 8  expression remained unchanged after 24 
and 48 h of treatment with zemmbone (5 and 10 pg/ml) compared with 
untreated control Huh7 cells. Therefore, cell death was independent of 
caspase activity.
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• DNA fragmentation was not detected in the Huh-7 cell line after zerumbone 
treatment, which indicates that cell death occurred via another cell death 
pathway in additions to apoptosis, sueh as necroptosis. The absence of 
PARP-1 cleavage at 5 pg/ml zerumbone treated cells also supports the 
necroptosis cell death pathway. Cell death in Huh-7 cells decreased when 
zerumbone treated cells were co-treated with an anti-neeroptosis agent Nec-1, 
which suggests that cell death occurred via the necroptosis pathway.
The effect of zerumbone on the human endothelial cell line 
EA.hv926
• Zerumbone significantly increased the LDH level of EA.hy926 cells in a time 
and dose dependent manner indicating cell death of cancer cells.
• Anti-proliferation effects of zerumbone were clearly observed by morphology 
change in EA.hy926 cells. Zerumbone induced PS extemalisation in 
EA.hy926 cells, which underwent a classical apoptosis pathway; in particular, 
early and late apoptosis phases increased in a time and dose dependent 
manner.
• Zemmbone induced PARP-1 cleavage in 10 pg/ml of zemmbone treatment 
but not in 5 pg, which indicates that the combination of cell death pathways 
were induced by zemmbone in EA.hy926 cell line.
• Zemmbone induced mitochondrial-dependent cell death following loss of 
mitochondrial membrane potential in a dose-dependent manner. Zemmbone 
was able to increase the ROS and mtROS production as a mechanism to 
induce cell death in EA.hy926.
• Zemmbone arrested the cell cycle in S/G2 phase in EA.hy926 cells. No DNA 
fragmentation was detected in EA.hy926 cells after zemmbone treatment.
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• No major change in LC3 expression after zerumbone treatment in EA.hy926 
cell lines was observed indicating that cell death by the autophagy pathway 
did not occur.
• EA.hy926 showed a significant decrease in cell death after zerumbone and 
Nec-1 combined treatment compared to zerumbone alone, which indicates 
that zerumbone killed the EA.hy926 cells via the necroptosis cell death 
pathway.
The synergistic effects of zerumbone and chemotherapy agents in a 
human cancer cell line
• The anti-proliferation effects of the synergistic combinations of zerumbone 
plus either oxaliplatin or a cisplatin drug were much greater than the drug 
alone and was in time and dose dependent manner in Caco-2 and Huh-7 cells.
• Decreased cell volume numbers and the shrinkage of both Caco-2 and Huh-7 
were detected after treated with zerumbone combined with oxaliplatin or 
cisplatin.
• Caco-2 and Huh-7 cell lines treated with the combined synergistic 
compounds (zerumbone combined with oxaliplatin or cisplatin) underwent 
classical apoptosis pathway. Early and late apoptosis cell death population 
detected by phosphatidylserine (PS) extemalisation were visible and 
increased in a time and dose dependent manner.
• Caeo-2 cells treated with the combination of zemmbone and oxaliplatin 
shows PARP-1 cleavages detected in all treated cells after 48 h. Huh-7 
treated with zemmbone and cisplatin combination also showed PARP-1 
cleavage in all treated cells after 24 and 48 h as a result of cell death.
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• Caco-2 colon cancer cell line showed increased LC3 expression in the 
combined zerumbone-drug treatment compared to oxaliplatin alone. In 
contrast, Huh-7 liver cancer cell line showed no significant difference in the 
LC3 expression after 24 and 48 h of the combined treatment and cisplatin on 
its own.
• For the combined treatment, caspase-9 expression in Caco-2 cells decreased 
significantly compared to the control. There was no caspase-9 expression for 
very high concentrations of zerumbone (10 pg/ml) and oxaliplatin (20 pM) 
combinations after 48 h of treatment. Similar results were observed in Huh-7 
cells after combined treatment with zerumbone and cisplatin, where no 
caspase-9 expression was detected after the increased combined dose (50 pM 
cisplatin with 10 pg/ml zerumbone) treatment 24 and 48h.
• No major change in Caco-2 cells caspase- 8  expression after 24 and 48 h of 
combined treatment (zerumbone and oxaliplatin) was observed.
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8.3 Future work
Suggested directions for future work:
1. For a more detailed picture of zerumbone effects on human cancer, it is 
necessary to investigate its effect in vivo. This can be carried out using animal 
models.
2. Investigation of the role of important proteins like Ripl and Rip2 in 
necroptosis cell death pathway.
3. Completion of the assessment of the other factors that contribute to the cell 
death pathway sueh as, TNF-alpha, p53, p27, p21 and cytochrome C.
4. Assessment of the effects of zerumbone on epigenetics by assessing the 
HD AC protein.
5. Assessment of the effects of zerumbone on the transcription level by 
performing real-time PCR on selected genes from the microarray results.
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Appendix 1
Professional visiting scholar at Plants for Human Health Institute in
Kannapolis, North Carolina State University at the NC Research Campus,
conducting research on “Extract and characterise the ginger components and
sesquiterpenes”, 1-27 November 2012.
Conferences Posters participations:
1. FHMS Festival of Research, 2012. “Cytotoxicity of ginger active component 
{Zingiber zemmbet Smith) on human cancer cell lines”.
2. 19th Euro-conference on Apoptosis “Metabolism, Epigenetics and Cell 
Death” 8 th Training course on 'Concepts and Methods in Programmed Cell 
Death” September 14-17, 2011 Stockholm, Sweden. “The effects of ginger 
active component (Zerumbone) on Caco-2 human colon cancer cells”.
3. EACR Anticancer Agents Research Congress: 13-16 October 2011. “The 
Effects of Ginger Active Component (zerumbone) On Caco-2 Human Colon 
Cancer Cells”.
4. FHMS Festival of Research on the 5th July 2011. “Effect of ginger {Zingiber 
zemmbet Smith) on human colon caco-2 cells”.
Conference attendants:
• BACR special meeting, 19 May 2011 Royal society of Medicine, London. 
“Cancer Epigenetics”
Oral presentations:
• Nutritional Sciences Division Research Meetings, 22nd September. 
“The effects of ginger components on Caco-2 colon cancer cells”
• Lab demonstration, food science module 2010/2011
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Appendix 2
e e
Annexin V-PE 
conjugate •  #
Plasma
membrane
Apoptosis 
 ►
Externatization of 
phosphatidylserine
ffit t
Cytoplasm Cytoplasm
Dead Cells Late Apoptotic
Viable Cells Early Apoptotic
Schematic representation for annexin-V assay.
Obtained from (www.abgab.com)
254
The effect of ginger active component (Zerumbone) on human cancer cells
Appendix 3
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Appendix 4
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Appendix 5
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Adapted from Cell Signaling Technology
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Appendix 6
Procaspase -  3 ,7  Cleaved
I caspase-9
Death signalling
Cytochrom C 
release
m em brane
cytoplasm
APAF-1
Procaspase-9
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caspase -  3 ,7
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Appendix 7
Some peaks detected by LC-MS and GC-MS.
LC-MS
Compound name(+) ESI-MS 
(m/z)
277 [6]-Shogaol
279 [6]-Paradol
291 1 -Dehydro-[6] -gingerdione
313 Methyl-[6]-shogoal
333 [10]-Shogaol
373 [10]-Gingerol
Adapted from He et al. (1998) and Jiang et al. (2005).
GC-MS Compound name
194 Zingerone
294 [6]-Gingerol
Adapted from Bilehal et al. (2011).
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